Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics
- Evaluate the expected performance of Edwards Lifesciences (EW) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 04/18/2025
|
Eight-Year Data Confirm Long-Term Durability of Edwards' RESILIA Tissue
- CAIRO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly improved long-term outcomes compared to those receiving non-RESILIA tissue bioprosthetic valves. For more than 65 years, Edwards has been the leader in heart valve innovations. To create a more durable heart valve, Edwards developed the RESILIA tissue technology more than two d.
- 04/18/2025
|
Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings
- EW's first-quarter 2025 performance is likely to have gained from growth drivers across its businesses amid macroeconomic headwinds.
- 04/17/2025
|
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2025 after the market closes on Wednesday April 23, 2025, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com. About Edwards L.
- 04/16/2025
|
Edwards SAPIEN M3 Receives CE Mark, Becoming World's First Transfemoral Transcatheter Mitral Valve Replacement System
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company's SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter edge-to-edge (TEER) therapy. Leveraging the company's SAPIEN technology, the SAPIEN M3 system is the world's first approved transcatheter valve replacement ther.
- 04/14/2025
|
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
- CHICAGO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new scientific evidence presented and published during the American College of Cardiology's (ACC) Annual Scientific Session & Expo, addressing the critical needs of patients with structural heart disease. Without treatment, 1 in 10 patients experiencing symptoms of severe aortic stenosis (AS) may die within five weeks. However, the symptoms of severe AS can be difficult to detect and may progress rapidly and unpredict.
- 03/31/2025
|
Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead
- Health Care and Energy sectors outperform in 2025, with the Health Care Select Sector SPDR Fund ETF up 7% YTD, while Edwards Lifesciences lags. Despite a solid Q4 earnings beat, EW's shares remain undervalued with a reduced P/E multiple of 33x, yielding a price target of $84. Key risks include slower TAVR growth in Japan and hospital demand uncertainties, but long-term sales growth targets remain optimistic.
- 03/22/2025
|
Scaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor
- SUNNYVALE, Calif.--(BUSINESS WIRE)--Intuitive Ventures today announced the appointment of Terri Burke, former head medtech investments at Epidarex Capital and a seasoned operator, as Senior Partner and Dr. Ross Jaffe, a co-founder of Versant Ventures, as Venture Advisor. Both medtech veterans, they will help support the continued growth of Intuitive Ventures in investing in start-ups reimagining the future of minimally invasive care. With more than two decades of medtech investing and operation.
- 03/06/2025
|
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 45th Annual Health Care Conference on Tuesday, Mar. 4, 2025. Scott Ullem, chief financial officer, is scheduled to present at 9:50 a.m. ET. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day. About Edwards Lifesciences Edwards Life.
- 02/25/2025
|
Should Edwards Lifesciences Stock Remain in Your Portfolio Now?
- EW stock is on investors' radars due to the promising structural heart opportunities following the divestment of the Critical Care arm.
- 02/20/2025
|
Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength
- On Tuesday, Edwards Lifesciences EW reported fourth-quarter sales of $1.39 billion, beating the consensus of $1.36 billion. This represents a 9% year-over-year growth, supported by gains in all product groups.
- 02/12/2025
|
EW Stock Up on Q4 Earnings and Revenue Beat, Margins Crash
- Edwards Lifesciences reports strong contributions from all product groups ??? TAVR, TTMT and surgical structural heart?
- 02/12/2025
|
Edwards Lifesciences Corporation (EW) Q4 2024 Earnings Call Transcript
- Edwards Lifesciences Corporation (NYSE:EW ) Q4 2024 Earnings Conference Call February 11, 2025 5:00 PM ET Company Participants Mark Wilterding - Senior Vice President, Investor Relations Bernard Zovighian - Chief Executive Officer Scott Ullem - Corporate Vice President and Chief Financial Officer Daveen Chopra - Corporate Vice President, TMTT Larry Wood - Corporate Vice President and Group President of TAVR and SSH Conference Call Participants David Roman - Goldman Sachs Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Pito Chickering - Deutsche Bank Travis Steed - Bank of America Vijay Kumar - Evercore ISI Frederick Wise - Stifel Matthew Miksic - Barclays Matthew Taylor - Jefferies Joanne Wuensch - Citibank Mark Wilterding [Starts Abruptly] included in the press release and accompanying financial schedules and then use the remaining time for Q&A. Please note that management will be making forward-looking statements that are based on estimates, assumptions and projections.
- 02/11/2025
|
Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 02/11/2025
|
Edwards Lifesciences beats profit estimate on strength in heart devices
- Edwards Lifesciences beat analysts' estimate for fourth-quarter profit on Tuesday, helped by strong demand for its artificial heart valves and other medical devices.
- 02/11/2025
|
Edwards Lifesciences Reports Fourth Quarter Results
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024. Highlights and Outlook Q4 sales grew 9% to $1.39 billion1, better than expected, with strength across all product groups Q4 TAVR sales grew 6%; constant currency2 sales grew 5% Q4 TMTT sales grew 88% to $105 million with increasing contribution to Edwards' growth Q4 EPS of $0.581; adjusted2 EPS of $0.59, driven by strong top-line performance Presen.
- 02/11/2025
|
Insights Into Edwards Lifesciences (EW) Q4: Wall Street Projections for Key Metrics
- Besides Wall Street's top -and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
- 02/06/2025
|
ITGR or EW: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integer (ITGR) and Edwards Lifesciences (EW). But which of these two stocks is more attractive to value investors?
- 02/04/2025
|
Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2024 after the market closes on Tuesday February 11, 2025, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com. About Edwar.
- 02/04/2025
|
Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion
- Edwards Lifesciences Corporation EW shares are trading higher on Thursday.
- 01/30/2025
|
Edwards Lifesciences Q4 Earnings Set to Benefit From TAVR Growth
- Favorable hospitalization trend, strong adoption of transcatheter heart valves and improved procedural volume are expected to have aided EW in the fourth quarter.
- 01/30/2025
|
Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for
- Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/28/2025
|
Should Edwards Lifesciences Stock Stay in Your Portfolio Now?
- EW stock is on investors' radar courtesy to the promising structural heart opportunities post the divestment of the Critical Care arm.
- 01/16/2025
|
Wedgewood Partners: Q4 And 2024 Top Performers And Detractors
- Texas Pacific Land and Taiwan Semiconductor Manufacturing were top contributors for both the quarter and the year, showcasing strong earnings growth and strategic market positioning. Despite Texas Pacific Land's strong performance, we sold our positions due to overvaluation driven by index additions, with plans to re-invest post-market correction. Edwards Lifesciences' EARLY TAVR trial results highlight significant potential for expanding aortic stenosis treatment, positioning the company for double-digit earnings growth in the coming years.
- 01/16/2025
|
Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025. Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived v.
- 01/07/2025
|
4 Strong Stock Charts For 2025 (Technical Analysis)
- After analyzing weekly charts of all S&P 500 stocks, I found only 21 with “confidently optimistic” patterns, indicating a challenging market in 2025. My focus is on stocks with better odds of appreciating in 2025, not on beating the S&P 500 or achieving the highest returns. The four stocks I picked out from the crowd —Edwards Lifesciences, Jabil Inc., Kroger, and Darden Restaurants—show strong technical potential despite mixed fundamentals.
- 12/30/2024
|
Is the Options Market Predicting a Spike in Edwards (EW) Stock?
- Investors need to pay close attention to Edwards (EW) stock based on the movements in the options market lately.
- 12/20/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, NY / ACCESSWIRE / December 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116540&wire=1 or contact Joseph E. Levi, Esq.
- 12/13/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK, NY / ACCESSWIRE / December 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116519&wire=1 or contact Joseph E. Levi, Esq.
- 12/13/2024
|
Investors who lost money on Edwards Lifesciences Corporation (EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / December 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116460&wire=1 or contact Joseph E. Levi, Esq.
- 12/13/2024
|
EW DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important December 13 Deadline in Securities Class Action – EW
- NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 12/13/2024
|
Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?
- Edward Lifesciences' robust potential in Structural heart and long-term strategy instill optimism.
- 12/13/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation (EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116440&wire=1 or contact Joseph E. Levi, Esq.
- 12/13/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation (EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116381&wire=1 or contact Joseph E. Levi, Esq.
- 12/13/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation (EW)
- NEW YORK, NY / ACCESSWIRE / December 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116367&wire=1 or contact Joseph E. Levi, Esq.
- 12/13/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116344&wire=1 or contact Joseph E. Levi, Esq.
- 12/13/2024
|
FINAL REMINDER EW DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Edwards Lifesciences Corporation Investors to Participate in the Class Action Lawsuit
- NEW YORK CITY, NY / ACCESSWIRE / December 13, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 12/13/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK , Dec. 13, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 12/13/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116279&wire=1 or contact Joseph E. Levi, Esq.
- 12/12/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116263&wire=1 or contact Joseph E. Levi, Esq.
- 12/12/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and certain of its officers.
- 12/12/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116253&wire=1 or contact Joseph E. Levi, Esq.
- 12/12/2024
|
EW FINAL DEADLINE FRIDAY: Edwards Lifesciences Investors have Until Tomorrow December 13 before Expiration of Court Deadline - Contact BFA Law
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 12/12/2024
|
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On July 24, 2024, Edwards Lifescien.
- 12/12/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116220&wire=1 or contact Joseph E. Levi, Esq.
- 12/12/2024
|
Faruqi & Faruqi Reminds Edwards Lifesciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 12, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 12/12/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116212&wire=1 or contact Joseph E. Levi, Esq.
- 12/12/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Lawsuit Over TAVM Platform Disclosures, Deadline Pending – Hagens Berman
- EW Investors with Losses Encouraged to Contact the Firm Before Dec. 13, 2024 Deadline EW Investors with Losses Encouraged to Contact the Firm Before Dec. 13, 2024 Deadline
- 12/12/2024
|
EW Deadline in 1 Days: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation (EW) Investors of Filing Deadline in Class Action Lawsuit
- RADNOR, PA / ACCESSWIRE / December 12, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 12/12/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116161&wire=1 or contact Joseph E. Levi, Esq.
- 12/12/2024
|
DEADLINE TOMORROW: Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / December 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/12/2024
|
Lost Money on Edwards Lifesciences Corporation(EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116153&wire=1 or contact Joseph E. Levi, Esq.
- 12/12/2024
|
EW COURT DEADLINE TOMORROW: BFA Law Alerts Edwards Lifesciences Investors of Tomorrow's December 13 Securities Fraud Class Action Deadline (NYSE:EW)
- NEW YORK, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 12/12/2024
|
FINAL EW DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Edwards Lifesciences Corporation. Investors to Join the Class Action Lawsuit
- NEW YORK CITY, NY / ACCESSWIRE / December 12, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 12/12/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116125&wire=1 or contact Joseph E. Levi, Esq.
- 12/12/2024
|
INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - EW
- SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), have until this upcoming Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v. Edwards Lifesciences Corporation, No. 24-cv-02221 (C.D. Cal.), the Edwards Lifesciences class action lawsuit charges Edwards Lifesciences and certain of Edwards Lifesciences' top executives with violations of the Securities Exchange Act of 1934.
- 12/12/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK , Dec. 12, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 12/12/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116101&wire=1 or contact Joseph E. Levi, Esq.
- 12/11/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- BENSALEM, Pa. , Dec. 11, 2024 /PRNewswire/ -- Law Offices of Howard G.
- 12/11/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116073&wire=1 or contact Joseph E. Levi, Esq.
- 12/11/2024
|
Investors With Losses Are Invited To Join The Schall Law Firm In A Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / December 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/11/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116062&wire=1 or contact Joseph E. Levi, Esq.
- 12/11/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Lawsuit Over TAVM Platform Disclosures, Deadline Pending – Hagens Berman
- EW Investors with Losses Encouraged to Contact the Firm Before Dec. 13, 2024 Deadline SAN FRANCISCO, CA / ACCESSWIRE / December 11, 2024 / Investors in Edwards Lifesciences Corporation (NYSE:EW) contend that the medical device giant misled them about the growth prospects of its core product, the Transcatheter Aortic Valve Replacement (TAVR) platform. A class action lawsuit has been filed, accusing the company of securities fraud and claiming that executives painted a misleading picture of TAVR's future growth potential.
- 12/11/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116045&wire=1 or contact Joseph E. Levi, Esq.
- 12/11/2024
|
EW SECURITIES FRAUD: Edwards Lifesciences Investors are Notified that the Company was Sued for Securities Fraud – Contact BFA Law by December 13 Deadline if You Lost Money
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 12/11/2024
|
EW Deadline: Rosen Law Firm Urges Edwards Lifesciences Corporation (NYSE: EW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
- NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024. Edwards describes itself as an “international company that researches, develops, provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions.” For more informa.
- 12/11/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=116023&wire=1 or contact Joseph E. Levi, Esq.
- 12/11/2024
|
EW Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation (EW) Investors of Filing Deadline in Class Action Lawsuit
- RADNOR, Pa., Dec. 11, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024.
- 12/11/2024
|
FRIDAY INVESTOR DEADLINE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - EW
- SAN DIEGO, CA / ACCESSWIRE / December 11, 2024 / Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE:EW) securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), have until this upcoming Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 12/11/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit.
- 12/11/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115990&wire=1 or contact Joseph E. Levi, Esq.
- 12/11/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115928&wire=1 or contact Joseph E. Levi, Esq.
- 12/11/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lifesciences Corporation Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115924&wire=1 or contact Joseph E. Levi, Esq.
- 12/11/2024
|
EW Shareholders Have Opportunity to Lead Edwards Lifesciences Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESSWIRE / December 11, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 12/11/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK, NY / ACCESSWIRE / December 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115880&wire=1 or contact Joseph E. Levi, Esq.
- 12/10/2024
|
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
- NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Edwards Lifesciences Corp (“Edwards” or the “Company”) (NYSE: EW) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). Investors have until December 13 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- 12/10/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lifesciences Corporation Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / December 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115849&wire=1 or contact Joseph E. Levi, Esq.
- 12/10/2024
|
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
- LOS ANGELES, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”).
- 12/10/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / December 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/10/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- NEW YORK , Dec. 10, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), of the important December 13, 2024 lead plaintiff deadline. So what: If you purchased Edwards securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 12/10/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115799&wire=1 or contact Joseph E. Levi, Esq.
- 12/10/2024
|
EW FRAUD ALERT: Edwards Lifesciences was Sued for Securities Fraud - Contact BFA Law about the Lawsuit before December 13 Class Action Deadline
- NEW YORK, NY / ACCESSWIRE / December 10, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 12/10/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115789&wire=1 or contact Joseph E. Levi, Esq.
- 12/10/2024
|
EW DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important December 13 Deadline in Securities Class Action – EW
- NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 12/10/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join – Contact The Gross Law Firm
- NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW).
- 12/10/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115763&wire=1 or contact Joseph E. Levi, Esq.
- 12/10/2024
|
EW Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation (EW) Investors of Filing Deadline in Class Action Lawsuit
- RADNOR, Pa. , Dec. 10, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024.
- 12/10/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115706&wire=1 or contact Joseph E. Levi, Esq.
- 12/10/2024
|
EW COURT ALERT: Suffer Losses on Your Edwards Lifesciences Investment? Contact BFA Law about the Class Action Lawsuit before December 13 Court Deadline (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 12/10/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115690&wire=1 or contact Joseph E. Levi, Esq.
- 12/10/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESSWIRE / December 10, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 12/10/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK , Dec. 10, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 12/10/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK, NY / ACCESSWIRE / December 9, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115616&wire=1 or contact Joseph E. Levi, Esq.
- 12/09/2024
|
Investors who lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / December 9, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115614&wire=1 or contact Joseph E. Levi, Esq.
- 12/09/2024
|
EW Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation (EW) Investors of Filing Deadline in Class Action Lawsuit
- RADNOR, PA / ACCESSWIRE / December 9, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 12/09/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 9, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115599&wire=1 or contact Joseph E. Levi, Esq.
- 12/09/2024
|
Investors Are Invited To Assist The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / December 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/09/2024
|
EDWARDS LIFESCIENCES (EW) Investors that Suffered Losses are Reminded of the December 13 Class Action Deadline - Contact BFA Law
- NEW YORK, NY / ACCESSWIRE / December 9, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 12/09/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 9, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115564&wire=1 or contact Joseph E. Levi, Esq.
- 12/09/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Lawsuit Over TAVM Platform Disclosures, Deadline Pending – Hagens Berman
- EW Investors with Losses Encouraged to Contact the Firm Before Dec. 13, 2024 Deadline EW Investors with Losses Encouraged to Contact the Firm Before Dec. 13, 2024 Deadline
- 12/09/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / December 9, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115559&wire=1 or contact Joseph E. Levi, Esq.
- 12/09/2024
|
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- 12/09/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / December 9, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115544&wire=1 or contact Joseph E. Levi, Esq.
- 12/09/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Dec. 9, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/09/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / December 9, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115533&wire=1 or contact Joseph E. Levi, Esq.
- 12/09/2024
|
INVESTOR DEADLINE FRIDAY: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - EW
- SAN DIEGO , Dec. 9, 2024 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), have until this Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 12/09/2024
|
Amentum Awarded $105M Research, Development, Test and Evaluation (RDT&E) Contract to Enhance Electronic Warfare (EW) Systems
- CHANTILLY, Va.--(BUSINESS WIRE)-- #AmentumWin--Amentum (NYSE: AMTM) has been awarded a $105 million contract to support Naval Surface Warfare Center Crane (NSWC Crane) Airborne Electronic Attack Systems Division (AEASD) to develop the next generation of Electronic Warfare (EW) and Intelligence, Surveillance, and Reconnaissance (ISR) mission and survivability systems. Amentum will replace aging or obsolete components and systems and install state-of-the-art technology to enhance the capabilities of EW and ISR.
- 12/09/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / December 9, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115474&wire=1 or contact Joseph E. Levi, Esq.
- 12/09/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 9, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115456&wire=1 or contact Joseph E. Levi, Esq.
- 12/09/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Stockholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 9, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 12/09/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - EW
- NEW YORK , Dec. 9, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 12/09/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115425&wire=1 or contact Joseph E. Levi, Esq.
- 12/08/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115410&wire=1 or contact Joseph E. Levi, Esq.
- 12/08/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Encourages Affected Stockholders To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / December 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/08/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / December 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115369&wire=1 or contact Joseph E. Levi, Esq.
- 12/08/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115363&wire=1 or contact Joseph E. Levi, Esq.
- 12/08/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115344&wire=1 or contact Joseph E. Levi, Esq.
- 12/08/2024
|
EW COURT UPDATE: The Edwards Lifesciences Class Action Deadline is December 13 –Investors with Losses are Urged to Contact BFA Law (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 12/08/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 8, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 12/08/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 EW
- NEW YORK, NY / ACCESSWIRE / December 7, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115324&wire=1 or contact Joseph E. Levi, Esq.
- 12/07/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / December 7, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115320&wire=1 or contact Joseph E. Levi, Esq.
- 12/07/2024
|
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / December 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/07/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / December 7, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115312&wire=1 or contact Joseph E. Levi, Esq.
- 12/07/2024
|
EW Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation (EW) Investors of Filing Deadline in Class Action Lawsuit
- RADNOR, PA / ACCESSWIRE / December 7, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 12/07/2024
|
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - EW
- SAN DIEGO, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v. Edwards Lifesciences Corporation, No. 24-cv-02221 (C.D. Cal.), the Edwards Lifesciences class action lawsuit charges Edwards Lifesciences and certain of Edwards Lifesciences' top executives with violations of the Securities Exchange Act of 1934.
- 12/07/2024
|
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options NEW YORK, NY / ACCESSWIRE / December 7, 2024 / If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE:EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 12/07/2024
|
EW CLASS ACTION ALERT: Lost Money on Edwards Lifesciences When the Stock Plummeted 31%? You May Have Been Affected by Fraud and Are Urged to Contact BFA Law
- NEW YORK, NY / ACCESSWIRE / December 7, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 12/07/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK, NY / ACCESSWIRE / December 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115233&wire=1 or contact Joseph E. Levi, Esq.
- 12/06/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and certain of its officers.
- 12/06/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115210&wire=1 or contact Joseph E. Levi, Esq.
- 12/06/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Lawsuit Over TAVM Platform Disclosures, Deadline Pending - Hagens Berman
- SAN FRANCISCO, CA / ACCESSWIRE / December 6, 2024 / Investors in Edwards Lifesciences Corporation (NYSE:EW) contend that the medical device giant misled them about the growth prospects of its core product, the Transcatheter Aortic Valve Replacement (TAVR) platform. A class action lawsuit has been filed, accusing the company of securities fraud and claiming that executives painted a misleading picture of TAVR's future growth potential.
- 12/06/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation (EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115183&wire=1 or contact Joseph E. Levi, Esq.
- 12/06/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Invites Shareholder Contributions
- LOS ANGELES, CA / ACCESSWIRE / December 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/06/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115156&wire=1 or contact Joseph E. Levi, Esq.
- 12/06/2024
|
EW COURT NOTICE: Edwards Lifesciences Investors with Losses are Notified of December 13 Court Deadline in Securities Fraud Class Action – Contact BFA Law (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 12/06/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation (EW) Shareholders
- NEW YORK, NY / ACCESSWIRE / December 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115144&wire=1 or contact Joseph E. Levi, Esq.
- 12/06/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 6, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 12/06/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK , Dec. 6, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 12/06/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- NEW YORK , Dec. 6, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), of the important December 13, 2024 lead plaintiff deadline. So what: If you purchased Edwards securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 12/06/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115092&wire=1 or contact Joseph E. Levi, Esq.
- 12/05/2024
|
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
- NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Edwards Lifesciences Corp (“Edwards” or the “Company”) (NYSE: EW) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). Investors have until December 13 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- 12/05/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115074&wire=1 or contact Joseph E. Levi, Esq.
- 12/05/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115050&wire=1 or contact Joseph E. Levi, Esq.
- 12/05/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- LOS ANGELES , Dec. 5, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") (NYSE: EW).
- 12/05/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115031&wire=1 or contact Joseph E. Levi, Esq.
- 12/05/2024
|
Edwards Lifesciences Corporation Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation Shareholders of Deadline in Securities Fraud Class Action Lawsuit
- RADNOR, Pa., Dec. 05, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024.
- 12/05/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit.
- 12/05/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114976&wire=1 or contact Joseph E. Levi, Esq.
- 12/05/2024
|
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 5, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 12/05/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114968&wire=1 or contact Joseph E. Levi, Esq.
- 12/05/2024
|
Investors With Losses Are Encouraged To Join The Schall Law Firm In A Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / December 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/05/2024
|
Lost Money on Edwards Lifesciences Corporation (EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114951&wire=1 or contact Joseph E. Levi, Esq.
- 12/05/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114916&wire=1 or contact Joseph E. Levi, Esq.
- 12/05/2024
|
PACS CLASS UPDATE: The January 13 Investor Deadline in the PACS Group Securities Fraud Class Action is Approaching - Contact BFA Law if You have Losses
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 12/05/2024
|
EW CLASS UPDATE: The December 13 Investor Deadline in the Edwards Lifesciences Securities Fraud Class Action is Approaching - Contact BFA Law if You have Losses
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 12/05/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 5, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 12/05/2024
|
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
- NEW YORK , Dec. 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 12/05/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114856&wire=1 or contact Joseph E. Levi, Esq.
- 12/04/2024
|
EW Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corporation
- RADNOR, Pa. , Dec. 4, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024.
- 12/04/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114852&wire=1 or contact Joseph E. Levi, Esq.
- 12/04/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Invites Stockholder Contributions
- LOS ANGELES, CA / ACCESSWIRE / December 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/04/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation (EW) Shareholders
- NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114845&wire=1 or contact Joseph E. Levi, Esq.
- 12/04/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114840&wire=1 or contact Joseph E. Levi, Esq.
- 12/04/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114813&wire=1 or contact Joseph E. Levi, Esq.
- 12/04/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW).
- 12/04/2024
|
Edwards Lifesciences Outlines Vision For Growth At Investor Conference
- On Wednesday, during its annual investor conference, Edwards Lifesciences Corporation EW detailed its strategy for sustained long-term growth and innovations in structural heart therapies.
- 12/04/2024
|
Investors who Lost Money on Edwards Lifesciences Corporation (EW) Should Contact Levi & Korsinsky About Pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114783&wire=1 or contact Joseph E. Levi, Esq.
- 12/04/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Lawsuit Over TAVM Platform Disclosures, Deadline Pending – Hagens Berman
- SAN FRANCISCO , Dec. 04, 2024 (GLOBE NEWSWIRE) -- Investors in Edwards Lifesciences Corporation (NYSE: EW) contend that the medical device giant misled them about the growth prospects of its core product, the Transcatheter Aortic Valve Replacement (TAVR) platform. A class action lawsuit has been filed, accusing the company of securities fraud and claiming that executives painted a misleading picture of TAVR's future growth potential.
- 12/04/2024
|
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
- LOS ANGELES, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”).
- 12/04/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Dec. 4, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/04/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114710&wire=1 or contact Joseph E. Levi, Esq.
- 12/04/2024
|
EW CLASS ACTION: A Securities Fraud Class Action Lawsuit has been Filed against Edwards Lifesciences – Investors with Losses can Contact BFA Law (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 12/04/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114702&wire=1 or contact Joseph E. Levi, Esq.
- 12/04/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 4, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 12/04/2024
|
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
- NEW YORK--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's focused strategy for long-term sustainable growth, provide an update on its technology pipeline to serve more patients and share financial guidance today during its annual investor conference. Edwards enters 2025, its first full year as a purely structural heart company, in a strong position with major growth drivers in Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral and Tric.
- 12/04/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114653&wire=1 or contact Joseph E. Levi, Esq.
- 12/03/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman
- EW Investors with Losses Encouraged to Contact the Firm Before Dec. 13, 2024 Deadline SAN FRANCISCO, CA / ACCESSWIRE / December 3, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 12/03/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114628&wire=1 or contact Joseph E. Levi, Esq.
- 12/03/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114623&wire=1 or contact Joseph E. Levi, Esq.
- 12/03/2024
|
Investors Are Urged To Reach Out To The Schall Law Firm About Leading A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / December 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/03/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114594&wire=1 or contact Joseph E. Levi, Esq.
- 12/03/2024
|
EW CLASS ACTION DEADLINE: BFA Law Reminds Investors of the December 13 Edwards Lifesciences Class Action Deadline – Contact the Firm if You have Losses
- NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 12/03/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / December 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114579&wire=1 or contact Joseph E. Levi, Esq.
- 12/03/2024
|
Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Edwards Lifesciences Corporation
- RADNOR, PA / ACCESSWIRE / December 3, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 12/03/2024
|
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options
- 12/03/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
- NEW YORK , Dec. 3, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 12/03/2024
|
Lead Plaintiff Deadline on December 13, 2024 for EW Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm
- RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffe.
- 12/02/2024
|
Edwards Lifesciences Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. December 13, 2024 Deadline to file Lead Plaintiff Motion.
- Investors can contact the law firm at no cost to learn more about recovering their losses
- 12/02/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- LOS ANGELES , Dec. 2, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") (NYSE: EW). Class Period: February 6, 2024 – July 24, 2024 Lead Plaintiff Deadline: December 13, 2024 If you wish to serve as lead plaintiff of the Edwards Lifesciences lawsuit, you can submit your contact information at www.glancylaw.com/cases/edwards-lifesciences-corporation/.
- 12/02/2024
|
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- 12/02/2024
|
EW INVESTOR NEWS: Edwards Lifesciences Investors are Notified that the Company has been Sued for Securities Fraud and are Urged to Contact BFA Law (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 12/02/2024
|
EW INVESTOR ALERT: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
- SAN DIEGO , Dec. 2, 2024 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, all dates inclusive (the "Class Period"), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 12/02/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK , Dec. 2, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 12/02/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / December 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114282&wire=1 or contact Joseph E. Levi, Esq.
- 12/01/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Dec. 01, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and certain of its officers.
- 12/01/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / December 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114268&wire=1 or contact Joseph E. Levi, Esq.
- 12/01/2024
|
Investors With Losses Are Invited To Join The Schall Law Firm In A Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / December 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 12/01/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / December 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114246&wire=1 or contact Joseph E. Levi, Esq.
- 12/01/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman
- SAN FRANCISCO, Dec. 01, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 – July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement (“TAVR”) platform.
- 12/01/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / December 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114238&wire=1 or contact Joseph E. Levi, Esq.
- 12/01/2024
|
EW FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Dec. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 12/01/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114182&wire=1 or contact Joseph E. Levi, Esq.
- 12/01/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
- NEW YORK, NY / ACCESSWIRE / December 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114188&wire=1 or contact Joseph E. Levi, Esq.
- 12/01/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114180&wire=1 or contact Joseph E. Levi, Esq.
- 12/01/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 1, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 12/01/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK, NY / ACCESSWIRE / December 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114184&wire=1 or contact Joseph E. Levi, Esq.
- 12/01/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK, NY / ACCESSWIRE / December 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114186&wire=1 or contact Joseph E. Levi, Esq.
- 12/01/2024
|
Investors who lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / November 30, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114177&wire=1 or contact Joseph E. Levi, Esq.
- 11/30/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Stockholder Participation
- LOS ANGELES, CA / ACCESSWIRE / November 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/30/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- NEW YORK, Nov. 30, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), of the important December 13, 2024 lead plaintiff deadline. So what: If you purchased Edwards securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 11/30/2024
|
Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuit Filed Against Edwards Lifesciences Corporation
- RADNOR, PA / ACCESSWIRE / November 30, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 11/30/2024
|
EW LEGAL DEADLINE: Edwards Lifesciences Class Action Deadline is Approaching – Contact BFA Law if You Suffered Losses (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/30/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit – EW
- NEW YORK, NY / ACCESSWIRE / November 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114152&wire=1 or contact Joseph E. Levi, Esq.
- 11/29/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman
- EW Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / November 29, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 11/29/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation (EW)
- NEW YORK, NY / ACCESSWIRE / November 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114117&wire=1 or contact Joseph E. Levi, Esq.
- 11/29/2024
|
Investors With Losses Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/29/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / November 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114100&wire=1 or contact Joseph E. Levi, Esq.
- 11/29/2024
|
Edwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, Pa., Nov. 29, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024.
- 11/29/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Nov. 29, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/29/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lifesciences Corporation Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / November 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114047&wire=1 or contact Joseph E. Levi, Esq.
- 11/29/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / November 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=114023&wire=1 or contact Joseph E. Levi, Esq.
- 11/29/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 29, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/29/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / November 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113973&wire=1 or contact Joseph E. Levi, Esq.
- 11/28/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113967&wire=1 or contact Joseph E. Levi, Esq.
- 11/28/2024
|
Lead Plaintiff Deadline Approaching in EW: Kessler Topaz Meltzer & Check, LLP Reminds Investors A Securities Fraud Class Action Has Been Filed Against Edwards Lifesciences Corporation
- RADNOR, Pa. , Nov. 28, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024.
- 11/28/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman
- SAN FRANCISCO, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now.
- 11/28/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113944&wire=1 or contact Joseph E. Levi, Esq.
- 11/28/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113930&wire=1 or contact Joseph E. Levi, Esq.
- 11/28/2024
|
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Nov. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 11/28/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 28, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/28/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113914&wire=1 or contact Joseph E. Levi, Esq.
- 11/28/2024
|
EW LEGAL UPDATE: A Lawsuit has been Filed Against Edwards Lifesciences for Securities Fraud - Contact BFA Law before Court Deadline (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/28/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 27, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113899&wire=1 or contact Joseph E. Levi, Esq.
- 11/27/2024
|
EW Case Alert: Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the Edwards Lifesciences Corporation Class Action
- SAN DIEGO , Nov. 27, 2024 /PRNewswire/ -- Robbins LLP reminds investors that a class action (Case No. 24-cv-02221) was filed on behalf of all investors who purchased or otherwise acquired Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024.
- 11/27/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK, NY / ACCESSWIRE / November 27, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113889&wire=1 or contact Joseph E. Levi, Esq.
- 11/27/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 27, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113873&wire=1 or contact Joseph E. Levi, Esq.
- 11/27/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- BENSALEM, Pa. , Nov. 27, 2024 /PRNewswire/ -- Law Offices of Howard G.
- 11/27/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / November 27, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113868&wire=1 or contact Joseph E. Levi, Esq.
- 11/27/2024
|
EW LEGAL NOTICE: BFA Law Reminds Edwards Lifesciences (EW) Investors with Losses to Contact the Firm before December 13 Court Deadline
- NEW YORK, NY / ACCESSWIRE / November 27, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/27/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 27, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113846&wire=1 or contact Joseph E. Levi, Esq.
- 11/27/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Stockholder Participation
- LOS ANGELES, CA / ACCESSWIRE / November 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/27/2024
|
New Evidence on SAPIEN 3 Ultra RESILIA Valve Set to Boost EW Stock
- Edwards' SAPIEN 3 Ultra RESILIA Valve continues to deliver excellent outcomes for patients in real-world data.
- 11/27/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / November 27, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113786&wire=1 or contact Joseph E. Levi, Esq.
- 11/27/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/27/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 27, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113770&wire=1 or contact Joseph E. Levi, Esq.
- 11/27/2024
|
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options
- 11/26/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113735&wire=1 or contact Joseph E. Levi, Esq.
- 11/26/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113711&wire=1 or contact Joseph E. Levi, Esq.
- 11/26/2024
|
EW INVESTOR ALERT: Edwards Lifesciences Investors that Lost Money are Reminded of December 13 Class Action Deadline – Contact BFA Law
- NEW YORK, NY / ACCESSWIRE / November 26, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/26/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113683&wire=1 or contact Joseph E. Levi, Esq.
- 11/26/2024
|
The Gross Law Firm Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW).
- 11/26/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113676&wire=1 or contact Joseph E. Levi, Esq.
- 11/26/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
- NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113661&wire=1 or contact Joseph E. Levi, Esq.
- 11/26/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113654&wire=1 or contact Joseph E. Levi, Esq.
- 11/26/2024
|
Investors With Losses Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/26/2024
|
EW INVESTOR DEADLINE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
- SAN DIEGO, CA / ACCESSWIRE / November 26, 2024 / The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE:EW) securities between February 6, 2024 and July 24, 2024, all dates inclusive (the "Class Period"), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 11/26/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation (EW)
- NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113644&wire=1 or contact Joseph E. Levi, Esq.
- 11/26/2024
|
Edwards Lifesciences (EW) Faces Securities Class Action - Hagens Berman
- EW Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / November 26, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 11/26/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113617&wire=1 or contact Joseph E. Levi, Esq.
- 11/26/2024
|
EW STOCK REPORT: Suffer Losses on Your Edwards Lifesciences Investment? Contact BFA Law about the Pending Class Action Lawsuit (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/26/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113600&wire=1 or contact Joseph E. Levi, Esq.
- 11/26/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/26/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK , Nov. 26, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 11/26/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113578&wire=1 or contact Joseph E. Levi, Esq.
- 11/26/2024
|
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
- NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Edwards Lifesciences Corp (“Edwards” or the “Company”) (NYSE: EW) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). Investors have until December 13 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- 11/25/2024
|
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 11/25/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113531&wire=1 or contact Joseph E. Levi, Esq.
- 11/25/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and certain of its officers.
- 11/25/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113523&wire=1 or contact Joseph E. Levi, Esq.
- 11/25/2024
|
EW LAWSUIT REMINDER: Edwards Lifesciences (EW) Investors are Reminded to Contact BFA Law about the Pending Class Action Lawsuit by December 13 Court Deadline
- NEW YORK, NY / ACCESSWIRE / November 25, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/25/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113507&wire=1 or contact Joseph E. Levi, Esq.
- 11/25/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman
- SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now.
- 11/25/2024
|
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
- LOS ANGELES, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”).
- 11/25/2024
|
Lost Money on Edwards Lifesciences Corporation (EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113488&wire=1 or contact Joseph E. Levi, Esq.
- 11/25/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113477&wire=1 or contact Joseph E. Levi, Esq.
- 11/25/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113451&wire=1 or contact Joseph E. Levi, Esq.
- 11/25/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Stockholder Participation
- LOS ANGELES, CA / ACCESSWIRE / November 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/25/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113444&wire=1 or contact Joseph E. Levi, Esq.
- 11/25/2024
|
EW Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corporation
- RADNOR, PA / ACCESSWIRE / November 25, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 11/25/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113403&wire=1 or contact Joseph E. Levi, Esq.
- 11/25/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113394&wire=1 or contact Joseph E. Levi, Esq.
- 11/25/2024
|
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- 11/25/2024
|
Edwards' SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
- LONDON--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions. An analysis of data from more than 9,000 propensity-matched patients in the STS/ACC TVT Registry1 demonstrated that those who received Edwards' newest gen.
- 11/25/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK, NY / ACCESSWIRE / November 24, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113303&wire=1 or contact Joseph E. Levi, Esq.
- 11/24/2024
|
Investors With Losses Are Invited To Join The Schall Law Firm In A Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/24/2024
|
Investors who lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / November 24, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113287&wire=1 or contact Joseph E. Levi, Esq.
- 11/24/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / November 24, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113267&wire=1 or contact Joseph E. Levi, Esq.
- 11/24/2024
|
EW LAWSUIT NOTICE: Edwards Lifesciences Investors are Notified of the Upcoming December 13 Deadline in Class Action Lawsuit – Contact BFA Law (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/24/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 24, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/24/2024
|
Lost Money on Edwards Lifesciences Corporation(EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 23, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113212&wire=1 or contact Joseph E. Levi, Esq.
- 11/23/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Stockholder Participation
- LOS ANGELES, CA / ACCESSWIRE / November 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/23/2024
|
EW ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against Edwards Lifesciences Corporation
- RADNOR, Pa., Nov. 23, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024.
- 11/23/2024
|
EW INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
- SAN DIEGO, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, all dates inclusive (the “Class Period”), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v. Edwards Lifesciences Corporation, No. 24-cv-02221 (C.D. Cal.), the Edwards Lifesciences class action lawsuit charges Edwards Lifesciences and certain of Edwards Lifesciences' executives with violations of the Securities Exchange Act of 1934.
- 11/22/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113176&wire=1 or contact Joseph E. Levi, Esq.
- 11/22/2024
|
What does the EDWARDS LIFESCIENCES (EW) Class Action Lawsuit mean for You? Investors with Losses are Urged to Contact BFA Law
- NEW YORK, NY / ACCESSWIRE / November 22, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/22/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline – EW
- NEW YORK, NY / ACCESSWIRE / November 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113166&wire=1 or contact Joseph E. Levi, Esq.
- 11/22/2024
|
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 11/22/2024
|
Investors With Losses Are Invited To Join The Schall Law Firm In A Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/22/2024
|
Investors who lost money on Edwards Lifesciences Corporation (EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / November 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113148&wire=1 or contact Joseph E. Levi, Esq.
- 11/22/2024
|
Faruqi & Faruqi Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options
- 11/22/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113136&wire=1 or contact Joseph E. Levi, Esq.
- 11/22/2024
|
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Edwards Lifesciences Corporation
- RADNOR, Pa. , Nov. 22, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024.
- 11/22/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113098&wire=1 or contact Joseph E. Levi, Esq.
- 11/22/2024
|
EW STOCK NEWS: Edwards Lifesciences Stock Plummeted 31% - Contact BFA Law about the Class Action Lawsuit if You Suffered Losses (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/22/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113091&wire=1 or contact Joseph E. Levi, Esq.
- 11/22/2024
|
EW STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 22, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/22/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact The Gross Law Firm
- NEW YORK , Nov. 22, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 11/22/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113057&wire=1 or contact Joseph E. Levi, Esq.
- 11/21/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113042&wire=1 or contact Joseph E. Levi, Esq.
- 11/21/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- LOS ANGELES , Nov. 21, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") (NYSE: EW).
- 11/21/2024
|
Investors who lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / November 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113034&wire=1 or contact Joseph E. Levi, Esq.
- 11/21/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Wants Affected Shareholders To Participate
- LOS ANGELES, CA / ACCESSWIRE / November 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/21/2024
|
EW CLASS ACTION NEWS: The Edwards Lifesciences (EW) Class Action Deadline is Approaching – Contact BFA Law before December 13 if You Suffered Losses
- NEW YORK, NY / ACCESSWIRE / November 21, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/21/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation (EW)
- NEW YORK, NY / ACCESSWIRE / November 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113015&wire=1 or contact Joseph E. Levi, Esq.
- 11/21/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit.
- 11/21/2024
|
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 21, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 11/21/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman
- SAN FRANCISCO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now.
- 11/21/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit – EW
- NEW YORK, NY / ACCESSWIRE / November 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112979&wire=1 or contact Joseph E. Levi, Esq.
- 11/21/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112948&wire=1 or contact Joseph E. Levi, Esq.
- 11/21/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESSWIRE / November 21, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/21/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
- NEW YORK , Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 11/21/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112912&wire=1 or contact Joseph E. Levi, Esq.
- 11/20/2024
|
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / November 20, 2024 / If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE:EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 11/20/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EW
- NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112895&wire=1 or contact Joseph E. Levi, Esq.
- 11/20/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112882&wire=1 or contact Joseph E. Levi, Esq.
- 11/20/2024
|
Did EDWARDS LIFESCIENCES (EW) Commit Securities Fraud? If You Suffered Losses on Your Investment Contact BFA Law about the Ongoing Class Action Lawsuit
- NEW YORK, NY / ACCESSWIRE / November 20, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/20/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112875&wire=1 or contact Joseph E. Levi, Esq.
- 11/20/2024
|
Investors With Losses Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/20/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112870&wire=1 or contact Joseph E. Levi, Esq.
- 11/20/2024
|
EW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
- SAN DIEGO , Nov. 20, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 11/20/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman
- EW Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / November 20, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 11/20/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112864&wire=1 or contact Joseph E. Levi, Esq.
- 11/20/2024
|
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
- LOS ANGELES, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”).
- 11/20/2024
|
EW LAWSUIT ALERT: The Gross Law Firm Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW).
- 11/20/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112779&wire=1 or contact Joseph E. Levi, Esq.
- 11/20/2024
|
EW CLASS ACTION: Edwards Lifesciences Sued for Securities Fraud after Stock Plummeted 31% - Contact BFA Law if You Suffered Losses (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/20/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Stockholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 20, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/20/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112713&wire=1 or contact Joseph E. Levi, Esq.
- 11/19/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112705&wire=1 or contact Joseph E. Levi, Esq.
- 11/19/2024
|
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
- NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Edwards Lifesciences Corp (“Edwards” or the “Company”) (NYSE: EW) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). Investors have until December 13 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- 11/19/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
- NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112698&wire=1 or contact Joseph E. Levi, Esq.
- 11/19/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112673&wire=1 or contact Joseph E. Levi, Esq.
- 11/19/2024
|
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 11/19/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112654&wire=1 or contact Joseph E. Levi, Esq.
- 11/19/2024
|
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- 11/19/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and certain of its officers.
- 11/19/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation (EW)
- NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112645&wire=1 or contact Joseph E. Levi, Esq.
- 11/19/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Wants Affected Shareholders To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / November 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/19/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112638&wire=1 or contact Joseph E. Levi, Esq.
- 11/19/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112628&wire=1 or contact Joseph E. Levi, Esq.
- 11/19/2024
|
Edwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, PA / ACCESSWIRE / November 19, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 11/19/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112576&wire=1 or contact Joseph E. Levi, Esq.
- 11/19/2024
|
EW FRAUD NEWS: Lose Money on Edwards Lifesciences (EW)? Contact BFA Law about the Securities Fraud Class Action Lawsuit
- NEW YORK, NY / ACCESSWIRE / November 19, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/19/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112569&wire=1 or contact Joseph E. Levi, Esq.
- 11/19/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 19, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/19/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK , Nov. 19, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 11/19/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112504&wire=1 or contact Joseph E. Levi, Esq.
- 11/18/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- NEW YORK , Nov. 18, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), of the important December 13, 2024 lead plaintiff deadline. So what: If you purchased Edwards securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 11/18/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112468&wire=1 or contact Joseph E. Levi, Esq.
- 11/18/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112460&wire=1 or contact Joseph E. Levi, Esq.
- 11/18/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman
- SAN FRANCISCO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 – July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com | 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement (“TAVR”) platform.
- 11/18/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112456&wire=1 or contact Joseph E. Levi, Esq.
- 11/18/2024
|
Investors With Losses Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/18/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit – EW
- NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit.
- 11/18/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation (EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112436&wire=1 or contact Joseph E. Levi, Esq.
- 11/18/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112419&wire=1 or contact Joseph E. Levi, Esq.
- 11/18/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Nov. 18, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/18/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112373&wire=1 or contact Joseph E. Levi, Esq.
- 11/18/2024
|
EW LEGAL DEADLINE: The Edwards Lifesciences Securities Class Action Deadline is Approaching – Contact BFA Law Now if You Lost Money (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/18/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112355&wire=1 or contact Joseph E. Levi, Esq.
- 11/18/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 18, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/18/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - EW
- NEW YORK , Nov. 18, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 11/18/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112330&wire=1 or contact Joseph E. Levi, Esq.
- 11/18/2024
|
EW INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
- SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v. Edwards Lifesciences Corporation, No. 24-cv-02221 (C.D. Cal.), the Edwards Lifesciences class action lawsuit charges Edwards Lifesciences and certain of Edwards Lifesciences' executives with violations of the Securities Exchange Act of 1934.
- 11/18/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK, NY / ACCESSWIRE / November 17, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112323&wire=1 or contact Joseph E. Levi, Esq.
- 11/17/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 17, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112292&wire=1 or contact Joseph E. Levi, Esq.
- 11/17/2024
|
Kessler Topaz Meltzer & Check, LLP Notifies Edwards Lifesciences Corporation Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
- RADNOR, Pa., Nov. 17, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024.
- 11/17/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 17, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112289&wire=1 or contact Joseph E. Levi, Esq.
- 11/17/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / November 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/17/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 17, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112265&wire=1 or contact Joseph E. Levi, Esq.
- 11/17/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 17, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112260&wire=1 or contact Joseph E. Levi, Esq.
- 11/17/2024
|
Lost Money on Edwards Lifesciences Corporation(EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 17, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112236&wire=1 or contact Joseph E. Levi, Esq.
- 11/17/2024
|
EW STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/17/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / November 17, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112227&wire=1 or contact Joseph E. Levi, Esq.
- 11/17/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 16, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112223&wire=1 or contact Joseph E. Levi, Esq.
- 11/16/2024
|
ROSEN, A TOP-RANKED LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Nov. 16, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 11/16/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 16, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112214&wire=1 or contact Joseph E. Levi, Esq.
- 11/16/2024
|
Investors With Losses Are Invited To Join The Schall Law Firm In A Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/16/2024
|
EW Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against Edwards Lifesciences Corporation
- RADNOR, Pa. , Nov. 16, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024.
- 11/16/2024
|
EW FRAUD ALERT: Suffer Losses on Your Edwards Lifesciences Securities? Contact BFA Law before December 13 Securities Fraud Class Action Deadline (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/16/2024
|
EW INVESTOR ALERT: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
- SAN DIEGO, CA / ACCESSWIRE / November 15, 2024 / Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE:EW) securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 11/15/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- LOS ANGELES , Nov. 15, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") (NYSE: EW). Class Period: February 6, 2024 – July 24, 2024 Lead Plaintiff Deadline: December 13, 2024 If you wish to serve as lead plaintiff of the Edwards Lifesciences lawsuit, you can submit your contact information at www.glancylaw.com/cases/edwards-lifesciences-corporation/.
- 11/15/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112173&wire=1 or contact Joseph E. Levi, Esq.
- 11/15/2024
|
Shareholders That Lost Money on Edwards Lifesciences Corporation (EW) Should Contact Levi & Korsinsky About Pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112161&wire=1 or contact Joseph E. Levi, Esq.
- 11/15/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Encourages Affected Shareholders To Take Part
- LOS ANGELES, CA / ACCESSWIRE / November 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/15/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - EW
- NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112145&wire=1 or contact Joseph E. Levi, Esq.
- 11/15/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman
- SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now.
- 11/15/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112141&wire=1 or contact Joseph E. Levi, Esq.
- 11/15/2024
|
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options
- 11/15/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112063&wire=1 or contact Joseph E. Levi, Esq.
- 11/15/2024
|
EW COURT ALERT: EDWARDS LIFESCIENCES (EW) Investors that Suffered Losses are Alerted of a Pending Class Action - Contact BFA Law before December 13 Court Deadline
- NEW YORK, NY / ACCESSWIRE / November 15, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/15/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Edwards Lifesciences Corporation to Contact the Firm Today!
- NEW YORK CITY, NY / ACCESSWIRE / November 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/15/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK , Nov. 15, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 11/15/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation (EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / November 14, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112025&wire=1 or contact Joseph E. Levi, Esq.
- 11/14/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 14, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112022&wire=1 or contact Joseph E. Levi, Esq.
- 11/14/2024
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 14, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 11/14/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, NY / ACCESSWIRE / November 14, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112017&wire=1 or contact Joseph E. Levi, Esq.
- 11/14/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, NY / ACCESSWIRE / November 14, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111983&wire=1 or contact Joseph E. Levi, Esq.
- 11/14/2024
|
EW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO , Nov. 14, 2024 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 11/14/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lifesciences Corporation Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / November 14, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111967&wire=1 or contact Joseph E. Levi, Esq.
- 11/14/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 14, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111949&wire=1 or contact Joseph E. Levi, Esq.
- 11/14/2024
|
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/14/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, NY / ACCESSWIRE / November 14, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111885&wire=1 or contact Joseph E. Levi, Esq.
- 11/14/2024
|
EW LEGAL UPDATE: Invest in Edwards Lifesciences and Lose Money? You may have been Affected by Fraud and are Urged to Contact BFA Law about the Class Action (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/14/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / November 14, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111873&wire=1 or contact Joseph E. Levi, Esq.
- 11/14/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 14, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/14/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK , Nov. 14, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 11/14/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111835&wire=1 or contact Joseph E. Levi, Esq.
- 11/13/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111827&wire=1 or contact Joseph E. Levi, Esq.
- 11/13/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization - Hagens Berman
- SAN FRANCISCO, CA / ACCESSWIRE / November 13, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 11/13/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111821&wire=1 or contact Joseph E. Levi, Esq.
- 11/13/2024
|
EW LEGAL NEWS: Edwards Lifesciences (EW) Investors that Suffered Losses may have been Affected by Fraud - Contact BFA Law about the Ongoing Class Action
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/13/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit – EW
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111811&wire=1 or contact Joseph E. Levi, Esq.
- 11/13/2024
|
ROSEN, A LEADING LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 11/13/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111798&wire=1 or contact Joseph E. Levi, Esq.
- 11/13/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and certain of its officers.
- 11/13/2024
|
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
- LOS ANGELES, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”).
- 11/13/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111785&wire=1 or contact Joseph E. Levi, Esq.
- 11/13/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit.
- 11/13/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111778&wire=1 or contact Joseph E. Levi, Esq.
- 11/13/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / November 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/13/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111766&wire=1 or contact Joseph E. Levi, Esq.
- 11/13/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Nov. 13, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/13/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111736&wire=1 or contact Joseph E. Levi, Esq.
- 11/13/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 13, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/13/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111701&wire=1 or contact Joseph E. Levi, Esq.
- 11/13/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / November 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111684&wire=1 or contact Joseph E. Levi, Esq.
- 11/12/2024
|
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
- NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Edwards Lifesciences Corp (“Edwards” or the “Company”) (NYSE: EW) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). Investors have until December 13 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- 11/12/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- NEW YORK , Nov. 12, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), of the important December 13, 2024 lead plaintiff deadline. So what: If you purchased Edwards Lifesciences Corporation securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 11/12/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / November 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111659&wire=1 or contact Joseph E. Levi, Esq.
- 11/12/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- BENSALEM, Pa. , Nov. 12, 2024 /PRNewswire/ -- Law Offices of Howard G.
- 11/12/2024
|
EW LEGAL ALERT: Edwards Lifesciences (EW) was Sued for Fraud - Investors are Urged to Contact BFA Law by December 13 Court Deadline
- NEW YORK, NY / ACCESSWIRE / November 12, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/12/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW).
- 11/12/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / November 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111614&wire=1 or contact Joseph E. Levi, Esq.
- 11/12/2024
|
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/12/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / November 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111606&wire=1 or contact Joseph E. Levi, Esq.
- 11/12/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111570&wire=1 or contact Joseph E. Levi, Esq.
- 11/12/2024
|
EW INVESTOR NEWS: Lost Money on Your Edwards Lifesciences Investment? Contact BFA Law about the Ongoing Securities Fraud Class Action (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/12/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111557&wire=1 or contact Joseph E. Levi, Esq.
- 11/12/2024
|
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- 11/12/2024
|
Lost Money on Edwards Lifesciences Corporation(EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111551&wire=1 or contact Joseph E. Levi, Esq.
- 11/12/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 12, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/12/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / November 12, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111514&wire=1 or contact Joseph E. Levi, Esq.
- 11/12/2024
|
EW INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v. Edwards Lifesciences Corporation, No. 24-cv-02221 (C.D. Cal.), the Edwards Lifesciences class action lawsuit charges Edwards Lifesciences as well as certain of Edwards Lifesciences' executives with violations of the Securities Exchange Act of 1934.
- 11/12/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK , Nov. 12, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 11/12/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111483&wire=1 or contact Joseph E. Levi, Esq.
- 11/11/2024
|
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / November 11, 2024 / If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE:EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 11/11/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / November 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111474&wire=1 or contact Joseph E. Levi, Esq.
- 11/11/2024
|
EW INVESTOR REPORT: Edwards Lifesciences (EW) Investors are Notified of Ongoing Class Action Lawsuit - Contact BFA Law if You Suffered Losses
- NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/11/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / November 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111468&wire=1 or contact Joseph E. Levi, Esq.
- 11/11/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman
- SAN FRANCISCO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now.
- 11/11/2024
|
EW Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corporation
- RADNOR, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024.
- 11/11/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lifesciences Corporation Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / November 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111456&wire=1 or contact Joseph E. Levi, Esq.
- 11/11/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Encourages Shareholder Participation
- LOS ANGELES, CA / ACCESSWIRE / November 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/11/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111397&wire=1 or contact Joseph E. Levi, Esq.
- 11/11/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / November 11, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111365&wire=1 or contact Joseph E. Levi, Esq.
- 11/11/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 11, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/11/2024
|
The Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK , Nov. 11, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 11/11/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111355&wire=1 or contact Joseph E. Levi, Esq.
- 11/10/2024
|
ROSEN, A TOP-RANKED LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Nov. 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 11/10/2024
|
Lost Money on Edwards Lifesciences Corporation(EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111337&wire=1 or contact Joseph E. Levi, Esq.
- 11/10/2024
|
Investors With Losses In Edwards Lifesciences Corporation Are Invited To Join The Schall Law Firm In A Securities Fraud Case
- LOS ANGELES, CA / ACCESSWIRE / November 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/10/2024
|
Edwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, Pa. , Nov. 10, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024.
- 11/10/2024
|
EW INVESTOR ALERT: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO , Nov. 8, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 11/10/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111311&wire=1 or contact Joseph E. Levi, Esq.
- 11/10/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / November 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111307&wire=1 or contact Joseph E. Levi, Esq.
- 11/10/2024
|
EW INVESTOR UPDATE: Did Edwards Lifesciences Mislead Investors Causing Losses? Contact BFA Law about the Pending Securities Fraud Lawsuit (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/10/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 10, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111296&wire=1 or contact Joseph E. Levi, Esq.
- 11/10/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 10, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/10/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / November 9, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111272&wire=1 or contact Joseph E. Levi, Esq.
- 11/09/2024
|
Edwards Lifesciences Corporation Is Being Sued And The Schall Law Firm Wants Shareholders With Losses To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / November 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/09/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, NY / ACCESSWIRE / November 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111260&wire=1 or contact Joseph E. Levi, Esq.
- 11/08/2024
|
Investors who lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / November 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111247&wire=1 or contact Joseph E. Levi, Esq.
- 11/08/2024
|
EW INVESTOR REPORT: Edwards Lifesciences Sued for Fraud - Contact BFA Law if You Suffered Losses
- NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/08/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111232&wire=1 or contact Joseph E. Levi, Esq.
- 11/08/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111210&wire=1 or contact Joseph E. Levi, Esq.
- 11/08/2024
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 11/08/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111206&wire=1 or contact Joseph E. Levi, Esq.
- 11/08/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Stockholder Participation
- LOS ANGELES, CA / ACCESSWIRE / November 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/08/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111187&wire=1 or contact Joseph E. Levi, Esq.
- 11/08/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Nov. 8, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/08/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / November 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111160&wire=1 or contact Joseph E. Levi, Esq.
- 11/08/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman
- EW Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 11/08/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation (EW)
- NEW YORK, NY / ACCESSWIRE / November 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111149&wire=1 or contact Joseph E. Levi, Esq.
- 11/08/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Stockholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 8, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/08/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lifesciences Corporation Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / November 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111123&wire=1 or contact Joseph E. Levi, Esq.
- 11/08/2024
|
EW INVESTOR NEWS: Edwards Lifesciences Investors with Losses May have been Affected by Fraud; Contact BFA Law before Class Action Deadline (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/08/2024
|
Lost Money on Edwards Lifesciences Corporation(EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111118&wire=1 or contact Joseph E. Levi, Esq.
- 11/08/2024
|
EW INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v. Edwards Lifesciences Corporation, No. 24-cv-02221 (C.D. Cal.), the Edwards Lifesciences class action lawsuit charges Edwards Lifesciences as well as certain of Edwards Lifesciences' executives with violations of the Securities Exchange Act of 1934.
- 11/08/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK , Nov. 8, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 11/08/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 7, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111112&wire=1 or contact Joseph E. Levi, Esq.
- 11/07/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- NEW YORK , Nov. 7, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), of the important December 13, 2024 lead plaintiff deadline. So what: If you purchased Edwards Lifesciences Corporation securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 11/07/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 7, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111101&wire=1 or contact Joseph E. Levi, Esq.
- 11/07/2024
|
ROSEN, LEADING LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 11/07/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / November 7, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111093&wire=1 or contact Joseph E. Levi, Esq.
- 11/07/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman
- SAN FRANCISCO , Nov. 07, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now.
- 11/07/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation (EW) Shareholders
- NEW YORK, NY / ACCESSWIRE / November 7, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111082&wire=1 or contact Joseph E. Levi, Esq.
- 11/07/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- LOS ANGELES , Nov. 7, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") (NYSE: EW).
- 11/07/2024
|
Did Edwards Lifesciences (EW) Commit Securities Fraud Resulting in 31% Stock Drop? Contact BFA Law about the Class Action Lawsuit
- NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/07/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit.
- 11/07/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK, NY / ACCESSWIRE / November 7, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111066&wire=1 or contact Joseph E. Levi, Esq.
- 11/07/2024
|
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/07/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / November 7, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=111018&wire=1 or contact Joseph E. Levi, Esq.
- 11/07/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 7, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/07/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 7, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110995&wire=1 or contact Joseph E. Levi, Esq.
- 11/07/2024
|
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK , Nov. 7, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 11/07/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, NY / ACCESSWIRE / November 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110974&wire=1 or contact Joseph E. Levi, Esq.
- 11/06/2024
|
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
- NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Edwards Lifesciences Corp (“Edwards” or the “Company”) (NYSE: EW) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). Investors have until December 13 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- 11/06/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110970&wire=1 or contact Joseph E. Levi, Esq.
- 11/06/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK, NY / ACCESSWIRE / November 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110965&wire=1 or contact Joseph E. Levi, Esq.
- 11/06/2024
|
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
- LOS ANGELES, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”).
- 11/06/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / November 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110945&wire=1 or contact Joseph E. Levi, Esq.
- 11/06/2024
|
EW STOCK ALERT: Why was Edwards Lifesciences Sued for Securities Fraud? Contact BFA Law if You Lost Money on Your Investment (NYSE:EW)
- NEW YORK, NY / ACCESSWIRE / November 6, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/06/2024
|
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
- NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW).
- 11/06/2024
|
EW Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation Shareholders of Deadline in Securities Fraud Class Action Lawsuit
- RADNOR, PA / ACCESSWIRE / November 6, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 11/06/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / November 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110915&wire=1 or contact Joseph E. Levi, Esq.
- 11/06/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / November 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/06/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / November 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110868&wire=1 or contact Joseph E. Levi, Esq.
- 11/06/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 6, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/06/2024
|
Lost Money on Edwards Lifesciences Corporation(EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110839&wire=1 or contact Joseph E. Levi, Esq.
- 11/06/2024
|
EW STOCK REPORT: Edwards Lifesciences Investors are Notified to Contact BFA Law about the Securities Fraud Class Action before Approaching Deadline
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/06/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 6, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110831&wire=1 or contact Joseph E. Levi, Esq.
- 11/06/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, NY / ACCESSWIRE / November 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110793&wire=1 or contact Joseph E. Levi, Esq.
- 11/05/2024
|
EW STOCK NEWS: Edwards Lifesciences was Sued for Securities Fraud after Stock Dropped 31%; Contact BFA Law if You Suffered Losses (NYSE:EW)
- NEW YORK, NY / ACCESSWIRE / November 5, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/05/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110788&wire=1 or contact Joseph E. Levi, Esq.
- 11/05/2024
|
EW INVESTORS: Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Edwards Lifesciences Corporation Class Action
- SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024. Edwards is an international company that researches, develops, and provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions.
- 11/05/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation (EW)
- NEW YORK, NY / ACCESSWIRE / November 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110783&wire=1 or contact Joseph E. Levi, Esq.
- 11/05/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization - Hagens Berman
- SAN FRANCISCO, CA / ACCESSWIRE / November 5, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 11/05/2024
|
Kessler Topaz Meltzer & Check, LLP Reminds EW Investors of December 13, 2024 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm
- RADNOR, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024.
- 11/05/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation (EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / November 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110776&wire=1 or contact Joseph E. Levi, Esq.
- 11/05/2024
|
EW INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO , Nov. 5, 2024 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 11/05/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / November 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110763&wire=1 or contact Joseph E. Levi, Esq.
- 11/05/2024
|
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/05/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / November 5, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110718&wire=1 or contact Joseph E. Levi, Esq.
- 11/05/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 5, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/05/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK , Nov. 5, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 11/05/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit – EW
- NEW YORK, NY / ACCESSWIRE / November 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110681&wire=1 or contact Joseph E. Levi, Esq.
- 11/04/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / November 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110652&wire=1 or contact Joseph E. Levi, Esq.
- 11/04/2024
|
Did Edwards Lifesciences Commit Securities Fraud Resulting in 31% Stock Drop? Contact BFA Law about the Class Action Lawsuit (NYSE:EW)
- NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/04/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman
- SAN FRANCISCO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 – July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement (“TAVR”) platform.
- 11/04/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation (EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit.
- 11/04/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110646&wire=1 or contact Joseph E. Levi, Esq.
- 11/04/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110604&wire=1 or contact Joseph E. Levi, Esq.
- 11/04/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Impacted Shareholders To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / November 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/04/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Nov. 4, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/04/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / November 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110583&wire=1 or contact Joseph E. Levi, Esq.
- 11/04/2024
|
Class Action Reminder for NASDAQ: EW: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation Investors of Securities Fraud Class Action Lawsuit
- RADNOR, Pa. , Nov. 4, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024.
- 11/04/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110561&wire=1 or contact Joseph E. Levi, Esq.
- 11/04/2024
|
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- 11/04/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / November 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110547&wire=1 or contact Joseph E. Levi, Esq.
- 11/04/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 4, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110518&wire=1 or contact Joseph E. Levi, Esq.
- 11/04/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 4, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/04/2024
|
EW LAWSUIT ALERT: A Securities Fraud Class Action has been filed against Edwards Lifesciences; Investors are Urged to Contact the Firm by December 13 (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/04/2024
|
The Gross Law Firm Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK , Nov. 4, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 11/04/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
- NEW YORK, NY / ACCESSWIRE / November 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110509&wire=1 or contact Joseph E. Levi, Esq.
- 11/03/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
- NEW YORK, NY / ACCESSWIRE / November 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110496&wire=1 or contact Joseph E. Levi, Esq.
- 11/03/2024
|
TOP RANKED ROSEN LAW FIRM Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Nov. 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 11/03/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110492&wire=1 or contact Joseph E. Levi, Esq.
- 11/03/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110482&wire=1 or contact Joseph E. Levi, Esq.
- 11/03/2024
|
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / November 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/03/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / November 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110472&wire=1 or contact Joseph E. Levi, Esq.
- 11/03/2024
|
EW INVESTOR DEADLINE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO, CA / ACCESSWIRE / November 3, 2024 / Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE:EW) securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 11/03/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 EW
- NEW YORK, NY / ACCESSWIRE / November 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110457&wire=1 or contact Joseph E. Levi, Esq.
- 11/03/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 3, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110449&wire=1 or contact Joseph E. Levi, Esq.
- 11/03/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 3, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/03/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 2, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110419&wire=1 or contact Joseph E. Levi, Esq.
- 11/02/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 11/02/2024
|
EDWARDS LIFESCIENCES has been Sued for Securities Fraud after Stock Plummets 31%; Contact the Firm before December 13 Class Action Deadline (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 11/02/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- NEW YORK , Nov. 1, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), of the important December 13, 2024 lead plaintiff deadline. So what: If you purchased Edwards Lifesciences Corporation securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 11/01/2024
|
EW CLASS ACTION NOTE: Contact BFA Law by December 13 Court Deadline in Edwards Lifesciences Securities Fraud Lawsuit (NYSE:EW)
- NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 11/01/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EW
- NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110404&wire=1 or contact Joseph E. Levi, Esq.
- 11/01/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit – EW
- NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110399&wire=1 or contact Joseph E. Levi, Esq.
- 11/01/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110391&wire=1 or contact Joseph E. Levi, Esq.
- 11/01/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and certain of its officers.
- 11/01/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110386&wire=1 or contact Joseph E. Levi, Esq.
- 11/01/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110372&wire=1 or contact Joseph E. Levi, Esq.
- 11/01/2024
|
EW Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation (EW) Investors that a Securities Fraud Class Action Lawsuit Has Been Filed
- RADNOR, PA / ACCESSWIRE / November 1, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 11/01/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110364&wire=1 or contact Joseph E. Levi, Esq.
- 11/01/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- LOS ANGELES , Nov. 1, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") (NYSE: EW). Class Period: February 6, 2024 – July 24, 2024 Lead Plaintiff Deadline: December 13, 2024 If you wish to serve as lead plaintiff of the Edwards Lifesciences lawsuit, you can submit your contact information at www.glancylaw.com/cases/edwards-lifesciences-corporation/.
- 11/01/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation (EW)
- NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110343&wire=1 or contact Joseph E. Levi, Esq.
- 11/01/2024
|
Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110291&wire=1 or contact Joseph E. Levi, Esq.
- 11/01/2024
|
EW STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / November 1, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 11/01/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK , Nov. 1, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 11/01/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK, NY / ACCESSWIRE / October 31, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110242&wire=1 or contact Joseph E. Levi, Esq.
- 10/31/2024
|
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
- LOS ANGELES, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”).
- 10/31/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation (EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / October 31, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110220&wire=1 or contact Joseph E. Levi, Esq.
- 10/31/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / October 31, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110215&wire=1 or contact Joseph E. Levi, Esq.
- 10/31/2024
|
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 10/31/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / October 31, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110211&wire=1 or contact Joseph E. Levi, Esq.
- 10/31/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman
- SAN FRANCISCO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 – July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement (“TAVR”) platform.
- 10/31/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation (EW) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / October 31, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110206&wire=1 or contact Joseph E. Levi, Esq.
- 10/31/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / October 31, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110179&wire=1 or contact Joseph E. Levi, Esq.
- 10/31/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / October 31, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110129&wire=1 or contact Joseph E. Levi, Esq.
- 10/31/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / October 31, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/31/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / October 31, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110113&wire=1 or contact Joseph E. Levi, Esq.
- 10/31/2024
|
EW CLASS ACTION: Edwards Lifesciences Investors with Losses are Notified of Ongoing Class Action; Contact BFA Law before December 13 Legal Deadline (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 10/31/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) should contact The Gross Law Firm about pending Class Action - EW
- NEW YORK , Oct. 31, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 10/31/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lifesciences Corporation Lawsuit – EW
- NEW YORK, NY / ACCESSWIRE / October 30, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110103&wire=1 or contact Joseph E. Levi, Esq.
- 10/30/2024
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options
- 10/30/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / October 30, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110096&wire=1 or contact Joseph E. Levi, Esq.
- 10/30/2024
|
Edwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, Pa., Oct. 30, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024.
- 10/30/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, NY / ACCESSWIRE / October 30, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110081&wire=1 or contact Joseph E. Levi, Esq.
- 10/30/2024
|
Data Presented at TCT Reinforce Edwards Lifesciences' Commitment to Structural Heart Innovation
- WASHINGTON--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced significant additions to the body of high-quality evidence presented and published during the Transcatheter Cardiovascular Therapeutics (TCT) conference, addressing the critical needs of patients with structural heart disease. “The data at TCT on Edwards' innovations underscore our commitment to scientific leadership and our focus to bring impactful and life-saving structural heart therapies to patients and physicians,.
- 10/30/2024
|
EDWARDS LIFESCIENCES (EW) Sued for Fraud; Contact BFA Law if You Suffered Losses on Your Investment before December 13 Court Deadline in Class Action
- NEW YORK, NY / ACCESSWIRE / October 30, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 10/30/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization - Hagens Berman
- EW Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / October 30, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 10/30/2024
|
Investors who Lost Money on Edwards Lifesciences Corporation (EW) Should Contact Levi & Korsinsky About Pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / October 30, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110071&wire=1 or contact Joseph E. Levi, Esq.
- 10/30/2024
|
Lost Money on Edwards Lifesciences Corporation(EW)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
- NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit.
- 10/30/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation (EW) Shareholders
- NEW YORK, NY / ACCESSWIRE / October 30, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110061&wire=1 or contact Joseph E. Levi, Esq.
- 10/30/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / October 30, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110006&wire=1 or contact Joseph E. Levi, Esq.
- 10/30/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / October 30, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109985&wire=1 or contact Joseph E. Levi, Esq.
- 10/30/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / October 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109968&wire=1 or contact Joseph E. Levi, Esq.
- 10/29/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
- NEW YORK, NY / ACCESSWIRE / October 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109958&wire=1 or contact Joseph E. Levi, Esq.
- 10/29/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / October 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109941&wire=1 or contact Joseph E. Levi, Esq.
- 10/29/2024
|
Shareholder Rights Law Firm Robbins LLP Encourages EW Investors with Large Losses to Obtain Counsel in Connection with the Class Action Against Edwards Lifesciences Corporation
- SAN DIEGO, CA / ACCESSWIRE / October 29, 2024 / Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Edwards Lifesciences Corporation (NYSE:EW) securities between February 6, 2024 and July 24, 2024.Edwards is an international company that researches, develops, and provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
- 10/29/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / October 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109928&wire=1 or contact Joseph E. Levi, Esq.
- 10/29/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK , Oct. 29, 2024 /PRNewswire/ -- Attorney Advertising-- --Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE: EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/29/2024
|
EW DEADLINE REMINDER: Edwards Lifesciences Investors that Lost Money are Reminded of Upcoming December 13 Court Deadline and are Urged to Contact BFA Law
- NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 10/29/2024
|
Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation (EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / October 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109920&wire=1 or contact Joseph E. Levi, Esq.
- 10/29/2024
|
Investors who lost money on Edwards Lifesciences Corporation(EW) should contact The Gross Law Firm about pending Class Action - EW
- NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW).
- 10/29/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / October 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109884&wire=1 or contact Joseph E. Levi, Esq.
- 10/29/2024
|
Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation Investors of Important Deadline in Securities Fraud Class Action Lawsuit
- RADNOR, Pa. , Oct. 29, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024.
- 10/29/2024
|
Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
- NEW YORK, NY / ACCESSWIRE / October 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109866&wire=1 or contact Joseph E. Levi, Esq.
- 10/29/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / October 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109824&wire=1 or contact Joseph E. Levi, Esq.
- 10/29/2024
|
EW Stockholders Have Opportunity to Lead Edwards Lifesciences Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESSWIRE / October 29, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/29/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / October 29, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109803&wire=1 or contact Joseph E. Levi, Esq.
- 10/29/2024
|
EW DEADLINE NOTICE: Edwards Lifesciences Investors are Notified of December 13 Court Deadline; Contact BFA Law if You Suffered Losses after 31% Stock Drop (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 10/29/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK , Oct. 29, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 10/29/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109789&wire=1 or contact Joseph E. Levi, Esq.
- 10/28/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109772&wire=1 or contact Joseph E. Levi, Esq.
- 10/28/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- BENSALEM, Pa. , Oct. 28, 2024 /PRNewswire/ -- Law Offices of Howard G.
- 10/28/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information – EW
- NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109769&wire=1 or contact Joseph E. Levi, Esq.
- 10/28/2024
|
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman
- SAN FRANCISCO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 – July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement (“TAVR”) platform.
- 10/28/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EW
- NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109758&wire=1 or contact Joseph E. Levi, Esq.
- 10/28/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK , Oct. 28, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE: EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/28/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109709&wire=1 or contact Joseph E. Levi, Esq.
- 10/28/2024
|
Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109689&wire=1 or contact Joseph E. Levi, Esq.
- 10/28/2024
|
International Markets and Edwards Lifesciences (EW): A Deep Dive for Investors
- Explore Edwards Lifesciences' (EW) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
- 10/28/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Oct. 28, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/28/2024
|
Lost Money on Edwards Lifesciences Corporation (EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109638&wire=1 or contact Joseph E. Levi, Esq.
- 10/28/2024
|
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- 10/28/2024
|
EW Shareholders Have Opportunity to Lead Edwards Lifesciences Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESSWIRE / October 28, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/28/2024
|
EW INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit
- SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), have until December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v. Edwards Lifesciences Corporation, No. 24-cv-02221 (C.D. Cal.), the Edwards Lifesciences class action lawsuit charges Edwards Lifesciences as well as certain of Edwards Lifesciences' top executives with violations of the Securities Exchange Act of 1934.
- 10/28/2024
|
The Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK , Oct. 28, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 10/28/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- NEW YORK , Oct. 27, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), of the important December 13, 2024 lead plaintiff deadline. So what: If you purchased Edwards Lifesciences Corporation securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 10/27/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK--(BUSINESS WIRE)---- $EW #EdwardsLifesciences--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired E.
- 10/27/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Edwards Lifesciences Corporation - EW
- NEW YORK, NY / ACCESSWIRE / October 27, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE:EW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 10/27/2024
|
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / October 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/27/2024
|
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Oct. 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 10/27/2024
|
EW FRAUD ALERT: BFA Law Notifies Edwards Lifesciences Investors of Upcoming December 13 Court Deadline and Encourages You to Contact the Firm (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 10/27/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Stockholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / October 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/27/2024
|
EW FRAUD NEWS: Edwards Lifesciences Sued for Securities Fraud after Stock Plummets 31%; Investors with Losses Urged to Contact BFA Law by December 13 Court Deadline
- NEW YORK, NY / ACCESSWIRE / October 26, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 10/26/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / October 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/26/2024
|
EW REMINDER: Kessler Topaz Meltzer & Check, LLP Urges EW Investors with Losses to Contact the Firm
- RADNOR, PA / ACCESSWIRE / October 26, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 10/26/2024
|
Edwards Lifesciences Q3: Divesting Critical Care And Focusing On Structural Hearts
- I reiterate my “Strong Buy” on Edwards Lifesciences Corporation, with a fair value of $85 per share, due to strategic focus on structural heart and new product investments. Edwards Lifesciences reported 9.6% organic revenue growth and a 7.2% increase in the Transcatheter Aortic Valve Replacement segment in Q3 2024. The sale of the Critical Care business for $4.2 billion will fund share buybacks, acquisitions, and strategic investments, enhancing growth in high-potential areas.
- 10/25/2024
|
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
- LOS ANGELES, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”).
- 10/25/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Edwards Lifesciences Corporation - EW
- NEW YORK , Oct. 25, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 10/25/2024
|
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Oct. 25, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 10/25/2024
|
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / October 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/25/2024
|
EW Q3 Earnings Match Estimates, Revenues Miss, Stock Falls
- Edwards Lifesciences reports strong contributions from all of the product groups - TAVR, TTMT and surgical structural heart - in the third quarter of 2024.
- 10/25/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman
- SAN FRANCISCO, CA / ACCESSWIRE / October 25, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 10/25/2024
|
EW LEGAL NEWS: Edwards Lifesciences Sued for Securities Fraud after Stock Drops 31%; Investors are Urged to Contact BFA Law before December 13 Court Deadline (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 10/25/2024
|
Edwards Lifesciences Corporation (EW) Q3 2024 Earnings Call Transcript
- Edwards Lifesciences Corporation (NYSE:EW ) Q3 2024 Earnings Conference Call October 24, 2024 5:30 PM ET Corporate Participants Mark Wilterding - Senior Vice President & Investor Relations Bernard Zovighian - Chief Executive Officer Scott Ullem - Corporate Vice President and Chief Financial Officer Larry Wood - Corporate Vice President and Group President of TAVR and SSH Daveen Chopra - Corporate Vice President, TMTT Conference Call Participants Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Robbie Marcus - JPMorgan David Roman - Goldman Sachs Travis Steed - Bank of America Matt Taylor - Jefferies Matt Miksic - Barclays Joanne Wuensch - Citibank Danielle Antalffy - UBS Patrick Wood - Morgan Stanley Adam Maeder - Piper Sandler Operator Greetings and welcome to Edwards Lifesciences Third Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode.
- 10/24/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- LOS ANGELES , Oct. 24, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") (NYSE: EW).
- 10/24/2024
|
Compared to Estimates, Edwards Lifesciences (EW) Q3 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 10/24/2024
|
EW Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges EW Investors with Losses to Contact the Firm
- RADNOR, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024.
- 10/24/2024
|
Edwards Reverses Course, Falling On A Mixed Third-Quarter Report
- Edwards Lifesciences stock briefly popped — and then slipped — on its mixed third-quarter report after wrapping up a key divestiture.
- 10/24/2024
|
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline.
- 10/24/2024
|
Edwards Lifesciences Reports Third Quarter Results
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Sept. 30, 2024. Highlights and Outlook Q3 sales from continuing operations grew 9%; constant currency1 sales grew 10% Q3 TAVR sales grew 6%; constant currency1 sales grew 7% TMTT sales grew 73%; PASCAL and EVOQUE commercial launches continue to progress well Q3 EPS of $5.13; adjusted1 EPS of $0.67 Completed sale of Critical Care in Q3, resulting in significant one-time gain Pi.
- 10/24/2024
|
EW LEGAL NOTICE: BFA Law Encourages Edwards Lifesciences Investors that Lost Money to Contact the Firm before December 13 Class Action Deadline
- NEW YORK, NY / ACCESSWIRE / October 24, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 10/24/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman
- SAN FRANCISCO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 – July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement (“TAVR”) platform.
- 10/24/2024
|
EW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- SAN DIEGO, CA / ACCESSWIRE / October 24, 2024 / The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE:EW) securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), have until December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 10/24/2024
|
EW INVESTOR ALERT: Edelson Lechtzin LLP Urges Edwards Lifesciences Corporation (NYSE: EW) Shareholders to Seek Legal Counsel About the Pending Securities Fraud Class Action
- NEWTOWN, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a leading class action law firm, announces the filing of a securities fraud class action on behalf of all purchasers of Edwards Lifesciences Corporation securities (NYSE: EW) between February 6, 2024, and July 24, 2024, inclusive (the “Class Period”).
- 10/23/2024
|
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Edwards Lifesciences Corporation (NYSE: EW); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
- SAN DIEGO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired Edwards Life Sciences Corporation. (NYSE: EW) (“Edwards” or the “Company”) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), charging the Company and certain of its current senior executives with violations of the federal securities laws (collectively, “Defendants”).
- 10/23/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- / ACCESSWIRE / October 23, 2024 / NEW YORK, NY / ACCESSWIRE / October 23, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109503&wire=1 or contact Joseph E. Levi, Esq.
- 10/23/2024
|
EW INVESTOR ALERT: Edwards Lifesciences Investors that Suffered Losses are Alerted to Contact BFA Law before December 13 Class Action Deadline (NYSE:EW)
- NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 10/23/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / October 23, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109483&wire=1 or contact Joseph E. Levi, Esq.
- 10/23/2024
|
Class Action Announcement for Edwards Lifesciences Corporation Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Edwards Lifesciences Corporation
- RADNOR, Pa. , Oct. 23, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024.
- 10/23/2024
|
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”). If you suffered a loss on your Edwards Lifesciences investments or would like.
- 10/23/2024
|
TFX or EW: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Instruments stocks have likely encountered both Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
- 10/23/2024
|
Edwards Lifesciences Corporation Class Action: The Gross Law Firm Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW).
- 10/23/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / October 23, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109468&wire=1 or contact Joseph E. Levi, Esq.
- 10/23/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman
- SAN FRANCISCO, CA / ACCESSWIRE / October 23, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 10/23/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / October 23, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109429&wire=1 or contact Joseph E. Levi, Esq.
- 10/23/2024
|
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / October 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/23/2024
|
Faruqi & Faruqi Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options
- 10/23/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / October 23, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109343&wire=1 or contact Joseph E. Levi, Esq.
- 10/23/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / October 23, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/23/2024
|
EW STOCK ALERT: Why is Edwards Lifesciences being Sued for Securities Fraud? Investors that Lost Money are Notified to Contact BFA Law by December 13 Deadline (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 10/23/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK , Oct. 23, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities fraud between February 6, 2024 and July 24, 2024.
- 10/23/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EW
- NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109308&wire=1 or contact Joseph E. Levi, Esq.
- 10/22/2024
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). NEW YORK CITY, NY / ACCESSWIRE / October 22, 2024 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE:EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 10/22/2024
|
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”). Investors suffering losses on their Edwards Lifesciences investments are encouraged to contact the Law Offices of H.
- 10/22/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109291&wire=1 or contact Joseph E. Levi, Esq.
- 10/22/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- NEW YORK , Oct. 22, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"). A class action has already been filed.
- 10/22/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109281&wire=1 or contact Joseph E. Levi, Esq.
- 10/22/2024
|
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109245&wire=1 or contact Joseph E. Levi, Esq.
- 10/22/2024
|
EW INVESTOR NEWS: Edwards Lifesciences Sued for Securities Fraud after Stock Plummets 31%; Investors with Losses are Urged to Contact BFA Law by December 13 Deadline
- NEW YORK, NY / ACCESSWIRE / October 22, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 10/22/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information- EW
- NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109211&wire=1 or contact Joseph E. Levi, Esq.
- 10/22/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109186&wire=1 or contact Joseph E. Levi, Esq.
- 10/22/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman
- SAN FRANCISCO, CA / ACCESSWIRE / October 22, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 10/22/2024
|
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
- NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109088&wire=1 or contact Joseph E. Levi, Esq.
- 10/21/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EW
- NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109081&wire=1 or contact Joseph E. Levi, Esq.
- 10/21/2024
|
Edwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, PA / ACCESSWIRE / October 21, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 10/21/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=109065&wire=1 or contact Joseph E. Levi, Esq.
- 10/21/2024
|
Edwards Lifesciences Corporation Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the EW Class Action
- SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024. Edwards is an international company that researches, develops, and provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions.
- 10/21/2024
|
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 13, 2024.
- 10/21/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman
- SAN FRANCISCO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 – July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement (“TAVR”) platform.
- 10/21/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and certain of its officers.
- 10/21/2024
|
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation (EW) Investors
- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation (EW) Investors.
- 10/21/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108972&wire=1 or contact Joseph E. Levi, Esq.
- 10/21/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Edwards Lifesciences Corporation - EW
- NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE:EW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 10/21/2024
|
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / October 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/21/2024
|
Edwards Lifesciences (EW) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
- Evaluate the expected performance of Edwards Lifesciences (EW) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 10/21/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lifesciences Corporation Lawsuit - EW
- NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108953&wire=1 or contact Joseph E. Levi, Esq.
- 10/21/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Oct. 21, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/21/2024
|
Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108934&wire=1 or contact Joseph E. Levi, Esq.
- 10/21/2024
|
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
- 10/21/2024
|
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108922&wire=1 or contact Joseph E. Levi, Esq.
- 10/21/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / October 21, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/21/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
- NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108888&wire=1 or contact Joseph E. Levi, Esq.
- 10/21/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / October 20, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108868&wire=1 or contact Joseph E. Levi, Esq.
- 10/20/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / October 20, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108837&wire=1 or contact Joseph E. Levi, Esq.
- 10/20/2024
|
Edwards Lifesciences Corporation Is Being Sued For Securities Law Violations And The Schall Law Firm Urges Shareholder Participation
- LOS ANGELES, CA / ACCESSWIRE / October 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/20/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / October 20, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/20/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Edwards Lifesciences Corporation - EW
- NEW YORK, NY / ACCESSWIRE / October 19, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE:EW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 10/19/2024
|
Class Action Announcement (EW): A Securities Fraud Class Action Lawsuit Was Filed Against Edwards Lifesciences Corporation
- RADNOR, PA / ACCESSWIRE / October 19, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE:EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Edwards losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/edwards-lifesciences-corporation?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=ew&mktm=r You can also contact attorney Jonathan Naji, Esq.
- 10/19/2024
|
Investors Are Encouraged To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / October 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/19/2024
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards Lifesciences To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards Lifesciences between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Oct. 19, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") (NYSE: EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 10/19/2024
|
EW INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- SAN DIEGO, Oct. 19, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), have until December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v. Edwards Lifesciences Corporation, No. 24-cv-02221 (C.D. Cal.), the Edwards Lifesciences class action lawsuit charges Edwards Lifesciences as well as certain of Edwards Lifesciences' top executives with violations of the Securities Exchange Act of 1934.
- 10/19/2024
|
EW LAWSUIT UPDATE: Edwards Lifesciences Corporation Investors are Notified of Imminent December 13 Legal Deadline; Contact BFA Law if You Lost Money (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 10/19/2024
|
RLF, A LEADING LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
- NEW YORK, Oct. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 13, 2024.
- 10/18/2024
|
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation (EW) Investors
- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”). Edwards Lifesciences investors have until December 13, 2024 to file a lead plaintiff motion. If.
- 10/18/2024
|
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation (EW) Investors
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”). Edwards Lifesciences Corporation investors have until December 13, 2024 to file a lead plaintiff motion. Investors suffering losses on their Edwards Lifesciences investments.
- 10/18/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Edwards Lifesciences Corporation Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK--(BUSINESS WIRE)---- $EW #EdwardsLifescience--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired E.
- 10/18/2024
|
EW LAWSUIT NOTICE: Edwards Lifesciences Corporation Investors are Alerted of Upcoming December 13 Court Deadline; Contact BFA Law about Securities Fraud Class Action
- NEW YORK, NY / ACCESSWIRE / October 18, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 10/18/2024
|
EW Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Edwards Lifesciences Corporation Class Action Lawsuit
- SAN DIEGO, CA / ACCESSWIRE / October 18, 2024 / Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Edwards Lifesciences Corporation (NYSE:EW) securities between February 6, 2024 and July 24, 2024. Edwards is an international company that researches, develops, and provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions.
- 10/18/2024
|
EW Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corporation - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024.
- 10/18/2024
|
Faruqi & Faruqi Reminds Edwards Lifesciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK CITY, NY / ACCESSWIRE / October 18, 2024 / Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE:EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 10/18/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Shareholder Participation
- LOS ANGELES, CA / ACCESSWIRE / October 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/18/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- NEW YORK , Oct. 17, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"). A class action has already been filed.
- 10/17/2024
|
EW FRAUD UPDATE: Edwards Lifesciences Corporation Investors have until December 13 to Contact BFA Law about the Court Deadline in Securities Fraud Class Action (NYSE:EW)
- NEW YORK, NY / ACCESSWIRE / October 17, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 10/17/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Edwards Lifesciences Corporation - EW
- NEW YORK , Oct. 17, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 10/17/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman
- EW Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / October 17, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic Valve Replacement ("TAVR") platform.
- 10/17/2024
|
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
- LOS ANGELES, CA / ACCESSWIRE / October 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/17/2024
|
Class Action Announcement for Edwards Lifesciences Corporation (EW): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corporation
- RADNOR, Pa. , Oct. 17, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 13, 2024.
- 10/17/2024
|
Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2024 after the market closes on Thursday, October 24, 2024, and will host a conference call at 5:30 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com. About Edw.
- 10/17/2024
|
EW FRAUD NOTICE: Lost Money on Your Edwards Lifesciences Corporation Securities? Contact BFA Law by December 13 Deadline in Securities Fraud Class Action (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 10/17/2024
|
The Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK , Oct. 17, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 10/17/2024
|
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman
- SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now.
- 10/16/2024
|
Edwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards”) (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is December 13, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suff.
- 10/16/2024
|
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corporation (EW)
- NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of all persons or entities who purchased or otherwise acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”). The lawsuit seeks to recover damages for the Company's investors under the federal securities laws.
- 10/16/2024
|
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
- NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108801&wire=1 or contact Joseph E. Levi, Esq.
- 10/16/2024
|
EW FRAUD ALERT: BFA Law Alerts Edwards Lifesciences Corporation Investors to Contact the Firm before Upcoming December 13 Court Deadline in Securities Fraud Class Action
- NEW YORK, NY / ACCESSWIRE / October 16, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 10/16/2024
|
Lost Money on Edwards Lifesciences Corporation (EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108789&wire=1 or contact Joseph E. Levi, Esq.
- 10/16/2024
|
The Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation (EW) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW).
- 10/16/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108768&wire=1 or contact Joseph E. Levi, Esq.
- 10/16/2024
|
Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Q3 Release
- Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/16/2024
|
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Encourages Shareholders With Losses To Take Part
- LOS ANGELES, CA / ACCESSWIRE / October 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
- 10/16/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108700&wire=1 or contact Joseph E. Levi, Esq.
- 10/16/2024
|
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Investors With Large Losses in Edwards Lifesciences Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights
- NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Edwards Lifesciences Corporation (“Edwards” or the “Company”) (NYSE: EW) between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”). For more information, submit a form at Edwards Lifesciences Corporation Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or call us at (212) 951-2030.
- 10/16/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108694&wire=1 or contact Joseph E. Levi, Esq.
- 10/16/2024
|
EW STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / October 16, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/16/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
- NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108662&wire=1 or contact Joseph E. Levi, Esq.
- 10/16/2024
|
Investors who lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108658&wire=1 or contact Joseph E. Levi, Esq.
- 10/16/2024
|
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Edwards Lifesciences Corporation
- SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024. Edwards is an international company that researches, develops, provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions.
- 10/16/2024
|
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Edwards Lifesciences Corporation (EW) on Behalf of Investors
- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Edwards Lifesciences investments or would like to inquire about potentially pursuing claims to recover your.
- 10/15/2024
|
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Edwards Lifesciences Corporation (EW) on Behalf of Investors
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) investors concerning the Company's possible violations of federal securities laws. On July 24, 2024, Edwards Lifesciences announced fiscal second quarter 2024 results which came in below expectations. The Company also announced lowered projections for its core Transcatheter Aortic Valve Replacement (TAVR) pla.
- 10/15/2024
|
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES--(BUSINESS WIRE)--EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm.
- 10/15/2024
|
The Law Offices of Frank R. Cruz Announces Investigation of Edwards Lifesciences Corporation (EW) on Behalf of Investors
- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On July 24, 2024, Edwards Lifesciences announced fiscal second quarter 2024 results which came in below expectations. The Company also announced lowere.
- 10/15/2024
|
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
- NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108648&wire=1 or contact Joseph E. Levi, Esq.
- 10/15/2024
|
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
- NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Edwards Lifesciences Corp (“Edwards” or the “Company”) (NYSE: EW) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). Investors have until December 13 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- 10/15/2024
|
Rosen Law Firm Urges Edwards Lifesciences Corporation (NYSE: EW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
- NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024. Edwards describes itself as an “international company that researches, develops, provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions.” For more information, su.
- 10/15/2024
|
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EW
- NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108625&wire=1 or contact Joseph E. Levi, Esq.
- 10/15/2024
|
EW LEGAL NEWS: Suffer Losses on Your Edwards Lifesciences Corporation Investment? Contact BFA Law before Expiration of Upcoming December 13 Deadline (NYSE:EW)
- NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
- 10/15/2024
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders
- NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108617&wire=1 or contact Joseph E. Levi, Esq.
- 10/15/2024
|
EW INVESTOR DEADLINE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- SAN DIEGO, CA / ACCESSWIRE / October 15, 2024 / The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE:EW) securities between February 6, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), have until December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v.
- 10/15/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108606&wire=1 or contact Joseph E. Levi, Esq.
- 10/15/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and certain of its officers.
- 10/15/2024
|
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108580&wire=1 or contact Joseph E. Levi, Esq.
- 10/15/2024
|
EW BREAKING NEWS: Edwards Lifesciences Corporation has been Sued for Securities Fraud; Investors with Losses are Urged to Contact BFA Law about Class Action Lawsuit (NYSE:EW)
- Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
- 10/15/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Edwards Lifesciences Corporation - EW
- NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE:EW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 10/15/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108450&wire=1 or contact Joseph E. Levi, Esq.
- 10/15/2024
|
EW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/15/2024
|
Investors who lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
- NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108405&wire=1 or contact Joseph E. Levi, Esq.
- 10/14/2024
|
EW INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead the Edwards Lifesciences Class Action Lawsuit
- SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), have until December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v. Edwards Lifesciences Corporation, No. 24-cv-02221 (C.D. Cal.), the Edwards Lifesciences class action lawsuit charges Edwards Lifesciences and certain of Edwards Lifesciences' top executives with violations of the Securities Exchange Act of 1934.
- 10/14/2024
|
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
- NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108401&wire=1 or contact Joseph E. Levi, Esq.
- 10/14/2024
|
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Edwards Lifesciences Corporation Securities and Sets a Lead Plaintiff Deadline of December 13, 2024
- NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Edwards Lifesciences Corporation (“Edwards” or the “Company”) (NYSE: EW) between February 6, 2024 to July 24, 2024, both dates inclusive . You are hereby notified that the class action lawsuit Dhimant Patel v.
- 10/14/2024
|
EW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / October 14, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edwards securities between February 6, 2024, and July 24, 2024, inclusive (the "Class Period").
- 10/14/2024
|
An Investigation Has Commenced on Behalf of Edwards Lifesciences Corporation Shareholders. Contact Levi & Korsinsky to Discuss your EW Losses
- NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 10/14/2024
|
Shareholder Rights Advocates at Levi & Korsinsky Investigate Edwards Lifesciences Corporation (EW) Regarding Possible Securities Fraud Violations
- NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 10/11/2024
|
Shareholder Rights Advocates at Levi & Korsinsky Investigate Edwards Lifesciences Corporation (EW) Regarding Possible Securities Fraud Violations
- NEW YORK, NY / ACCESSWIRE / October 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 10/10/2024
|
Edwards Lifesciences Corporation (EW) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
- NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 10/09/2024
|
Edwards Lifesciences Soars on TTVR Approval, But Challenges Remain
- Edwards Lifescience (EW, Financial), a medical device company that specializes in cardiovascular, today by soaring 6% to $68.49 per share at the time this article was written. Technical analysis suggests that it's the moment of “strong buy”.
- 10/08/2024
|
ATTENTION EW SHAREHOLDERS: Investors who lost money on Edwards Lifesciences Corporation are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESSWIRE / October 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 10/08/2024
|
TFX vs. EW: Which Stock Is the Better Value Option?
- Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
- 10/07/2024
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Edwards Lifesciences Corporation (EW)
- NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 10/07/2024
|
Is it the Right Time to Hold EW Stock in Your Portfolio Now?
- Edward Lifesciences' Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.
- 10/03/2024
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Edwards Lifesciences Corporation (EW)
- NEW YORK, NY / ACCESSWIRE / October 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 10/02/2024
|
EW ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Edwards Lifesciences Corporation
- NEW YORK, NY / ACCESSWIRE / September 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/30/2024
|
Edwards Lifesciences Corporation Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - EW
- NEW YORK, NY / ACCESSWIRE / September 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/30/2024
|
Edwards Lifesciences Corporation Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - EW
- NEW YORK, NY / ACCESSWIRE / September 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/28/2024
|
ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM
- NAPERVILLE, Ill. , Sept. 28, 2024 /PRNewswire/ -- Endotronix, an Edwards Lifesciences company (NYSE: EW), today announced the one-year clinical results from PROACTIVE-HF, evaluating outcomes for the Cordella Pulmonary Artery (PA) Sensor System.
- 09/28/2024
|
Shareholder Rights Advocates at Levi & Korsinsky Investigate Edwards Lifesciences Corporation (EW) Regarding Possible Securities Fraud Violations
- NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/27/2024
|
Investors who lost money on Edwards Lifesciences Corporation should contact Levi & Korsinsky about an ongoing investigation - EW
- NEW YORK, NY / ACCESSWIRE / September 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/26/2024
|
ATTENTION EW SHAREHOLDERS: Investors who Lost Money on Edwards Lifesciences Corporation are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / September 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/25/2024
|
What's Happening With Edwards Lifesciences Stock?
- Edwards Lifesciences (NYSE: EW), a medical technology company specializing in artificial heart valves, currently trades at $67 per share, about 50% lower than the peak level of $131 seen in December 2021. EW has fared much worse than its peer – Medtronic stock (NYSE: MDT) – down 7% over this period.
- 09/24/2024
|
Levi & Korsinsky Announces an Investigation on Behalf of Edwards Lifesciences Corporation (EW) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESSWIRE / September 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/24/2024
|
Edwards Lifesciences Corporation INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Edwards Lifesciences (EW)
- NEW YORK, NY / ACCESSWIRE / September 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/23/2024
|
TFX vs. EW: Which Stock Should Value Investors Buy Now?
- Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 09/20/2024
|
EW STOCK ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / September 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/20/2024
|
ATTENTION EW SHAREHOLDERS: Investors who lost money on Edwards Lifesciences Corporation are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/19/2024
|
Edwards Lifesciences: Solvable Problems Offer Excellent Opportunities
- Edwards Lifesciences faces temporary issues, but its strong market position and competitive edge make it an attractive long-term investment opportunity. The company is transitioning, focusing on its cardiovascular business after divesting its Critical Care segment and acquiring Endotronix and JenaValve. Growth opportunities include international expansion and increasing awareness of heart conditions, with significant potential in low- and middle-income countries.
- 09/18/2024
|
Edwards Lifesciences Corporation Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - EW
- NEW YORK, NY / ACCESSWIRE / September 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/18/2024
|
EW STOCK ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / September 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/17/2024
|
Lost Money on Edwards Lifesciences Corporation (EW)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / September 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/16/2024
|
Lost Money on Edwards Lifesciences Corporation (EW)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/13/2024
|
Edwards Lifesciences Corporation Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - EW
- NEW YORK, NY / ACCESSWIRE / September 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/12/2024
|
Edwards Lifesciences Corporation Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/11/2024
|
EW STOCK ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / September 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/10/2024
|
Lost Money on Edwards Lifesciences Corporation(EW)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/09/2024
|
EW STOCK ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / September 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/06/2024
|
Edwards Lifesciences Corporation Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - EW
- NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/05/2024
|
EW Stock Dips Following the Divestiture of Critical Care Wing
- Edwards completes the sale of its Critical Care operations and announces a $1 billion share repurchase program.
- 09/04/2024
|
ATTENTION EW SHAREHOLDERS: Investors who lost money on Edwards Lifesciences Corporation are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESSWIRE / September 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/04/2024
|
East West Petroleum Announces Payment Date of Previously Announced Cash Distribution to Shareholders
- Vancouver, British Columbia--(Newsfile Corp. - September 3, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to announce that, further to its news releases of August 16, 2024 and August 29, 2024, the special distribution to holders of common shares of the Company ("Shareholders") by way of a return of capital, in the amount of $0.03 per common share of the Company, for an aggregate distribution amount of $ 2,714,569.95 (the "Distribution"), will be paid by the Company's paying agent, Computershare Investor Services Inc. (the "Paying Agent"), on September 12, 2024. Each registered Shareholder of record on September 5, 2024 (the "Record Date") will receive a cheque from the Paying Agent representing their pro rata share of the Distribution.
- 09/03/2024
|
Levi & Korsinsky Announces an Investigation on Behalf of Edwards Lifesciences Corporation (EW) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESSWIRE / September 3, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 09/03/2024
|
EW Stock to Benefit From Favorable RHEIA Trial Data on TAVI
- Edwards' first all-female TAVI Trial demonstrates favorable outcomes for women receiving Edwards valves.
- 09/02/2024
|
CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
- LONDON--(BUSINESS WIRE)--Please replace the release with the following corrected version. The updated release reads: FIRST ALL-FEMALE TAVI TRIAL SHOWS EXCELLENT OUTCOMES FOR WOMEN RECEIVING EDWARDS VALVES Edwards Lifesciences (NYSE: EW) today announced the results from the RHEIA Trial, a first-of-its-kind trial focused exclusively on outcomes for women receiving transcatheter aortic valve implantation (TAVI). Presenting one-year results during a Hot Line session at the ESC Congress 2024, invest.
- 08/31/2024
|
First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
- LONDON--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced the results from the RHEIA Trial, a first-of-its-kind trial focused exclusively on outcomes for women receiving transcatheter aortic valve implantation (TAVI). Presenting one-year results during a Hot Line session at the ESC Congress 2024, investigators reported superior outcomes for women receiving the Edwards SAPIEN 3 Ultra or SAPIEN 3 Ultra RESILIA valves as compared to those receiving surgical aortic valve replacement.
- 08/31/2024
|
EW STOCK ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/29/2024
|
East West Petroleum Announces Cash Distribution to Shareholders by Way of Return of Capital
- Vancouver, British Columbia--(Newsfile Corp. - August 29, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to announce that, further to its news release of August 16, 2024, it will distribute to holders of common shares of the Company ("Shareholders") by way of a return of capital, $0.03 per common share of the Company, for an aggregate distribution amount, based on today's issued and outstanding shares, of $2,714,569.95 (the "Distribution"). At the special meeting of Shareholders held on August 16, 2024 (the "Meeting"), Shareholders approved the reduction of the stated capital of the Company (the "Capital Reduction") for the purposes of the Distribution.
- 08/29/2024
|
Edwards Lifesciences Being Investigated on Behalf of Edwards Lifesciences Corporation Investors. Contact Levi & Korsinsky For Details.
- NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/28/2024
|
EW ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Edwards Lifesciences Corporation
- NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/27/2024
|
ATTENTION EW SHAREHOLDERS: Investors who lost money on Edwards Lifesciences Corporation are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/26/2024
|
Edwards Lifesciences (EW) Up 19.4% Since Last Earnings Report: Can It Continue?
- Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock?
- 08/23/2024
|
Edwards Lifesciences Corporation Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - EW
- NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/23/2024
|
ATTENTION EW SHAREHOLDERS: Investors who Lost Money on Edwards Lifesciences Corporation are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/22/2024
|
ATTENTION Edwards Lifesciences Corporation Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
- NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/21/2024
|
Levi & Korsinsky Announces an Investigation on Behalf of Edwards Lifesciences Corporation (EW) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/20/2024
|
TFX or EW: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Teleflex (TFX) or Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
- 08/19/2024
|
ATTENTION EW SHAREHOLDERS: Investors who lost money on Edwards Lifesciences Corporation are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/19/2024
|
East West Petroleum Shareholders Approve Return of Capital
- Vancouver, British Columbia--(Newsfile Corp. - August 16, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") announces that its shareholders have today approved its previously announced return of capital by way of a reduction in stated capital of the Company. In accordance with the special resolution passed by the shareholders, the board of directors of the Company has determined that the stated capital of the Company, which is currently $39,868,761, will be reduced by up to $3 million, pursuant to the Business Corporations Act (British Columbia), for the purposes of distributing to the holders of common shares of the Company a portion of the Company's cash in the amount of $0.03 per common share (the "Distribution").
- 08/16/2024
|
Should You Hold Edward Lifesciences (EW) in Your Portfolio Now?
- Edward Lifesciences' (EW) promising TAVR business and the Critical Care divestment move bode well in the long term.
- 08/16/2024
|
Did Edwards Lifesciences Corporation Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - EW
- NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/16/2024
|
Investors who Lost Money on Edwards Lifesciences Corporation Should Contact Levi & Korsinsky About an Ongoing Investigation - EW
- NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/15/2024
|
Levi & Korsinsky Announces an Investigation on Behalf of Edwards Lifesciences Corporation (EW) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/14/2024
|
Did Edwards Lifesciences Corporation Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - EW
- NEW YORK, NY / ACCESSWIRE / August 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/13/2024
|
Lost Money on Edwards Lifesciences Corporation(EW)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / August 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/12/2024
|
Lost Money on Edwards Lifesciences Corporation (EW)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/09/2024
|
EW ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Edwards Lifesciences Corporation investment
- NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/08/2024
|
Edwards Lifesciences Corporation (EW) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
- NEW YORK, NY / ACCESSWIRE / August 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/07/2024
|
Edwards Lifesciences Corporation Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - EW
- NEW YORK, NY / ACCESSWIRE / August 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/06/2024
|
Edwards Lifesciences Corporation Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - EW
- NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/05/2024
|
TFX or EW: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 08/02/2024
|
Shareholders that lost money on Edwards Lifesciences Corporation (EW) should contact Levi & Korsinsky about Securities Fraud Investigation - EW
- NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/02/2024
|
Top 3 Health Care Stocks That Are Set To Fly This Quarter
- The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
- 08/01/2024
|
Investors who lost money on Edwards Lifesciences Corporation should contact Levi & Korsinsky about an ongoing investigation - EW
- NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 08/01/2024
|
7 Leading MedTech Stocks for Next-Gen Health Solutions
- While technology lately has been framed in the context of computer hardware or software, it can also apply to the broader field of medicine. Therefore, investors should consider the viable field of MedTech stocks.
- 07/31/2024
|
ATTENTION EW SHAREHOLDERS: Investors who lost money on Edwards Lifesciences Corporation are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 07/30/2024
|
East West Petroleum Provides Update on Proposed Return of Capital
- Vancouver, British Columbia--(Newsfile Corp. - July 30, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to provide this update in regard to the status of the proposed return of capital announced on June 19, 2024. The Company has prepared and mailed its management information circular (the "Circular") and related proxy materials (collectively, the "Meeting Materials") to its shareholders ("Shareholders") in connection with the special meeting of Shareholders to be held at 10:00 a.m.
- 07/30/2024
|
Edwards Lifesciences (EW) Reliance on International Sales: What Investors Need to Know
- Evaluate Edwards Lifesciences' (EW) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
- 07/29/2024
|
An Investigation Has Commenced on Behalf of Edwards Lifesciences Corporation Shareholders. Contact Levi & Korsinsky to Discuss your EW Losses.
- NEW YORK, NY / ACCESSWIRE / July 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 07/29/2024
|
3 Healthcare Stocks to Buy at a 52-Week Low in July
- Finding value in this market is difficult because the S&P 500 has increased over 50% since its bottom in October 2022. Certainly, you won't find it in technology or mega caps, which have soared due to the AI craze.
- 07/29/2024
|
Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut
- Edwards Lifesciences cut TAVR guidance, stock price dropped by over 31%. Recent acquisitions and divestiture of the Critical Care business show strategic focus on the structural heart market. Analyst reiterates 'Strong Buy' rating with a fair value of $72 per share, confident in long-term growth potential.
- 07/26/2024
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Edwards Lifesciences Corporation (EW)
- NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 07/26/2024
|
S&P 500 Gains and Losses Today: Edwards Lifesciences Sinks on Outlook for Key Product
- Major U.S. equities indexes were mixed after a report showing U.S. gross domestic product (GDP) grew at a greater-than-expected annualized rate of 2.8% in the second quarter.
- 07/25/2024
|
Edwards Lifesciences Stock Plummeted Today. Here's Why
- Edwards Lifesciences (EW) shares swooned Thursday, dropping after the company damped expectations for heart valve replacement sales growth on Wednesday.
- 07/25/2024
|
Edwards Lifesciences Stock Tumbles, Highlights Slowdown In TAVR Business
- Edwards Lifesciences Corp EW reported Wednesday second-quarter adjusted EPS of 70 cents, beating the consensus of 69 cents.
- 07/25/2024
|
These Analysts Slash Their Forecasts On Edwards Lifesciences Following Q2 Results
- Edwards Lifesciences Corporation EW reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix.
- 07/25/2024
|
Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash
- Edwards Lifesciences (EW) reports strong contributions from the TMTT product group in the second quarter of 2024.
- 07/25/2024
|
Why Is Edwards Lifesciences (EW) Stock Down 22% Today?
- Edwards Lifesciences (NYSE: EW ) stock is down on Thursday after the heart disease care company announced earnings for its second quarter of 2024. That earnings report starts with its adjusted EPS of 70 cents.
- 07/25/2024
|
Peijia Medical's Licensing Partner, JenaValve Technology, Inc., is Expected to be Acquired by Edwards Lifesciences
- Peijia to maintain exclusive rights in Greater China to commercialize JenaValve's Trilogy Transcatheter Heart Valve (THV) System SUZHOU, China , July 25, 2024 /PRNewswire/ -- Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, today commented on the expected acquisition of JenaValve Technology, Inc. ("JenaValve"), an exclusive technology licensing partner of Peijia, by Edwards Lifesciences ("Edwards"). On July 24, 2024, Edwards announced that it had entered into an agreement to acquire JenaValve, a pioneer in the transcatheter treatment of aortic regurgitation (AR), a deadly disease that impacts a significant and growing population and is currently untreated today.
- 07/25/2024
|
Edwards Lifesciences Stock Plunges 24% After Earnings. What Wall Street Thinks.
- The medical-technologies company misses second-quarter sales estimates.
- 07/25/2024
|
Edwards Lifesciences Corporation INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Edwards Lifesciences (EW)
- NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 07/25/2024
|
Edwards Lifesciences Corporation (EW) Q2 2024 Earnings Call Transcript
- Edwards Lifesciences Corporation (NYSE:EW ) Q2 2024 Earnings Conference Call July 24, 2024 5:00 PM ET Company Participants Mark Wilterding - SVP & IR Bernard Zovighian - CEO Scott Ullem - CFO Larry Wood - Group President of TAVR and Surgical Structural Heart Daveen Chopra - Global Leader of TMTT Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan David Roman - Goldman Sachs Joshua Jennings - TD Cowen Travis Steed - Bank of America Matthew Taylor - Jefferies Vijay Kumar - Evercore ISI Patrick Wood - Morgan Stanley Operator Greetings, and welcome to the Edwards Lifesciences Second Quarter 2024 Results. At this time, all participants are in a listen-only mode.
- 07/24/2024
|
Edwards Lifesciences (EW) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- While the top- and bottom-line numbers for Edwards Lifesciences (EW) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 07/24/2024
|
Edwards Lifesciences (EW) Q2 Earnings Match Estimates
- Edwards Lifesciences (EW) came out with quarterly earnings of $0.70 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.66 per share a year ago.
- 07/24/2024
|
Edwards Lifesciences misses Q2 revenue estimates on weak demand for heart devices
- Edwards Lifesciences missed second-quarter revenue estimates on Thursday, hurt by lower-than-expected demand for its artificial heart valves.
- 07/24/2024
|
Edwards Lifesciences Corporation Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - EW
- NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
- 07/24/2024
|
Can These 4 MedTech Stocks Hit Targets This Earnings Season?
- Here is a sneak peek into how four MedTech bigshots, BSX, TMO, ALGN and EW, are expected to fare in their second-quarter results, slated to be released tomorrow.
- 07/23/2024
|
Edwards Lifesciences (EW) Buys Innovalve to Boost TMVR Solutions
- Edwards Lifesciences (EW) exercises the option to acquire Innovalve Bio-Medical Ltd., strengthening its TMVR technology portfolio and addressing unmet needs in structural heart disease.
- 07/18/2024
|
Edwards Lifesciences (EW) Reports Next Week: Wall Street Expects Earnings Growth
- Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/17/2024
|
Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings?
- Edwards Lifesciences' (EW) TMTT segment's PASCAL platform is likely to have maintained strong growth momentum in the second quarter globally, backed by its portfolio of differentiated therapies.
- 07/15/2024
|
HOLX or EW: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Hologic (HOLX) or Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 07/12/2024
|
Final Trades: Edwards Lifesciences, First Citizens, UnitedHealth and iShares US Real Estate ETF
- The Investment Committee give you their top stocks to watch for the second half.
- 07/10/2024
|
Final Trades: Edwards Lifesciences, American Tower & TransDigm
- The Investment Committee discuss their top stocks to watch for the second half.
- 06/26/2024
|
HOLX vs. EW: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Instruments sector have probably already heard of Hologic (HOLX) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 06/26/2024
|
East West Petroleum Announces Proposed Return of Capital
- Vancouver, British Columbia--(Newsfile Corp. - June 19, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") announces that the Board of directors has determined that its in the best interest of the Company to return capital to its shareholders by way of a reduction in stated capital of the Company. The Company will call a special meeting of its shareholders, to be held in August 2024 (the "Meeting"), where shareholders will be asked to consider and, if advisable, approve, among other things, a reduction in the stated capital of the Company (the "Capital Reduction"), which is currently $39,868,761, by up to $ 3 million, pursuant to the Business Corporations Act (British Columbia), for the purposes of distributing to the holders of common shares of the Company a portion of the Company's cash in the amount of $0.03 per common share (the "Distribution").
- 06/19/2024
|
HOLX vs. EW: Which Stock Should Value Investors Buy Now?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Hologic (HOLX) or Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 06/10/2024
|
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
- NEW YORK--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient's annulus size or sex. These data were presented during the late-breaking clini.
- 06/05/2024
|
Becton Dickinson Buys Critical Care Unit From Edwards Lifesciences for $4.2B
- Shares of Becton Dickinson (BDX) advanced close to 3% Monday as the maker of syringes and other medical devices announced it was buying the Critical Care product unit of Edwards Lifesciences (EW) for $4.2 billion in cash.
- 06/03/2024
|
Calls of the Day: Costco, Edwards Lifesciences, Citigroup, American Express & Fedex
- The Investment Committee give you their take on the latest Calls of the Day.
- 06/03/2024
|
Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash
- The buyer intends to fund deal with a combination of $1 billion in cash and $3.2 billion of new debt in a transaction that is one of its largest of many.
- 06/03/2024
|
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln
- Edwards Lifesciences on Monday said it has agreed to sell its Critical Care products unit to Becton Dickinson in an all-cash transaction valued at $4.2 billion.
- 06/03/2024
|
Edwards Lifesciences to sell its critical care product group for $4.2 billion to Becton Dickinson
- Shares of Edwards Lifesciences Corp. EW, -1.14% rallied 3% in premarket trading Monday, after the company announced an agreement to sell its critical care product group to Becton Dickinson & Co. BDX, +2.29% in a cash deal valued at $4.2 billion. Edwards said it plans to use the proceeds from the sale to fund investments for growth, such as in technologies for technologies for aortic, mitral, tricuspid and pulmonic patients, and in therapeutic areas for interventional heart failure.
- 06/03/2024
|
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
- Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS Expands BD's portfolio of smart connected care solutions with complementary and broad set of leading monitoring technologies, advanced AI-enabled clinical decision tools and robust innovation pipeline Critical Care to operate as a separate business unit within BD's Medical segment, based in Irvine, Calif. and led by Katie Szyman FRANKLIN LAKES, N.J.
- 06/03/2024
|
Edwards Lifesciences to Sell Critical Care to BD
- IRVINE, CA--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin-off of Critical Care. Edwards will use the after-tax cash proceeds to fund strategic growth investments. The sale enhances Edwards' balance sheet flexibilit.
- 06/03/2024
|
HOLX or EW: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Hologic (HOLX) or Edwards Lifesciences (EW). But which of these two stocks presents investors with the better value opportunity right now?
- 05/24/2024
|
Here's Why You Should Retain Edward Lifesciences (EW) for Now
- Investors are optimistic about Edward Lifesciences (EW), led by the strong performance of its SAPIEN 3 Ultra RESILIA platform and strong solvency.
- 05/24/2024
|
Edwards Lifesciences hit with Meril's EU antitrust complaint
- U.S. heart valve maker Edwards Lifesciences has been hit with an EU antitrust complaint by Indian rival Meril including for allegedly anti-competitive practices related to patents, a move that could bolster EU regulators' scrutiny of Edwards.
- 05/13/2024
|
ALC vs. EW: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Instruments sector have probably already heard of Alcon (ALC) and Edwards Lifesciences (EW). But which of these two stocks presents investors with the better value opportunity right now?
- 05/07/2024
|
Is Edwards Lifesciences (EW) Outperforming Other Medical Stocks This Year?
- Here is how Edwards Lifesciences (EW) and SNDL Inc. (SNDL) have performed compared to their sector so far this year.
- 05/01/2024
|
Down -10.22% in 4 Weeks, Here's Why You Should You Buy the Dip in Edwards Lifesciences (EW)
- The heavy selling pressure might have exhausted for Edwards Lifesciences (EW) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- 05/01/2024
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
- Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
- 04/30/2024
|
Investing in Edwards Lifesciences (EW)? Don't Miss Assessing Its International Revenue Trends
- Explore how Edwards Lifesciences' (EW) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
- 04/29/2024
|
Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up
- Strong performance of SAPIEN 3 Ultra RESILIA platform and sustainable TAVR growth drives Edwards Lifesciences (EW) Q1 revenues.
- 04/26/2024
|
Edwards Lifesciences Corporation (EW) Q1 2024 Earnings Call Transcript
- Edwards Lifesciences Corporation (NYSE:EW ) Q1 2024 Earnings Conference Call April 25, 2024 5:00 PM ET Company Participants Mark Wilterding - SVP & IR Bernard Zovighian - CEO Scott Ullem - CFO Daveen Chopra - Global Leader of TMTT Larry Wood - Group President of TAVR and Surgical Structural Heart Katie Szyman - Global Leader of Critical Care Conference Call Participants Robbie Marcus - JPMorgan Travis Steed - Bank of America Larry Biegelsen - Wells Fargo Matt Taylor - Jefferies Joanne Wuensch - Citi Matt Miksic - Barclays Shagun Singh - RBC Capital Markets Chris Pasquale - Nephron Research Philip Chickering - Deutsche Bank Richard Newitter - Truist Securities Danielle Antalffy - UBS Joshua Jennings - TD Cowen Operator Greetings, and welcome to the Edwards Lifesciences First Quarter 2024 Results. At this time, all participants are in a listen-only mode.
- 04/25/2024
|
Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 04/25/2024
|
Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates
- Edwards Lifesciences (EW) came out with quarterly earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.62 per share a year ago.
- 04/25/2024
|
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength
- Edwards Lifesciences Corp on Thursday reported upbeat first-quarter profit due to strong demand for its artificial heart valves and other medical devices.
- 04/25/2024
|
Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff
- Edwards Lifesciences stock was muted late Thursday after the company beat first-quarter calls and gave more color into a looming spinoff.
- 04/25/2024
|
Edwards Lifesciences Reports First Quarter Results
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2024. Highlights and Outlook Q1 sales grew 10% on a reported and constant currency1 basis to $1.6 billion Q1 TAVR sales grew 6%; constant currency sales grew 8% adjusted for billing days Q1 TMTT sales grew 75% Q1 EPS of $0.58; adjusted1 EPS of $0.66 Raising 2024 sales guidance to the high end of previous 8 to 10%1 range Raising full-year 2024 sales guidance for TMTT.
- 04/25/2024
|
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
- Here is a sneak peek into how the three major MedTech stocks, LH, EW and RMD, are expected to fare in their quarterly results slated to be released tomorrow.
- 04/24/2024
|
Unveiling Edwards Lifesciences (EW) Q1 Outlook: Wall Street Estimates for Key Metrics
- Besides Wall Street's top -and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
- 04/22/2024
|
5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings
- We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
- 04/19/2024
|
Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/18/2024
|
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com. About Edwards L.
- 04/18/2024
|
Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings?
- The strong adoption of transcatheter heart valves is expected to have led to Edwards Lifesciences' (EW) growth in the first quarter.
- 04/17/2024
|
ITGR vs. EW: Which Stock Should Value Investors Buy Now?
- Investors with an interest in Medical - Instruments stocks have likely encountered both Integer (ITGR) and Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
- 04/16/2024
|
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
- The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth.
- 04/15/2024
|
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
- A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
- 04/10/2024
|
Are Medical Stocks Lagging Edwards Lifesciences (EW) This Year?
- Here is how Edwards Lifesciences (EW) and Avinger (AVGR) have performed compared to their sector so far this year.
- 03/25/2024
|
Edwards Lifesciences (EW) Up 21.8% YTD: What's Driving It?
- Investors are optimistic about Edwards Lifescience's (EW) substantial growth across each of its four product groups.
- 03/19/2024
|
Edwards Lifesciences (EW) Hits 52-Week High: What's Driving It?
- Edwards Lifesciences (EW) outperforms the industry, owing to a robust 2023 fourth-quarter performance, as well as the strong potential in the TMTT division.
- 03/15/2024
|
Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024
- We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.
- 03/14/2024
|
Medical Devices ETF Hits 52-Week High: Stocks to Watch
- Historically viewed as a defensive area, health care also boasts many growth aspects and benefits from advances in technology.
- 03/13/2024
|
Edwards Lifesciences' (EW) SAPIEN TAVR Study Outcome Favorable
- Edwards Lifesciences' (EW) recent study provides insights into the actual performance of small Edwards valves and reaffirms the excellent outcomes for patients receiving SAPIEN TAVR.
- 03/13/2024
|
Edwards (EW) Gains From RESILIA's Global Adoption, TAVR Growth
- With the Critical Care spin-off, Edwards (EW) is looking to pursue growth in TAVR, TMTT and Surgical, as well as new investments in interventional heart failure technologies.
- 03/06/2024
|
HOLX or EW: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Instruments stocks are likely familiar with Hologic (HOLX) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 02/27/2024
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
- Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
- 02/27/2024
|
Here's Why You Should Buy Edward Lifesciences (EW) Stock Now
- Investors are optimistic about Edward Lifesciences' (EW) progress with the Structural Heart business and strong TAVR potential.
- 02/26/2024
|
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen Healthcare Conference on Tuesday, March 5, 2024. Bernard Zovighian, chief executive officer, and Scott Ullem, chief financial officer, are scheduled to present at 10:30 a.m. ET. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day. A.
- 02/23/2024
|
Edwards (EW) Gains From Balanced Core Growth and New Launches
- Edwards (EW) is demonstrating the strong performance of the SAPIEN 3 Ultra valve in the United States, Europe and Rest of World.
- 02/15/2024
|
3 Medtech Stocks Likely to Top Estimates This Earnings Season
- Here are three stocks, GMED, GKOS and PRCT, which are expected to beat earnings estimates in the ongoing reporting cycle.
- 02/13/2024
|
Edwards Lifesciences (EW) Q4 Earnings Meet, Margins Dip
- Edwards Lifesciences' (EW) Q4 revenues register year-over-year growth on its strong differentiated portfolio of advanced therapies.
- 02/07/2024
|
Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript
- Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript
- 02/06/2024
|
Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 02/06/2024
|
Edwards Lifesciences (EW) Q4 Earnings Match Estimates
- Edwards Lifesciences (EW) came out with quarterly earnings of $0.64 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.64 per share a year ago.
- 02/06/2024
|
Edwards Lifesciences beats quarterly estimates on strong heart device sales
- Edwards Lifesciences reported fourth-quarter profit on Tuesday that beat Wall Street estimates, helped by strong demand for the company's artificial heart valves and other devices.
- 02/06/2024
|
Edwards Lifesciences (EW) Wins FDA Nod for the EVOQUE System
- Edwards Lifesciences' (EW) EVOQUE valve replacement system becomes the first transcatheter therapy to earn FDA approval for a tricuspid valve.
- 02/06/2024
|
ITGR or EW: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer (ITGR) or Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
- 02/05/2024
|
Stay Ahead of the Game With Edwards Lifesciences (EW) Q4 Earnings: Wall Street's Insights on Key Metrics
- Beyond analysts' top -and-bottom-line estimates for Edwards Lifesciences (EW), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
- 02/01/2024
|
Strength Seen in Edwards Lifesciences (EW): Can Its 6.2% Jump Turn into More Strength?
- Edwards Lifesciences (EW) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- 02/01/2024
|
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2023 after the market closes on Tuesday, February 6, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com. About Edwar.
- 01/30/2024
|
ITGR vs. EW: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integer (ITGR) and Edwards Lifesciences (EW). But which of these two stocks presents investors with the better value opportunity right now?
- 01/19/2024
|
What's in Store for Edwards Lifesciences (EW) in Q4 Earnings?
- Edwards Lifesciences' (EW) Q4 results are likely to reflect continued demand for its state-of-the-art HemoSphere monitoring platform and Smart Recovery portfolio in Critical Care.
- 01/19/2024
|
Edwards Lifesciences: Undervalued With A Substantial Upside Potential
- Edwards Lifesciences is down 3.10% over the last year but I am bullish due to its optimistic outlook and growth initiatives. The company is committed to its shareholders through EPS growth and share buyback program. EW stock is undervalued with a double-digit upside potential, warranting a buy rating.
- 01/09/2024
|
ITGR vs. EW: Which Stock Should Value Investors Buy Now?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer (ITGR) or Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 01/03/2024
|
Here's Why You Should Retain Edward Lifesciences (EW) Stock Now
- Investors remain optimistic about Edward Lifesciences (EW) due to the strength of its product group.
- 01/03/2024
|
Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 9, 2024. Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived ve.
- 01/02/2024
|
Edwards Lifesciences To Spin-Off Critical Care Unit In 2024
- On December 7, 2024, Edwards Lifesciences EW Corporation (NYSE: EW, $76.90, Market Capitalization: $46.6 billion) in its annual investor call announced its plans to spin-off its Critical Care unit into an independent listed company to focus on structural heart disease (SHD) business.
- 12/19/2023
|
ITGR or EW: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer (ITGR) or Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
- 12/18/2023
|
Edwards Lifesciences (EW) Forwards Growth Strategy and Outlook
- Edwards Lifesciences' (EW) TAVR remains strong, driven by greater awareness, patient activation and advances in new technologies such as RESILIA.
- 12/11/2023
|
Edwards Lifesciences to spin off critical care unit to focus on heart devices
- Edwards Lifesciences said on Thursday it would spin off its critical care unit at the end of 2024 to concentrate on its larger heart devices business.
- 12/07/2023
|
Could Ozempic Harm These 3 Medical Device Stocks?
- Ozempic could make some medical devices less necessary than before. If that happens, it would lead to lower revenue for the device makers.
- 11/25/2023
|
Here's Why You Should Retain Edward Lifesciences (EW) Stock Now
- Investors remain optimistic about Edward Lifesciences (EW) due to Surgical's differentiated portfolio and TMTT franchise.
- 11/23/2023
|
ITGR or EW: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer (ITGR) or Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 11/15/2023
|
ITGR or EW: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Instruments stocks have likely encountered both Integer (ITGR) and Edwards Lifesciences (EW). But which of these two stocks is more attractive to value investors?
- 10/30/2023
|
Why Edwards Lifesciences Stock Plummeted Today
- The maker of medical devices posted third-quarter results that broadly met analyst expectations. That wasn't the reason for the resulting investor sell-off, however.
- 10/26/2023
|
Edwards Lifesciences (EW) Q3 Earnings Match Mark, Margins Dip
- Edwards Lifesciences (EW) TMTT performance benefits from the accelerated adoption of the differentiated PASCAL precision platform in the third quarter.
- 10/26/2023
|
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
- Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include PepsiCo (PEP), The J.M.
- 10/26/2023
|
Edwards Lifesciences Corporation (EW) Q3 2023 Earnings Call Transcript
- Edwards Lifesciences Corporation (NYSE:EW ) Q3 2023 Earnings Conference Call October 25, 2023 5:00 PM ET Company Participants Mark Wilterding - SVP, IR and Treasurer Bernard Zovighian - CEO Scott Ullem - CFO Larry Wood - Group President, TAVR and Surgical Structural Heart Daveen Chopra - Global Leader of TMTT Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Joshua Jennings - Cowen Travis Steed - Bank of America Joanne Wuensch - Citibank Matt Miksic - Barclays Danielle Antalffy - UBS Pito Chickering - Deutsche Bank Operator Greetings, and welcome to the Edwards Lifesciences Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
- 10/26/2023
|
Edwards Lifesciences (EW) Reports Q3 Earnings: What Key Metrics Have to Say
- While the top- and bottom-line numbers for Edwards Lifesciences (EW) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 10/25/2023
|
Edwards Lifesciences (EW) Q3 Earnings Match Estimates
- Edwards Lifesciences (EW) came out with quarterly earnings of $0.59 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.61 per share a year ago.
- 10/25/2023
|
Edwards Lifesciences quarterly sales jump on robust demand for heart devices
- Edwards Lifesciences Corp on Wednesday reported a 12% rise in third-quarter sales, helped by strong demand for the company's artificial heart valves and other devices.
- 10/25/2023
|
5 Large-Cap Stocks to Buy Ahead of Q3 Earnings This Week
- We have narrowed our search to five large-cap stocks that are set to declare third-quarter earnings results this week. These are: EW, VICI, VMC, GLPI, MBLY.
- 10/25/2023
|
What's in Store for Edwards Lifesciences (EW) in Q3 Earnings?
- Outside the United States, Edwards Lifesciences (EW) TAVR sales growth will likely be driven by broad-based adoption of the SAPIEN platform.
- 10/23/2023
|
4 Medical Product Stocks Set to Outpace Q3 Earnings Estimates
- Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EW, PODD, DXCM and IQV are poised ahead of their earnings release.
- 10/19/2023
|
Why Edwards Lifesciences (EW) Could Beat Earnings Estimates Again
- Edwards Lifesciences (EW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/18/2023
|
EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 25, 2023
- IRVINE, Calif. , Oct. 18, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2023 after the market closes on Wednesday, October 25, 2023, and will host a conference call at 5:00 p.m.
- 10/18/2023
|
MedTech Earnings in the Age of Ozempic May Not Be That Bad
- September-quarter earnings among medical-device makers may prove better than expected in the age of weight-loss drugs.
- 10/17/2023
|
Here's Why You Should Buy Edward Lifesciences (EW) Stock Now
- Investors remain optimistic about Edward Lifesciences (EW) on the strength of the Critical Care business and TAVR sales.
- 10/17/2023
|
Why you can trust the stock market's current ‘buy' signals
- The stock market, as measured by the S&P 500 Index SPX, has bounced off support, but it remains to be seen if this just an oversold rally or if it is the beginning of a new bullish trend. The support came in two forms: the 4200 level (horizontal blue line on the accompanying SPX chart) and the rising 200-day Moving Average of SPX.
- 10/12/2023
|
ITGR or EW: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer (ITGR) or Edwards Lifesciences (EW). But which of these two stocks presents investors with the better value opportunity right now?
- 09/21/2023
|
Here's Why You Should Invest in Edward Lifesciences (EW) Now
- Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of TAVR and a solid balance sheet.
- 09/13/2023
|
ITGR vs. EW: Which Stock Is the Better Value Option?
- Investors interested in Medical - Instruments stocks are likely familiar with Integer (ITGR) and Edwards Lifesciences (EW). But which of these two stocks is more attractive to value investors?
- 09/05/2023
|
Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains
- When you consider healthcare stocks, do you automatically think of pharmaceutical companies? Most people do.
- 08/30/2023
|
Will Edwards Lifesciences Stock Recover To Its Pre-Inflation Shock Highs Of $130?
- Investors still have concerns about a potential recession despite a steady decline in the inflation rate in response to the Fed's aggressive rate hike plan.
- 08/29/2023
|
EDWARDS LIFESCIENCES TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE
- IRVINE, Calif., Aug. 28, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the 2023 Wells Fargo Healthcare Conference on Thursday, September 7, 2023.
- 08/28/2023
|
Edwards Lifesciences (EW) Rides on TAVR Amid Rise in Costs
- Edwards Lifesciences' (EW) Surgical Structural Heart business growth is driven by increased penetration of its premium RESILIA products across all regions.
- 08/21/2023
|
Edwards Lifesciences: Rising Dominance In Structural Heart Disease
- Edwards Lifesciences is the global leader in medical devices for structural heart disease and critical care monitoring. Their Transcatheter Aortic Valve Replacement technology dominates the market and is expected to continue its leading position. EW's growth is driven by the under-penetrated TAVR market and advancements in surgical structural heart and critical care therapies.
- 08/21/2023
|
ITGR vs. EW: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integer (ITGR) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 08/18/2023
|
Here's Why You Should Invest in Edward Lifesciences (EW) Now
- Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of a solid foundation for innovative therapies.
- 08/16/2023
|
3 MedTech Stocks Likely to Top Estimates This Earnings Season
- MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EYE, CAH and HSIC are poised ahead of their earnings releases.
- 08/03/2023
|
You can still run with the stock market's bulls, but watch the exits
- The stock market, as measured by the S&P 500 Index SPX, -0.64% ), has been moving upward. The U.S. benchmark index is essentially crawling up the higher “modified Bollinger Bands” (mBB), which is a bit of an overbought condition, but not a sell signal.
- 07/27/2023
|
Edwards Lifesciences (EW) Q2 Earnings Top Estimates, View Up
- The growing adoption of the PASCAL Precision system in Europe and the United States and Edwards' premium products across all regions have driven Edwards Lifesciences' (EW) Q2 revenues.
- 07/27/2023
|
Edwards Lifesciences Corporation (EW) Q2 2023 Earnings Call Transcript
- Edwards Lifesciences Corporation (NYSE:EW ) Q2 2023 Earnings Conference Call July 26, 2023 5:00 PM ET Company Participants Mark Wilterding - SVP, IR and Treasurer Bernard Zovighian - CEO Scott Ullem - CFO Larry Wood - Group President, TAVR and Surgical Structural Hear Daveen Chopra - Global Leader of TMTT Conference Call Participants Robbie Marcus - JPMorgan Matthew Taylor - Jefferies Vijay Kumar - Evercore ISI Larry Biegelsen - Wells Fargo Travis Steed - Bank of America Josh Jennings - Cowen Chris Pasquale - Nephron Matt Miksic - Barclays Danielle Antalffy - UBS Richard Newitter - Truist Securities Pito Chickering - Deutsche Bank Adam Maeder - Piper Sandler Operator Greetings, and welcome to the Edwards Lifesciences Second Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode.
- 07/26/2023
|
Edwards Lifesciences shares fall as slow heart-valve growth dulls forecast raise
- Edwards Lifesciences Corp on Wednesday slightly raised its annual forecasts for sales and profit, but slower-than-expected revenue growth in the company's artificial heart valves dragged its shares down 6% after the bell.
- 07/26/2023
|
Edwards Lifesciences Sinks Despite An Earnings Beat, Outlook Increase
- Edwards Lifesciences stock fell late Wednesday after the medtech company reported Q2 earnings, narrowly topping profit and revenue expectations.
- 07/26/2023
|
AVNS vs. EW: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Instruments sector have probably already heard of Avanos Medical (AVNS) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 07/24/2023
|
Here's Why You Should Invest in Edward Lifesciences (EW) Now
- Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of the Surgical Structural Heart business.
- 07/19/2023
|
EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JULY 26, 2023
- IRVINE, Calif. , July 19, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2023 after the market closes on Wednesday, July 26, 2023, and will host a conference call at 5:00 p.m.
- 07/19/2023
|
Edwards Lifesciences (EW) Recently Broke Out Above the 20-Day Moving Average
- Edwards Lifesciences (EW) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, EW broke through the 20-day moving average, which suggests a short-term bullish trend.
- 07/11/2023
|
4 GARP Stocks to Scoop Up for Maximum Returns
- Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RACE, GWW, ALLE and EW are some stocks that hold promise.
- 07/05/2023
|
Edwards Lifesciences' (EW) TMTT Sales Aid Amid Margin Woes
- Edwards Lifesciences (EW) continues to expect the global TAVR opportunity to increase to $10 billion by 2028.
- 06/16/2023
|
Edwards Lifesciences: Slowly Approaching Its Intrinsic Value
- Edwards Lifesciences is still reporting solid top-line growth in Q1/23 but the bottom line declined and fiscal 2022 also saw low growth rates. Aside from actual growth rates in the last few quarters, Edwards Lifesciences is a high-quality business with a wide economic moat based on patents and switching costs. For the years to come, analysts as well as management are expecting double-digit growth rates again.
- 06/12/2023
|
Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed
- Medical device stocks, including Edwards Lifesciences, have struggled in recent years, with EW's stock wavering amid uncertainty around its Transcatheter Aortic Valve Replacement procedure. Despite solid Q1 results and increased full-year sales guidance, risks remain regarding growth potential away from TAVR, leading to a hold rating on valuation. The technical picture is also mixed, with some recent weaknesses amid softer momentum.
- 06/12/2023
|
Here's Why You Should Invest in Edward Lifesciences (EW) Now
- Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of the Surgical Structural Heart business and the Critical Care segment.
- 06/05/2023
|
Edwards Lifesciences: Quality at a Bear Market Price
- Edwards Lifesciences Corp. ( EW , Financial) is another of the stocks that suffered due to the 2022 bear market.
- 05/30/2023
|
Edwards Lifesciences' (EW) TAVR Study Outcome Favorable
- Edwards Lifesciences' (EW) latest findings of the study confirm the value of the Edwards Benchmark programme for standardizing clinical pathways for patients undergoing TAVR in Europe.
- 05/18/2023
|
ITGR vs. EW: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer (ITGR) or Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 05/16/2023
|
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
- Medtronic has raised its dividend for 45 consecutive years. Edwards Lifesciences had a strong first quarter and upgraded 2023 guidance.
- 05/01/2023
|
ALC or EW: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Instruments stocks are likely familiar with Alcon (ALC) and Edwards Lifesciences (EW). But which of these two stocks is more attractive to value investors?
- 04/28/2023
|
Edwards Lifesciences (EW) Q1 Earnings Top Estimates, '23 View Up
- Edwards Lifesciences (EW) continues to register strong momentum in TMTT, led by the continued adoption of the PASCAL Precision system in Europe.
- 04/27/2023
|
Edwards Lifesciences Corporation (EW) Q1 2023 Earnings Call Transcript
- Edwards Lifesciences Corporation (EW) Q1 2023 Earnings Call Transcript.
- 04/26/2023
|
Edwards Lifesciences (EW) Beats Q1 Earnings and Revenue Estimates
- Edwards Lifesciences (EW) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.60 per share a year ago.
- 04/26/2023
|
Here's Why You Should Invest in Edwards Lifesciences (EW) Now
- Investors are optimistic about Edwards Lifesciences (EW) on the increased adoption of its premium RESILIA technologies.
- 04/25/2023
|
What's in Store for Edwards Lifesciences (EW) in Q1 Earnings?
- Continued demand for the HemoSphere monitoring platform and Smart Recovery is likely to have contributed to the Edwards Lifesciences' (EW) Q1 growth.
- 04/20/2023
|
EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2023
- IRVINE, Calif. , April 19, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2023 after the market closes on Wednesday, April 26, 2023, and will host a conference call at 5:00 p.m.
- 04/19/2023
|
HOLX or EW: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic (HOLX) and Edwards Lifesciences (EW). But which of these two stocks presents investors with the better value opportunity right now?
- 04/10/2023
|
3 No-Brainer Medical Device Stocks to Buy Right Now
- Edwards Lifesciences' state-of-the-art heart valves have a big growth runway. Abbott Laboratories has received several encouraging FDA approvals recently.
- 04/06/2023
|
HOLX or EW: Which Is the Better Value Stock Right Now?
- HOLX vs. EW: Which Stock Is the Better Value Option?
- 03/07/2023
|
Why Is Edwards Lifesciences (EW) Down 2% Since Last Earnings Report?
- Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock?
- 03/02/2023
|
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
- The Zacks Medical - Instruments industry is growing on rising demand for digital health. EW, IDXX and HOLX are set to gain the most.
- 02/23/2023
|
Edwards Lifesciences (EW) Gains on Innovation, Margin Growth
- In Edwards Lifesciences' (EW) Smart Recovery portfolio, the adoption of FloTrac and ClearSight sensors remains strong.
- 02/20/2023
|
SONVY or EW: Which Is the Better Value Stock Right Now?
- SONVY vs. EW: Which Stock Is the Better Value Option?
- 02/16/2023
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- 02/13/2023
|
Edwards Lifesciences (EW) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 02/01/2023
|
Edwards Lifesciences Corp (EW) Q4 2022 Earnings Call Transcript
- Edwards Lifesciences Corp (NYSE:EW ) Q4 2022 Earnings Conference Call January 31, 2023 5:00 PM ET Company Participants Mark Wilterding - VP, IR Michael Mussallem - Chairman & CEO Scott Ullem - Corporate VP & CFO Bernard Zovighian - Corporate VP, Transcatheter Mitral & Tricuspid Therapies Daveen Chopra - Corporate VP, Surgical Heart Valve Therapies Larry Wood - Corporate VP, Transcatheter Aortic Valve Replacement Conference Call Participants Robert Marcus - JPMorgan Chase & Co. Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Matthew Miksic - Barclays Joanne Wuensch - Citibank Chris Pasquale - Nephron Cecila Furlong - Morgan Stanley Travis Steed - Bank of America Joshua Jennings - Cowen Adam Maeder - Piper Sandler Richard Newitter - Truist Securities Operator Greetings, and welcome to the Edwards Lifesciences Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions]Please note, this conference is being recorded.
- 01/31/2023
|
Edwards Lifesciences (EW) Q4 Earnings and Revenues Surpass Estimates
- Edwards Lifesciences (EW) delivered earnings and revenue surprises of 4.92% and 1.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 01/31/2023
|
Edwards Lifesciences Stock Jumps After Beating Fourth-Quarter Views
- Edwards Lifesciences narrowly beat fourth-quarter forecasts, and EW stock rose in after-hours action Tuesday. The post Edwards Lifesciences Stock Jumps After Beating Fourth-Quarter Views appeared first on Investor's Business Daily.
- 01/31/2023
|
Should You Buy Edwards Lifesciences (EW) Ahead of Earnings?
- Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 01/30/2023
|
EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 31, 2023
- IRVINE, Calif. , Jan. 24, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2022 after the market closes on Tuesday, January 31, 2023, and will host a conference call at 5:00 p.m.
- 01/24/2023
|
HOLX vs. EW: Which Stock Is the Better Value Option?
- HOLX vs. EW: Which Stock Is the Better Value Option?
- 01/23/2023
|
Ranking The Diversified Healthcare Giants
- The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles.
- 01/22/2023
|
Edwards Lifesciences (EW) Gains From Innovation Amid Cost Woe
- Edwards Lifesciences (EW) continues to witness strong momentum of the RESILIA portfolio globally.
- 01/18/2023
|
Edwards Lifesciences: Short-Term Growth Worries Have Created An Opportunity
- Edwards Lifesciences is a high quality business by any and all measures. Edwards has an excellent financial profile, a history of organic growth as opposed to growth via M&A, and a history of returning cash to shareholders via share repurchases.
- 01/18/2023
|
What's in Store for Edwards Lifesciences (EW) in Q4 Earnings?
- Strong adoption of the MITRIS RESILIA valve and increased demand for the HemoSphere monitoring platform will likely drive Edwards Lifesciences' (EW) Q4 revenues.
- 01/16/2023
|
HOLX or EW: Which Is the Better Value Stock Right Now?
- HOLX vs. EW: Which Stock Is the Better Value Option?
- 01/06/2023
|
EDWARDS LIFESCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
- IRVINE, Calif. , Jan. 5, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P.
- 01/05/2023
|
Edwards Lifesciences: Catalysts For 2023 And Beyond
- Down 40%+ this year, EW is now trading at levels not seen in years. I believe the sell-off is unjust, and investors over the next few months will benefit immensely.
- 12/30/2022
|
Tesla is not alone: 18 (and a half) other big stocks are headed for their worst year on record
- In the worst year for stocks since the Great Recession, several big names are headed for their worst year on record with just one trading day left in 2022.
- 12/29/2022
|
Unreliable Contrarianism
- It appears to us at Smead Capital Management that investors are behaving in a way that will damage their capital and cause them to suffer stock market failure. In 2022, as the favorite tech stocks of the last ten years got trounced, individual investors poured $100 billion into mutual funds and ETFs dominated by ownership of the very stocks which have created the most damage to their results.
- 12/20/2022
|
Jim Cramer recommends these 5 healthcare stocks in 2023
- Cramer said that healthcare stocks have stayed relatively steady this year because they tend to be recession-resistant stocks.
- 12/15/2022
|
EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE
- IRVINE, Calif. , Dec. 8, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance1 today during its annual investor conference.
- 12/08/2022
|
Gurus Prescribed These Health Care Stocks in the 3rd Quarter
- Amid rising concerns about the state of the global economy, rising inflation, central bank interest rate hikes and increased Covid-19 restrictions in China, marked indexes were mixed on Wednesday morning.
- 11/30/2022
|
These Are the Five Best and Worst Performing Healthcare Stocks in October 2022
- The healthcare sector has gained momentum following the COVID-19 pandemic. Several companies gained early regulatory approval for developing COVID-19 drugs and distributing vaccines.
- 11/28/2022
|
Edwards Life Sciences Stock Disaster Could Be Your Bounty
- Heart disease equipment maker Edwards Life Sciences (NYSE: EW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report.
- 11/07/2022
|
5 Broadly Held Guru Stocks Trading at a Discount on Halloween
- As investors get ready for Halloween, five broadly held guru stocks that tumbled more than 10% during October are Meta Platforms Inc. ( META , Financial), Amazon.com Inc. ( AMZN , Financial), Alibaba Group Holding Ltd. ( BABA , Financial), Edwards Lifesciences Corp. ( EW , Financial) and SVB Financial Group ( SIVB , Financial) according to the All-in-One Screener, a Premium feature of GuruFocus.
- 10/31/2022
|
7 Stocks to Buy at the ‘Midterm Elections' Bottom
- Although the concept of stocks to buy at the ‘midterm elections' bottom seems farfetched considering the broader volatility this year, the calendar might provide a change of heart. According to The New York Times, the U.S. equities sector generally follows election-related patterns.
- 10/31/2022
|
Edwards Lifesciences: Opening My Heart
- Edwards Lifesciences has seen shares cut nearly in half from the highs of last year. This is mostly in response to higher interest rates and an overreaction seen towards the upside last year.
- 10/30/2022
|
Edwards Lifesciences (EW) Q3 Earnings Miss, Margins Rise
- Edwards Lifesciences (EW) continues to register strong momentum in TMTT on a portfolio of differentiated therapies, positive pivotal trial results and favorable real-world clinical outcomes.
- 10/28/2022
|
Why Edwards Lifesciences Stock Crashed 16% Today
- Did investors overreact to the company's miss?
- 10/28/2022
|
Edwards Lifesciences Stock Slumps on Guidance Cut
- Edwards Lifesciences says quarterly sales for its transcatheter aortic valve replacement rose 1% but were impacted by, among other things, 'persistent U.S. hospital staffing shortages.'
- 10/28/2022
|
Edwards Lifesciences Corp (EW) Q3 2022 Earnings Call Transcript
- Edwards Lifesciences Corp (NYSE:EW ) Q3 2022 Earnings Conference Call October 27, 2022 5:00 PM ET Company Participants Mark Wilterding - VP, IR Michael Mussallem - Chairman & CEO Scott Ullem - Corporate VP & CFO Bernard Zovighian - Corporate VP, Transcatheter Mitral & Tricuspid Therapies Daveen Chopra - Corporate VP, Surgical Heart Valve Therapies Larry Wood - Corporate VP, Transcatheter Aortic Valve Replacement Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Robert Marcus - JPMorgan Chase & Co. Joshua Jennings - Cowen and Company Joanne Wuensch - Citigroup Richard Newitter - Truist Securities Frederick Wise - Stifel, Nicolaus & Company Cecilia Furlong - Morgan Stanley Philip Chickering - Deutsche Bank Vijay Kumar - Evercore ISI Travis Steed - Bank of America Merrill Lynch Adam Maeder - Piper Sandler & Co. Operator Good afternoon, and welcome to the Edwards Lifesciences Third Quarter 2022 Results Conference Call. [Operator Instructions].
- 10/27/2022
|
Edwards Slashes 2022 Profit Outlook, Citing Hospital, Dollar Challenges
- Edwards Lifesciences slashed its 2022 profit outlook on Thursday, noting hospital and dollar challenges. But EW stock remained muted.
- 10/27/2022
|
EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 27, 2022
- IRVINE, Calif. , Oct. 20, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2022 after the market closes on Thursday, October 27, 2022, and will host a conference call at 5:00 p.m.
- 10/20/2022
|
What's in Store for Edwards Lifesciences (EW) in Q3 Earnings?
- Within the TAVR arm, Edwards Lifesciences (EW) is likely to have witnessed continued growth in procedures across the United States and worldwide.
- 10/18/2022
|
Edwards Lifesciences (EW) TAVR Sales Strong Amid Macro Issues
- Edwards Lifesciences (EW) expects full-year 2022 underlying sales growth in the mid-single-digit range on the back of strength in demand for products used in more intense surgeries.
- 10/07/2022
|
These Are the Top 10 Holdings of David Rolfe
- David A. Rolfe is the chief investment officer at Wedgewood Partners and has been managing Wedgewood's portfolio for 18 years.
- 10/04/2022
|
Edwards Lifesciences (EW) Debuts SAPIEN 3 Ultra RESILIA Valve
- Edwards Lifesciences' (EW) SAPIEN 3 Ultra RESILIA valve combines its breakthrough RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve.
- 09/13/2022
|
Edward Lifesciences (EW) Gains From New Products Amid Cost Woe
- Edwards Lifesciences (EW) expects full-year 2022 underlying sales to grow on the back of strength in demand for products used in more intense surgeries.
- 09/07/2022
|
OCPNY or EW: Which Is the Better Value Stock Right Now?
- OCPNY vs. EW: Which Stock Is the Better Value Option?
- 09/06/2022
|
Edwards Lifesciences Best Able to Withstand Medtech Slowdown, Says Analyst
- Investors do not seem convinced that Edwards Lifesciences Corp. ( EW , Financial) is well equipped to handle a downturn in the medical device industry. Despite what one analyst thinks, the Irving, California-based company has lost 25% of its value this year.
- 08/22/2022
|
Edwards Lifesciences (EW) Gets CE Mark for PASCAL Precision
- Edwards Lifesciences' (EW) PASCAL Precision system enables precise navigation and implant delivery during mitral and tricuspid regurgitation treatment.
- 08/18/2022
|
Edwards Lifesciences (EW) Q2 Earnings Meet Estimates, Margins Up
- Edwards Lifesciences (EW) posts Q2 earnings in line with the Zacks Consensus Estimate, with robust performances across all product groups driving the top line.
- 07/29/2022
|
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q2 2022 Results - Earnings Call Transcript
- Edwards Lifesciences Corporation (NYSE:EW ) Q2 2022 Earnings Conference Call July 28, 2022 5:00 PM ET Company Participants Mark Wilterding - VP, IR and Treasurer Mike Mussallem - Chairman and CEO Scott Ullem - CFO Larry Wood - Global Leader, TAVR Bernard Zovighian - Global Leader, TMTT Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Joanne Wuensch - Citi Cecilia Furlong - Morgan Stanley Travis Steed - Bank of America Suraj Kalia - Oppenheimer Ed Ridley - Redburn Bill Plovanic - Canaccord Adam Maeder - Piper Sandler Josh Jennings - Cowen Operator Greetings, and welcome to the Edwards Lifesciences' Second Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode.
- 07/28/2022
|
Edwards Lifesciences (EW) Matches Q2 Earnings Estimates
- Edwards Lifesciences (EW) delivered earnings and revenue surprises of 0% and 1.61%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 07/28/2022
|
Edwards Lifesciences (EW) to Post Q2 Earnings: What's in Store?
- Edwards Lifesciences' (EW) Q2 performance will likely reflect the continued adoption of the RESILIA tissue valves and enhanced sales of the HemoSphere platform.
- 07/25/2022
|
EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JULY 28, 2022
- IRVINE, Calif. , July 21, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2022 after the market closes on Thursday, July 28, 2022, and will host a conference call at 5:00 p.m.
- 07/21/2022
|
A Debt-Free and Fairly Valued Medical Devices Company
- LeMaitre Vascular Inc. ( LMAT , Financial) has been on a roll—it has generated robust financial results and metrics that produced a high GF Score. But the share price has been in a slump.
- 07/20/2022
|
4 Profitable Companies With Solid Financial Conditions
- When screening the market for value opportunities, investors may want to consider stocks that represent companies with high profitability and robust financial conditions. The companies below meet these criteria, as they have GuruFocus profitability and financial strength ratings of at least 6 out of 10.
- 07/20/2022
|
2 Medical Device Stocks With Extremely High GF Scores
- The GF Score system from GuruFocus is a unique metric that takes into account a company's financial strength, profitability, growth, valuation and momentum to determine if the stock is likely to outperform. Those stocks with higher GF Scores generally produce higher returns than those with lower GF Scores, according to a backtesting study by GuruFocus.
- 07/18/2022
|
Growth stocks remain resilient in weakening economy, says Neuberger's Jason Tauber
- Jason Tauber, Neuberger Berman large cap disciplined growth and the disruptors portfolio manager, joins 'Closing Bell: Overtime' to discus his bullish case for the growth trade.
- 07/08/2022
|
Here's Why You Should Retain Edwards Lifesciences (EW) Now
- Investors are optimistic about Edwards Lifesciences' (EW) strong segmental performance and the growing demand for its RESILIA tissue valves.
- 07/06/2022
|
OCPNY vs. EW: Which Stock Is the Better Value Option?
- OCPNY vs. EW: Which Stock Is the Better Value Option?
- 06/24/2022
|
OCPNY vs. EW: Which Stock Should Value Investors Buy Now?
- OCPNY vs. EW: Which Stock Is the Better Value Option?
- 06/06/2022
|
Edwards Lifesciences: Seeking 60% Upside For Potential Exit At $160 Per Share
- Edwards Lifesciences is well positioned to absorb cost headwinds in the medical technology segment. The company's propensity to drive free cash flow below the bottom line has ensured a robust schedule of growth in earnings and equity value.
- 06/02/2022
|
Heathcare Stock for Bulls to Watch This June
- Edwards Lifesciences Corp (NYSE:EW) has taken a tumble in the second quarter, shedding nearly 25% since its mid-April peak near the $131 mark.
- 05/26/2022
|
Why Is Edwards Lifesciences (EW) Down 11.8% Since Last Earnings Report?
- Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock?
- 05/26/2022
|
EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE
- IRVINE, Calif. , May 23, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the Bernstein 38th Annual Strategic Decisions Conference on Thursday, June 2, 2022.
- 05/23/2022
|
7 Growth Stocks That Analysts Love Right Now
- These growth stocks are receiving buy ratings and significantly higher price targets from analysts, making them ideal names to consider. The post 7 Growth Stocks That Analysts Love Right Now appeared first on InvestorPlace.
- 05/17/2022
|
IART vs. EW: Which Stock Is the Better Value Option?
- IART vs. EW: Which Stock Is the Better Value Option?
- 04/28/2022
|
5 Quality Stocks With High GF Scores and Momentum
- In light of U.S. markets gyrating up and down during the final week of April, five high-quality stocks with high GF Scores and momentum ranks include Apple Inc. ( AAPL , Financial), Alphabet Inc. ( GOOGL , Financial)( GOOG , Financial), Amphenol Corp. ( APH , Financial), Fastenal Co. ( FAST , Financial) and Edwards Lifesciences Corp. ( EW , Financial) according to the All-in-One Screener, a Premium feature of GuruFocus.
- 04/27/2022
|
Edwards Lifesciences (EW) Q1 Earnings Top Estimates, Margins Up
- Increased adoption of the PASCAL platform along with continued strength in the HemoSphere monitoring platform drove Edwards Lifesciences' (EW) Q1 revenues.
- 04/27/2022
|
Edwards Lifesciences Clocks 10% Top-Line Growth In Q1; Forecasts Lower Than Expected Q2 Sales
- Edwards Lifesciences Corp (NYSE: EW) posted a Q1 adjusted EPS of $0.60, compared to $0.54 posted a year ago and beating the consensus of $0.57. Sales increased 10% to $1.34 billion (underlying 13%), beating the consensus of $1.31 billion.
- 04/27/2022
|
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q1 2022 Results - Earnings Call Transcript
- Edwards Lifesciences Corporation (NYSE:EW ) Q1 2022 Earnings Conference Call April 26, 2022 5:00 PM ET Company Participants Mark Wilterding - Vice President, Investor Relations & Treasurer Mike Mussallem - Chairman & Chief Executive Officer Scott Ullem - Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Matt Miksic - Credit Suisse William Plovanic - Canaccord Genuity Shagun Singh - RBC Capital Markets Cecilia Furlong - Morgan Stanley Josh Jennings - Cowen Rick Wise - Stifel Nicolaus Operator Greetings, and welcome to the Edwards Lifesciences First Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode.
- 04/26/2022
|
Edwards Lifesciences (EW) Beats Q1 Earnings and Revenue Estimates
- Edwards Lifesciences (EW) delivered earnings and revenue surprises of 3.45% and 2.44%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 04/26/2022
|
Edwards Lifesciences (EW) to Post Q1 Earnings: What's in Store?
- Improvement in TAVR and TMTT businesses is expected to have contributed to Edwards Lifesciences' (EW) first-quarter performance.
- 04/20/2022
|
Edwards Lifesciences (EW) Earnings Expected to Grow: Should You Buy?
- Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/19/2022
|
EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2022
- IRVINE, Calif. , April 19, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2022 after the market closes on Tuesday, April 26, 2022, and will host a conference call at 5:00 p.m.
- 04/19/2022
|
Edwards Lifesciences' (EW) Global Sales Robust Amid Cost Woes
- Edwards Lifesciences (EW) is registering robust HemoSphere sales in the United States.
- 04/08/2022
|
HOLX vs. EW: Which Stock Is the Better Value Option?
- HOLX vs. EW: Which Stock Is the Better Value Option?
- 04/05/2022
|
7 Medical Device Stocks to Buy as Covid-19 Fears Fade
- With concerns about Covid-19 fading into the rearview mirror, the normalization of healthcare could benefit these medical device stocks. The post 7 Medical Device Stocks to Buy as Covid-19 Fears Fade appeared first on InvestorPlace.
- 04/05/2022
|
Edwards Lifesciences (EW) Gets FDA Nod for MITRIS RESILIA Valve
- Edwards Lifesciences' (EW) MITRIS RESILIA valve has been designed to resemble the appearance and function of the native mitral valve.
- 04/01/2022
|
Drink Some TEA
- Drink Some TEA
- 03/31/2022
|
Edwards Lifesciences (EW) Up 7.5% Since Q4 Earnings Release
- Edwards Lifesciences' (EW) stock rallies on impressive fourth-quarter performance and bullish 2022 guidance.
- 03/30/2022
|
Here's Why You Should Retain Edwards Lifesciences (EW) Now
- Investors are optimistic about Edwards Lifesciences' (EW) robust segmental performance and growing product uptake.
- 03/22/2022
|
IHI: A Standout Performer With Equally Strong Future Growth Prospects
- IHI: A Standout Performer With Equally Strong Future Growth Prospects
- 03/05/2022
|
Why Is Edwards Lifesciences (EW) Up 7.5% Since Last Earnings Report?
- Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock?
- 02/25/2022
|
Riding The Stock Waves: Update On The Medical Devices Sector
- Riding The Stock Waves: Update On The Medical Devices Sector
- 02/21/2022
|
4 Stocks With Solid Financial Strength
- Benjamin Graham, the father of value investing, recommended investors look for stocks that have a current ratio higher than 2 and more working capital than long-term debt.
- 02/06/2022
|
Cramer says the problems weighing on medical device stocks are temporary, expects a bounce back
- "Mad Money" host Jim Cramer explained Tuesday why he expects to see a bounce back in shares of Edwards Lifesciences, Intuitive Surgical and Stryker.
- 02/01/2022
|
Jim Cramer says these three medical device stocks look like 'true steals' here
- "I think there are some true steals are developing in the medical device space because of omicron," the "Mad Money" host said.
- 02/01/2022
|
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q4 2021 Results - Earnings Call Transcript
- Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q4 2021 Results - Earnings Call Transcript
- 01/26/2022
|
5 Good Companies Outperforming the S&P 500
- According to the Good Companies Screen, a Premium value screen nested under the All-in-One Screener, five good companies that have outperformed the Standard & Poor's 500 index benchmark over the past 12 months include AutoZone Inc. ( AZO , Financial), Edwards Lifesciences Corp. ( EW , Financial), The Home Depot Inc. ( HD , Financial), Winmark Corp. ( WINA , Financial) and Fastenal Co. ( FAST , Financial).
- 01/24/2022
|
Why Edwards Lifesciences (EW) Might Surprise This Earnings Season
- Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 01/21/2022
|
Edwards Lifesciences (EW) to Post Q4 Earnings: What's in Store?
- Improvement in TAVR and TMTT businesses is expected to have contributed to Edwards Lifesciences' (EW) fourth-quarter results.
- 01/20/2022
|
Edwards Lifesciences (EW) to Report Q4 Results: Wall Street Expects Earnings Growth
- Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/19/2022
|
EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 26, 2022
- IRVINE, Calif., Jan. 19, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2021 after the market closes on Wednesday, January 26, 2022, and will host a conference call at 5:00 p.m.
- 01/19/2022
|
Edwards LifeSciences: When Even A Pandemonium Makes Room
- There are medical emergency times when both a National Emergency and a Personal Emergency must have attention. People skills, facilities, time will be shared to preserve life. Easiest to picture is a failed heart valve replacement. Do or die. Now.
- 01/14/2022
|
Edwards Lifesciences (EW) Stock Sinks As Market Gains: What You Should Know
- Edwards Lifesciences (EW) closed at $118.26 in the latest trading session, marking a -1.83% move from the prior day.
- 01/14/2022
|
Why Edwards Lifesciences (EW) Could Beat Earnings Estimates Again
- Edwards Lifesciences (EW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/10/2022
|
EDWARDS LIFESCIENCES TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
- IRVINE, Calif., Jan. 5, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate at the J.P.
- 01/05/2022
|
Edwards Lifesciences (EW) at 52-Week High: What's Driving It?
- Robust performance across the Critical Care and TAVR businesses is driving the top line for Edwards Lifesciences (EW).
- 12/27/2021
|
Final Trades: PayPal, MGM Resorts, Match Group & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 12/22/2021
|
Edwards Lifesciences' (EW) SAPIEN 3 With Alterra Gets FDA Nod
- Edwards Lifesciences' (EW) SAPIEN 3 system with Alterra adaptive prestent is indicated for use in the management of pediatric and adult patients with severe pulmonary regurgitation.
- 12/21/2021
|
What History Shows Us About 2022 Market Returns
- What to Expect From the Markets In 2022
- 12/20/2021
|
Edwards (EW) States Long-Term Strategy, Provides 2022 View
- Edwards Lifesciences (EW) expects to reach significant milestones in 2022 including new product launches and progress in multiple significant clinical trials.
- 12/13/2021
|
Edwards Lifesciences CEO on outlook for 2022: 'We are just getting started'
- Edwards Lifesciences CEO Michael Mussallem appeared on Wednesday's episode of "Mad Money," after the medical technology firm held its annual investor conference.
- 12/08/2021
|
Here's Why You Should Retain Edwards Lifesciences (EW) Stock
- Investors are optimistic about Edwards Lifesciences (EW) on strong third-quarter results and bullish 2021 guidance.
- 11/12/2021
|
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q3 2021 Results - Earnings Call Transcript
- Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q3 2021 Results - Earnings Call Transcript
- 10/27/2021
|
Edwards Lifesciences (EW) Tops Q3 Earnings Estimates
- Edwards Lifesciences (EW) delivered earnings and revenue surprises of 1.89% and -0.92%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 10/27/2021
|
Edwards Lifesciences To Host Earnings Conference Call On October 27, 2021
- IRVINE, Calif., Oct. 20, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2021 after the market closes on Wednesday, October 27, 2021, and will host a conference call at 5:00 p.m.
- 10/20/2021
|
OCPNY or EW: Which Is the Better Value Stock Right Now?
- OCPNY vs. EW: Which Stock Is the Better Value Option?
- 10/19/2021
|
Notable Edwards Lifesciences Insider Trades $4.6M In Company Stock
- Michael Mussallem, Chairman And CEO at Edwards Lifesciences (NYSE:EW), made a large buy and sell of company shares on October 1, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Michael Mussallem exercised options to purchase 57,550 Edwards Lifesciences shares at prices ranging from ($0.00) to $21.76 per share for a total of $980,288 on October 1.
- 10/04/2021
|
4 Stock Picks for a 'Buy and Hold' Approach
- The GuruFocus business predictability rating ranks companies on a five-star scale, defining the more predictable companies as businesses whose revenue per share and Ebitda per share have been growing steadily and who have produced a strong long-term performance of their stock prices.
- 09/29/2021
|
What's Happening With Edward Lifesciences Stock?
- A few months back we discussed that Edward Lifesciences stock may continue to see higher levels after rising 10% in a month following the positive developments around Resilia tissue valves. EW stock has since rallied 16% to levels of $121 currently.
- 09/20/2021
|
5 Good Companies With High Profitability
- According to the “Good Companies Screen,” one of several Premium screens under the All-in-One Screener, five stocks with high financial strength and profitability are Edwards Lifesciences Corp. ( EW , Financial), Lululemon Athletica Inc. ( LULU , Financial), Masimo Corp. ( MASI , Financial), Graco Inc. ( GGG , Financial) and Usana Health Sciences Inc. ( USNA , Financial).
- 09/17/2021
|
4 High Ebitda Margin Stock Picks
- If you want to have a higher chance to discover companies that are in good shape from a financial standpoint, you may want to consider the following four stocks, as their trailing 12-month (TTM) Ebitda margins are topping the S&P 500's 20.4% as of the writing of this article.
- 09/05/2021
|
Edwards Lifesciences (EW) at a 52-Week High: What's Driving It?
- Investors are optimistic about Edwards Lifesciences (EW) on strong sales growth across all four product groups in the second quarter and raised 2021 guidance.
- 08/19/2021
|
Final Trades: Estee Lauder, Chipotle, Abbvie & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 08/17/2021
|
3 Medical Instruments Stocks Countering Industry Headwinds
- The Zacks Medical - Instruments industry is growing on base business recovery. ISRG, IDXX and ALC are set to gain the most.
- 08/04/2021
|
Amazon, Mastercard, Pinterest and More Friday Afternoon Analyst Upgrades and Downgrades
- With the trading day nearly halfway over, the broad markets were pulling back into the weekend.
- 07/30/2021
|
Edwards Lifesciences (EW) Beats on Q2 Earnings, Margins Up
- Strong sales growth across all four products along with steady improvement in surgical procedure volumes during the second quarter drove Edwards Lifesciences' (EW) revenues.
- 07/30/2021
|
Edwards Lifesciences Beats Q2 Earnings On Demand Recovery, Boosts FY2021 Guidance; Analysts Raise Price Target
- Edwards Lifesciences (NYSE: EW), a cardio device company, reported Q2 earnings of $489.5 million, or $0.64, ahead of the consensus of $0.55. "Vaccine adoption in key regions has contributed to an increased number of patients seeking and, most importantly, receiving treatment," CEO Michael A.
- 07/30/2021
|
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q2 2021 Results - Earnings Call Transcript
- Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q2 2021 Results - Earnings Call Transcript
- 07/30/2021
|
Edwards Lifesciences: TAVR And TMTT Strengths Key Growth Levers
- Edwards Lifesciences presents with the economic pillars that round out a robust investment case. Central to the sell-side's thesis is EW's valuation, which we firmly believe is justified at 46X earnings and 36X EBITDA.
- 07/28/2021
|
What's in Store for Edwards Lifesciences (EW) Q2 Earnings?
- Continued adoption of TruWave disposable pressure monitoring devices and progress in transfemoral EVOQUE and SAPIEN M3 platforms are likely to have driven Edwards Lifesciences' (EW) Q2 revenues.
- 07/23/2021
|
Study Data Presented at TVT on the Economics of Minimalist TAVR, PARTNER 3 Bicuspid TAVR
- IRVINE, Calif., July 22, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that clinical and economic results from the 3M (multidisciplinary, multimodality, but minimalist) Transcatheter Aortic Valve Replacement (TAVR) Economic Study and the PARTNER 3 Bicuspid Registry for SAPIEN 3 TAVR Study were presented at TVT 2021: The Structural Heart Summit.
- 07/22/2021
|
Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021
- IRVINE, Calif., July 22, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2021 after the market closes on Thursday, July 29, 2021, and will host a conference call at 5:00 p.m.
- 07/22/2021
|
Cardiology Space Gains Momentum in 2021: 5 Stocks to Focus on
- These cardiology device stocks Medtronic (MDT), Boston Scientific (BSX), Edwards Lifesciences (EW), Merit Medical (MMSI), BD (BDX) are expected to continue their run over the next few months.
- 06/18/2021
|
Edwards Lifesciences (EW) at a 52-Week High: What's Driving It?
- Investors are optimistic about Edwards Lifesciences (EW) on its promising Surgical Structural Heart business and bullish 2021 guidance.
- 06/14/2021
|
Edwards Receives Clearance For Hypotension Prediction Index Software For Noninvasive Acumen IQ Cuff
- IRVINE, Calif., June 1, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that Acumen Hypotension Prediction Index (HPI) software with the Acumen IQ finger cuff has received U.S. Food and Drug Administration clearance.
- 06/01/2021
|
Edwards Lifesciences (EW) Down 4.8% Since Last Earnings Report: Can It Rebound?
- Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock?
- 05/20/2021
|
Clinical Data Updates On Edwards' Transcatheter Mitral, Tricuspid Programs Presented At EuroPCR
- IRVINE, Calif., May 18, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that clinical results from the company's transcatheter mitral and tricuspid programs were presented as part of the late-breaking clinical trials at EuroPCR 2021, demonstrating positive outcomes for patients impacted by mitral or tricuspid heart valve disease.
- 05/18/2021
|
Top 1st-Quarter Trades of Frank Sands' Firm
- Sands Capital Management recently disclosed its portfolio updates for the first quarter of 2021, which ended on March 31.
- 05/14/2021
|
Edwards Announces Updates From Annual Meeting
- IRVINE, Calif., May 5, 2021 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced updates from its annual meeting, in which Edwards' stockholders voted with the board's recommendations on all proxy proposals: All eight director nominees were elected as directors of the company for a one-year term; Stockholders advised that they approve the compensation of the company's named executive officers; Stockholders have approved the Amendment and Restatement of the company's U.S. and International Employee Stock Purchase Plans; Stockholders have ratified the appointment of the company's independent registered public accounting firm for fiscal year 2021; Stockholders have advised that they do not approve the stockholder proposal regarding action by written consent; and Stockholders have advised that they do not approve the stockholder proposal to adopt a policy to include non-management employees as prospective director candidates.
- 05/05/2021
|
Edwards Lifesciences (EW) Surges 6.3%: Is This an Indication of Further Gains?
- Edwards Lifesciences (EW) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- 04/22/2021
|
Edwards Lifesciences and Intuitive Surgical: Right Place, Right Time and Wide Moats
- Edwards Lifesciences Corp. (NYSE:EW) and Intuitive Surgical Inc. (NASDAQ:ISRG) are on the Wall Street radar this week.
- 04/21/2021
|
Providence Partners with Edwards Lifesciences, Cities of Irvine, Santa Ana, Costa Mesa and Tustin to Open Two Free Mass COVID-19 Vaccination Clinics
- ORANGE COUNTY, Calif., April 21, 2021 /PRNewswire/ -- Providence, a national nonprofit health system, is partnering with Edwards Lifesciences (NYSE: EW), the Orange County-based medical technology company, and the Cities of Irvine, Santa Ana, Costa Mesa and Tustin to open two mass vaccination clinics at one of Edwards Lifesciences' campus buildings in Santa Ana and the Orange County Great Park in Irvine, providing convenient access for residents to protect themselves from COVID-19.
- 04/21/2021
|
Edwards Lifesciences (EW) Beats on Q1 Earnings, Margins Down
- Despite coronavirus-led business challenges, Edwards Lifesciences (EW) witnessed robust segmental performances in Q1.
- 04/21/2021
|
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q1 2021 Results - Earnings Call Transcript
- Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q1 2021 Results - Earnings Call Transcript
- 04/20/2021
|
Edwards Lifesciences (EW) Q1 Earnings and Revenues Surpass Estimates
- Edwards Lifesciences (EW) delivered earnings and revenue surprises of 14.89% and 4.93%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 04/20/2021
|
Edwards Lifesciences Reports First Quarter Results
- IRVINE, Calif., April 20, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2021.
- 04/20/2021
|
Edwards Lifesciences's Earnings Outlook
- Edwards Lifesciences (NYSE:EW) releases its next round of earnings this Tuesday, April 20. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.
- 04/19/2021
|
AMD, Boston Scientific, Intel, Nvidia and More Thursday Afternoon Analyst Calls
- With the trading day about halfway over, the broad markets were pushing much higher with solid gains across the board.
- 04/15/2021
|
Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for
- Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/13/2021
|
What's in Store for Edwards Lifesciences (EW) in Q1 Earnings?
- Continued strength in the adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve are likely to have driven Edwards Lifesciences' (EW) Q1 revenues.
- 04/13/2021
|
Edwards Lifesciences To Host Earnings Conference Call On April 20, 2021
- IRVINE, Calif., April 13, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2021 after the market closes on Tuesday, April 20, 2021, and will host a conference call at 5:30 p.m.
- 04/13/2021
|
Guidance Will Be Key When Edwards Lifesciences Reports Q1 Earnings
- Edwards Lifesciences has shown consistent earnings and revenue growth in the last few years and it has strong profitability measurements. The company is scheduled to report first quarter earnings results on April 20 with earnings expected to decline slightly from Q1 2020.
- 04/06/2021
|
Warren Buffett's Berkshire Reveals 4th-Quarter Trades
- Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway Inc. (NYSE:BRK.A)(NYSE:BRK.B) disclosed on Tuesday its fourth-quarter 2020 portfolio, revealing new holdings in Verizon Inc. (NYSE:VZ), Chevron Corp. (NYSE:CVX) and The E.W. Scripps Co. (NYSE:EW).
- 02/16/2021
|
Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years
- AUSTIN, Texas, Jan. 31, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE clinical trial that demonstrate Edwards' bioprosthetic surgical aortic valve with the company's novel RESILIA tissue platform show favorable safety and hemodynamic...
- 01/31/2021
|
Edwards Lifesciences (EW) Q4 Earnings Fall Shy of Estimates
- Despite coronavirus-led business challenges, Edwards Lifesciences (EW) witnessed robust performances in TMTT business in Q4.
- 01/28/2021
|
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q4 2020 Results - Earnings Call Transcript
- Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q4 2020 Results - Earnings Call Transcript
- 01/27/2021
|
5 Must-See Large Cap Earnings Charts
- While technology stocks remain hot in 2021, there are other sectors that should be on your radar this earnings season.
- 01/27/2021
|
Edwards Lifesciences (EW) Q4 Earnings Lag Estimates
- Edwards Lifesciences (EW) delivered earnings and revenue surprises of -5.66% and 0.71%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 01/27/2021
|
Recap: Edwards Lifesciences Q4 Earnings
- Shares of Edwards Lifesciences (NYSE:EW) decreased 4.5% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 65.75% over the past year to $0.50, which missed the estimate of $0.53.
- 01/27/2021
|
What's in Store for Edwards Lifesciences in (EW) Q4 Earnings?
- Robust customer adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve is likely to have driven Edwards Lifesciences' (EW) Q4 revenues.
- 01/20/2021
|
Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021
- IRVINE, Calif., Jan. 13, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2020 after the market closes on Wednesday, January 27, 2021, and will host a conference call at 5:00 p.m. ET that day to discuss those...
- 01/13/2021
|
Edwards Lifesciences: TAVR, Mitral And Tricuspid Segments Are Each Meaningful Compounders
- Edwards Lifesciences is a quality name that sits at the tip of the spear in cardiovascular value procedure offerings. The company has remained resilient in the face of the pandemic, and is well positioned to benefit from the rebound in procedure deferrals.
- 01/11/2021
|
Edwards Treats First Patient In U.S. Clinical Trial Evaluating Minimally Invasive Device For Mitral Valve Disease
- IRVINE, Calif., Dec. 21, 2020 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW), today announced that the first patient has been treated in the RESTORE clinical trial, which will evaluate the safety and effectiveness of the investigational HARPOON Beating Heart Mitral Valve Repair System in...
- 12/21/2020
|
Edwards Lifesciences CEO on the state of elective surgeries amid pandemic
- Edward Lifesciences CEO Mike Mussallem explained why he is concerned about how patients with structural heart disease are being treated for health issues as hospitals are overwhelmed by Covid-19 patients.
- 12/10/2020
|
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
- IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance today during its annual investor conference. Highlights1 of...
- 12/10/2020
|
7 ESG Investing Ideas That Could Add to Your Wallet and to Your Soul
- ESG investing can help create value both for society and shareholders. These seven ESG stocks are a good place to start.
- 11/30/2020
|
Edwards Lifesciences Research Update: Dislocation In Valuation Remains
- Strong Q3 exit with +6.4% growth in TAVR therapy sales, in spite of pressures from COVID-19. Shareholders have enjoyed +70% gains since March, however, with high volatility to the downside, which needs to be priced into the valuation.
- 10/27/2020
|
Were Hedge Funds Wrong About Edwards Lifesciences Corporation (EW)?
- In this article we will take a look at whether hedge funds think Edwards Lifesciences Corporation (NYSE:EW) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips from investment bankers and industry insiders. Sure they sometimes fail miserably, but their consensus stock picks historically outperformed the market after adjusting for known risk factors.
- 10/26/2020
|
Vestmark Advisory Solutions Inc. Decreases Stock Position in Edwards Lifesciences Co. (NYSE:EW)
- Vestmark Advisory Solutions Inc. lessened its stake in Edwards Lifesciences Co. (NYSE:EW) by 6.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,269 shares of the medical research company’s stock after selling 448 shares during the period. Vestmark Advisory Solutions […]
- 10/22/2020
|
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
- Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 21)
Amicus Therapeutics, Inc. (...
- 10/22/2020
|
Lisa Edwards wird Chief Operating Officer bei Diligent Corporation
- Diligent Corporation, ein weltweit führendes zukunftsorientiertes Governance-Unternehmen, auf das fast 700.000 Vorstandsmitglieder und Führungskräfte
- 10/16/2020
|
Edwards Lifesciences Co. (NYSE:EW) Stake Lessened by Tributary Capital Management LLC
- Tributary Capital Management LLC cut its stake in Edwards Lifesciences Co. (NYSE:EW) by 2.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,950 shares of the medical research company’s stock after selling 150 shares during the period. Tributary Capital Management […]
- 10/15/2020
|
Edwards Lifesciences Co. (NYSE:EW) Position Raised by Flagship Harbor Advisors LLC
- Flagship Harbor Advisors LLC increased its position in shares of Edwards Lifesciences Co. (NYSE:EW) by 12.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,256 shares of the medical research company’s stock after purchasing an additional 921 […]
- 10/15/2020
|
Edwards Lifesciences Co. (NYSE:EW) CFO Scott B. Ullem Sells 33,150 Shares
- Edwards Lifesciences Co. (NYSE:EW) CFO Scott B. Ullem sold 33,150 shares of Edwards Lifesciences stock in a transaction on Monday, October 12th. The stock was sold at an average price of $83.81, for a total transaction of $2,778,301.50. Following the transaction, the chief financial officer now directly owns 60,264 shares in the company, valued at […]
- 10/14/2020
|
Hunt Valve Company Announces Senior Leadership Change
- Hunt Valve Company announces that Charles Ferrer has been promoted to President & Chief Executive Officer. He joins and will report to the Board o
- 10/13/2020
|
Cypress Capital Group Trims Stock Position in Edwards Lifesciences Corp (NYSE:EW)
- Cypress Capital Group lessened its holdings in shares of Edwards Lifesciences Corp (NYSE:EW) by 9.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,110 shares of the medical research company’s stock after selling 444 shares during the period. […]
- 10/10/2020
|
Exane Derivatives Trims Position in Edwards Lifesciences Corp (NYSE:EW)
- Exane Derivatives decreased its position in shares of Edwards Lifesciences Corp (NYSE:EW) by 3.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 5,178 shares of the medical research company’s stock after selling 210 shares during the period. Exane Derivatives’ holdings in Edwards Lifesciences were worth $413,000 as […]
- 10/10/2020
|
First Hawaiian Bank Has $1.16 Million Holdings in Edwards Lifesciences Corp (NYSE:EW)
- First Hawaiian Bank lowered its stake in Edwards Lifesciences Corp (NYSE:EW) by 22.1% in the third quarter, Holdings Channel.com reports. The institutional investor owned 14,559 shares of the medical research company’s stock after selling 4,119 shares during the quarter. First Hawaiian Bank’s holdings in Edwards Lifesciences were worth $1,162,000 as of its most recent SEC […]
- 10/08/2020
|
Brokerages Set Edwards Lifesciences Corp (NYSE:EW) Price Target at $84.42
- Shares of Edwards Lifesciences Corp (NYSE:EW) have earned a consensus rating of “Buy” from the twenty-two analysts that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and fifteen have issued a buy recommendation on the company. The average twelve-month target […]
- 10/04/2020
|
Esports Market - Roadmap for Recovery From COVID-19 | Branding Through Esports to Boost the Market Growth | Technavio
- The Global Esports Market will grow by USD 1.40 bn during 2020-2024
- 09/18/2020
|
Why Stocks Could Be Ready To Rally
- The market indexes pulled back significantly in the past week, with the NASDAQ 100 ETF losing 11% from its September high to its low this week.
- 09/11/2020
|
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
- Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
- 09/04/2020
|
The Sell-Off Accelerates, What To Do Now
- The S&P 500's sell-off accelerates. The best sectors and stocks to consider when it bottoms.
- 09/03/2020
|
You Can Still Buy Industrial And Technology Stocks, But Risk Controls Are Key
|
Bullish On Baxter: Cruising Along, Business As Usual; $90 Price Target Set
- Baxter continues to chug on slowly as it has done for the past 10 years, delivering ongoing value to shareholders.
- 08/28/2020
|
The Best Stocks To Buy On A Sell-Off
- We're seeing shifts in sector leadership that are worth watching. Our overbought indicator suggests reigning in risk.
- 08/25/2020
|
The Most Popular Guru Buys of the 2nd Quarter
- These stocks had the most buys from gurus Continue reading...
- 08/18/2020
|
David Rolfe's Top 5 2nd-Quarter Trades
- Guru adds to Edwards Lifesciences, trims Nvidia and Apple Continue reading...
- 08/18/2020
|
Why I'm Worrying Over A Market Drop
- Our overbought indicator reaches rarefied air. It could be a good time to rein in risk by reducing margin and avoiding short-term calls.
- 08/17/2020
|
Top 5 Latest Buys of Frank Sands' Firm
- Sands Capital Management invests in communications and health care in 2nd quarter Continue reading...
- 08/13/2020
|
Edwards Lifesciences Corporation's (NYSE:EW) Share Price Matching Investor Opinion
- Edwards Lifesciences Corporation's (NYSE:EW) price-to-earnings (or "P/E") ratio of 64.3x might make it look like a...
- 08/12/2020
|
How Is Edwards Lifesciences' (NYSE:EW) CEO Compensated?
- Mike Mussallem became the CEO of Edwards Lifesciences Corporation (NYSE:EW) in 2000, and we think it's a good time to...
- 08/12/2020
|
Edwards Lifesciences Corp (NYSE:EW) VP Sells $927,360.00 in Stock
- Edwards Lifesciences Corp (NYSE:EW) VP Donald E. Bobo, Jr. sold 12,000 shares of the company’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $77.28, for a total value of $927,360.00. Following the completion of the transaction, the vice president now owns 72,832 shares of the company’s […]
- 08/11/2020
|
Orbimed Advisors reduced stake in Inspire Medical Systems Inc.
- Orbimed Advisors reduced stake in Inspire Medical Systems Inc.
- 08/11/2020
|
Nvidia Stock May Get a Lift From Microsoft and Sony
- The next generation of videogame consoles could spur gamers to upgrade their systems, creating demand for graphics-processing cards, according to BofA Securities analyst Vivek Arya.
- 08/10/2020
|
Long-Term Leaders List Welcomes This Giant Software Company
- IBD's Long-Term Leaders continue to power higher as the raging bull market hits new highs. Long-Term Leader Portfolio Welcomes Salesforce.com Led by founder Marc Benioff, Salesforce.com (CRM) remains the dominant player in customer relationship management software. Since going public in 2004, CRM stock is up over 4,700% and appears to be making another run higher. Saleseforce.com broke out of a...
- 08/07/2020
|
TMO vs. EW: Which Stock Is the Better Value Option?
- TMO vs. EW: Which Stock Is the Better Value Option?
- 08/06/2020
|
Edwards Lifesciences Shows Surprising Resilience, And TAVR Remains A Growth Market (NYSE:EW)
- TAVR procedures were surprisingly resilient in the second quarter, driving a large revenue and profit beat for Edwards.
- 08/04/2020
|
Vanguard Health Care Fund Adds 3 Stocks to Portfolio
- Fund focused on health reveals 2nd-quarter trades Continue reading...
- 07/31/2020
|
Thermo Fisher Long Case: Trajectory Is Clear, Buy On Value
- Strong quarter exit and clear guidance for Q4 2020 on the back of $1.3 billion in COVID-19 related sales YTD.
- 07/31/2020
|
The Top 5 Trades of the Eaton Vance Worldwide Health Sciences Fund
- Health care-focused fund releases 2nd-quarter portfolio Continue reading...
- 07/27/2020
|
Edwards Lifesciences (NYSE:EW) Price Target Raised to $89.00
- Edwards Lifesciences (NYSE:EW) had its price target increased by Canaccord Genuity from $86.00 to $89.00 in a research report released on Friday, The Fly reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other research firms have also recently weighed in on EW. Oppenheimer began coverage on shares of […]
- 07/27/2020
|
Stifel Nicolaus Boosts Edwards Lifesciences (NYSE:EW) Price Target to $90.00
- Edwards Lifesciences (NYSE:EW) had its target price raised by Stifel Nicolaus from $85.00 to $90.00 in a research report report published on Friday, BenzingaRatingsTable reports. Stifel Nicolaus currently has a buy rating on the medical research company’s stock. A number of other brokerages have also commented on EW. Barclays reissued an underweight rating and set […]
- 07/27/2020
|
Edwards Inches Closer To Breakout On $100 Million Heart-Valve Beat
- Edwards Lifesciences handily topped Wall Street's second-quarter expectations amid a resurgence in heart-valve replacements. EW stock inched slightly closer to a buy point Friday.
- 07/24/2020
|
P/E Ratio Insights for Edwards Lifesciences
- In the current session, Edwards Lifesciences Inc. (NYSE: EW) is trading at $77.38, after a 0.05% rise. Over the past month, the stock increased by 20.14%, and in the past year, by 11.87%. With performance like this, long-term shareholders optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.Assuming that all other factors are held constant, this could present itself as an opportunity for shareholders trying to capitalize on the higher share price. The stock is currently below from its 52 week high by 68.75%.The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E indicates that shareholders do not expect the stock to perform better in the future, and that the company is probably undervalued. It shows that shareholders are less than willing to pay a high share price, because they do not expect the company to exhibit growth, in terms of future earnings.View more earnings on EWMost often, an industry will prevail in a particular phase of a business cycle, than other industries.Edwards Lifesciences Inc. has a lower P/E than the aggregate P/E of 150.61 of the Medical Devices industry. Ideally, one might believe that they might perform worse than its peers, but it's also probable that the stock is undervalued.Price to earnings ratio is not always a great indicator of the company's performance. Depending on the earnings makeup of a company, investors may not be able to attain key insights from trailing earnings.See more from Benzinga * Edwards Lifesciences: Q2 Earnings Insights * Earnings Scheduled For July 23, 2020 * Stocks That Hit 52-Week Lows On Friday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 07/24/2020
|
Edwards Lifesciences (EW) Beats on Q2 Earnings, Ups EPS View
- Despite coronavirus-hit sales, Edwards Lifesciences (EW) witnessed steady improvement in TAVR procedure volumes in Q2. Regulatory approvals look encouraging.
- 07/24/2020
|
Edwards Lifesciences Blows Past Q2 Earnings Estimates
- Investors might not be overly excited about Edwards Lifesciences' (NYSE: EW) stock performance so far in 2020. Edwards Lifesciences announced its second-quarter results after the market closed on Thursday, and the stock jumped 5% in after-hours trading.
- 07/24/2020
|
Edwards Lifesciences Corp (EW) Q2 2020 Earnings Call Transcript
- With me on today's call are Mike Mussallem, Chairman and Chief Executive Officer and Scott Ullem Chief Financial Officer. Just after the close of regular trading, Edwards Lifesciences released second quarter 2020 financial results.
- 07/24/2020
|
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
- Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
- 07/24/2020
|
Edwards Lifesciences' (EW) CEO Mike Mussallem on Q2 2020 Results - Earnings Call Transcript
- Edwards Lifesciences Corp. (NYSE:EW) Q2 2020 Earnings Conference Call July 23, 2020 5:00 PM ET Company Participants Mark Wilterding – Vice President-Investor Relations Mike Mussallem – Chairman and Chief Executive Officer Scott Ullem – Chief Financial Officer Conference Call Participants Josh Jennings – Cowen and Company David Lewis – Morgan Stanley Matt Miksic – Credit Suisse Bob Hopkins – Bank of America Robbie Marcus – JPMorgan Larry Biegelsen – Wells Fargo Matt Taylor – UBS Raj Denhoy – Jefferies Chris Pasquale – Guggenheim Vijay Kumar – Evercore ISI Pito Chickering – Deutsche Bank Joanne Wuensch – Citi Rick Wise – Stifel Presentation Operator Greetings, and welcome to the Edwards Lifescience Corporation Second Quarter 2020 Results Conference Call and Webcast.
- 07/23/2020
|
Edwards Lifesciences (EW) Q2 Earnings and Revenues Beat Estimates
- Edwards Lifesciences (EW) delivered earnings and revenue surprises of 126.67% and 18.15%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 07/23/2020
|
Edwards Lifesciences: Q2 Earnings Insights
- Shares of Edwards Lifesciences (NYSE:EW) moved higher by 3.5% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share decreased 75.36% year over year to $0.34, which beat the estimate of $0.17.Revenue of $925,000,000 declined by 14.90% year over year, which beat the estimate of $789,420,000.Looking Ahead The upcoming fiscal year's EPS expected to be between $1.75 and $1.95.Q3 revenue expected between $4,000,000,000 and $4,500,000,000.Details Of The Call Date: Jul 23, 2020View more earnings on EWTime: 05:00 PMET Webcast URL: https://event.webcasts.com/starthere.jsp?ei=1335563&tp_key=cabc10f160Technicals 52-week high: $247.6452-week low: $66.23Price action over last quarter: Up 8.39%Company Overview Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters and retractors, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.See more from Benzinga * Earnings Scheduled For July 23, 2020 * Stocks That Hit 52-Week Lows On Friday * Stocks That Hit 52-Week Lows On Monday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 07/23/2020
|
Edwards Lifesciences Stares Down A Buy Point After Its Earnings Beat
- Late Thursday, Edwards Lifesciences reported adjusted income of 34 cents per share on $925 million in sales for its second quarter ended June 30. In response, EW stock popped.
- 07/23/2020
|
Edwards Lifesciences Reports Second Quarter Results
- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2020.
- 07/23/2020
|
The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results
- Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
ABIOMED, Inc. (NASDAQ: ABMD)
Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO)
Bio-Rad Laboratories,...
- 07/23/2020
|
If You Own Edwards Lifesciences (EW) Stock, Should You Sell It Now?
- Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Large-Cap Growth Fund posted a return of 27.86% for the quarter, outperforming its benchmark, the Russell 1000 Growth Index which returned 27.84% in the same quarter. You should check out Brown Advisory’s top 5 stock picks for […]
- 07/22/2020
|
Why Earnings Season Could Be Great for Edwards Lifesciences (EW)
- Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 07/22/2020
|
Abbott Labs Leveraging An Opportunity In Diagnostics While Looking Forward To Normalization
- Abbott posted a good second quarter, with the expected outperformance in diagnostics, but also better results in devices, diabetes, and nutrition.
- 07/21/2020
|
Is Edwards Lifesciences Corporation's(NYSE:EW) Recent Stock Performance Tethered To Its Strong Fundamentals?
- Most readers would already be aware that Edwards Lifesciences' (NYSE:EW) stock increased significantly by 9.3% over...
- 07/20/2020
|
Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for
- Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/16/2020
|
What's in Store for Edwards Lifesciences (EW) in Q2 Earnings?
- Robust customer adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve are likely to have driven Edwards Lifesciences' (EW) Q2 revenues.
- 07/16/2020
|
Paul LaViolette Appointed To Edwards Lifesciences Board Of Directors
- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that Paul A. LaViolette has been appointed to its board of directors. LaViolette has 40 years of experience in global medical technology, operating leadership and investing, serving in executive-level roles at companies including Boston Scientific Corp. and C.R. Bard Inc.
- 07/15/2020
|
Octapharma Reports Positive Data from octagam® Usage in Critically Ill COVID-19 Patients
- Topline results from a retrospective study in 93 critically ill COVID-19 patients have become available. The data shows that IVIG treatment reduces in
- 07/15/2020
|
The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits
- Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) * Altimmune Inc (NASDAQ: ALT) (announced positive preclinical data for its intranasal vaccine candidate AdCOVID) * argenx SE - ADR (NASDAQ: ARGX) * Axonics Modulation Technologies Inc (NASDAQ: AXNX) (reacted to preliminary second-quarter results) * Beigene Ltd (NASDAQ: BGNE) - announced $421 million in additional investment by Amgen, Inc. (NASDAQ: AMGN) in a $2.1-billion direct offering by the Chinese biotech * BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) * Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) * Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) * Catalent Inc (NYSE: CTLT) * DexCom, Inc. (NASDAQ: DXCM) * Equillium Inc (NASDAQ: EQ (announced positive results for COVID-19 study of the drug it is co-developing with India's Biocon) * Fulgent Genetics Inc (NASDAQ: FLGT) * GENMAB A/S/S ADR (NASDAQ: GMAB) * Heat Biologics Inc (NASDAQ: HTBX) * Hologic, Inc. (NASDAQ: HOLX) * I-Mab ADR (NASDAQ: IMAB) * Inari Medical Inc (NASDAQ: NARI) * ITAMAR MED LTD/S ADR (NASDAQ: ITMR) * Meridian Bioscience, Inc. (NASDAQ: VIVO) * Novavax, Inc. (NASDAQ: NVAX) * Pacira Biosciences Inc (NASDAQ: PCRX) ) * Quidel Corporation (NASDAQ: QDEL) * TFF Pharmaceuticals Inc (NASDAQ: TFF) * TIZIANA LF SCIE/S ADR (NASDAQ: TLSA) * West Pharmaceutical Services Inc. (NYSE: WST)Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 13) * ADiTx Therapeutics Inc (NASDAQ: ADTX) * Generation Bio Co (NASDAQ: GBIO) * Gritstone Oncology Inc (NASDAQ: GRTS) (reacted to Phase 1 readouts of its cancer vaccine candidates) * INVENTIVA SA/ADR (NASDAQ: IVA) (went public Friday) * NextCure Inc (NASDAQ: NXTC) (said it is pulling the plug on NC318 monotherapy study in non-small cell lung and ovarian cancers, and the departure of its chief medical officer) * ORIC Pharmaceuticals Inc (NASDAQ: ORIC) * Poseida Therapeutics, Inc. (NASDAQ: PSTX) (went public Friday) * Recro Pharma Inc (NASDAQ: REPH) * Repare Therapeutics Inc (NASDAQ: RPTX) * Sonnet Biotherapeutics Holdings Inc (NASDAQ: SONN) * VIVUS, Inc. (NASDAQ: VVUS)Stocks In Focus Blueprint Out-Licenses Late-Stage Cancer Drug To Roche For Up To $1.7B Blueprint Medicines Corp (NASDAQ: BPMC) and Roche Holdings AG Basel ADR Common Stock (OTC: RHHBY) announced a licensing agreement in which Blueprint will provide exclusive rights to Roche for global co-development and commercialization of pralsetinib outside the U.S., excluding Greater China. Prasetinib is Blueprint's investigational, once-daily oral precision therapy for the treatment of people with RET-altered non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancer, as well as other solid tumours.The companies also said they plan to expand development of pralsetinib in multiple treatment settings and explore development of a next-generation RET inhibitor under the collaboration.The agreement provides for Blueprint receiving an upfront cash payment of $675 million and a $100-million equity investment. In addition, Blueprint is eligible to receive up to $927 million in contingent development, regulatory and sales-based milestones, and royalties on net product sales outside the U.S.In premarket trading Tuesday, Blueprint shares were jumping 9.59% to $84.FDA Allows Expanded Access To Single Patient For Vanda's Gastroparesis Investigational Therapy Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) said the FDA has allowed a single patient in an Individual Patient Expanded Access protocol, enabling access to continued treatment with tradipitant for gastroparesis beyond the 12 weeks of a Phase 3 study in which he originally participated. The company said the treating physician had judged tradipitant was the only treatment that effectively managed the patient's gastroparesis symptoms.The stock was up 11.8% premarket at $12.70.Eisai, Biogen Begin Late-Stage Study Of Drug To Treat Preclinical Alzheimer's The Alzheimer's Clinical Trials Consortium, along with Biogen Inc (NASDAQ: BIIB) and Eisai Co., Ltd (OTC: ESALY) said a new Phase 3 clinical study -- dubbed AHEAD 3-45 -- of BAN2401, an anti-amyloid beta protofibril antibody, has been initiated in the U.S. for individuals with preclinical Alzheimer's disease.Such patients, according to the companies, are clinically normal and have intermediate or elevated levels of amyloid in their brains. BAN2401 is being studied in a pivotal Phase 3 clinical study in symptomatic early Alzheimer's disease.The AHEAD 3-45 will be conducted in the U.S., Japan, Canada, Australia, Singapore and Europe, the companies said.See also: The Week Ahead In Biotech: J&J; Kickstarts Pharma Earnings, Repare Therapeutics IPO Edwards Lifesciences, Abbott Settle Patent Heart Valve Repair Lawsuits Edwards Lifesciences Corp (NYSE: EW) said it has reached an agreement with Abbott Laboratories (NYSE: ABT) to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products.Although the companies said the settlement terms are confidential, Edwards Lifesciences said it will record a one-time settlement expense in the quarter ended June 30 and incur royalty expenses through May 2024.Edwards shares were up 1.95% to $68.50 and Abbott was up 0.89% at $93.92 premarket. Immunomedics, Roche Expand Cancer Drug Collaboration Immunomedics, Inc. (NASDAQ: IMMU) announced an extension of its clinical collaboration with Roche to evaluate Trodelvy, the former's anti-Trop-2 antibody-drug-conjugate, in combination with Tecentriq, the latter's PD-L1-blocking checkpoint inhibitor, in patients with metastatic urothelial cancer and metastatic non-small cell lung cancer.Immunomedics shares were up 2.08% at $40.80 at the time of publication.INmune Reports Positive Early Readout For Alzheimer's Drug INmune Bio Inc (NASDAQ: INMB) reported interim data from its Phase 1b clinical study of its lead drug XPro1595 in Alzheimer's disease, with the data demonstrating XPro1595 decreased neuroinflammation in patients with Alzheimer's disease.XPro1595 decreased white matter free water, a biomarker of neuroinflammation measured by MRI, the company said. "Not only do we see a clear reduction in neuroinflammation, but we also know where in the brain this is occurring, which may inform us on the domains of cognition that might be affected," said CJ Barnum, director of neuroscience at INmune.The stock was jumping 65.54% premarket to $14.65. Verrica's Viral Skin Infection Drug Rejected By FDA Verrica Pharmaceuticals Inc (NASDAQ: VRCA) said the FDA issued a Complete Response Letter regarding the NDA for VP-102, its investigational, proprietary drug-device combination for the treatment of molluscum contagiosum.The company said the CRL required additional chemistry, manufacturing and controls and human factors information, but did not raise any safety or efficacy issues.The decision was expected, as the FDA had previously issued a letter noting deficiencies that precluded discussion of labeling and post-marketing requirements/commitments.The stock was slipping 16.36% to $7.36 in premarket trading Tuesday.VolitionRx Reports Positive Clinical Trial Results For Prognostic COVID-19 Test VolitionRX Ltd (NYSE: VNRX) announced results from two proof-of-concept clinical studies using its Nu.Q assays, with the test showing correlation with more severe COVID-19 cases, implying strong prognostic potential.The company said it is now focused on the completion of larger longitudinal studies that would be needed to support a potential COVID-19 product launch.The stock was soaring 72.86% to $6.05 in premarket trading.Galera Completes Patient Enrollment In Phase 1b/2a Pancreatic Cancer Study Galera Therapeutics Inc (NASDAQ: GRTX) said it has completed patient enrollment in its pilot Phase 1b/2a safety and anti-cancer efficacy clinical trial of avasopasem manganese, codenamed GC4419, in combination with stereotactic body radiation therapy, in patients with locally advanced pancreatic cancer.Offerings Osmotica Pharmaceuticals PLC (NASDAQ: OSMT) announced the commencement of a proposed public offering of 5 million ordinary shares. All of the shares are being offered by the company.The stock was falling 17.62% premarket to $6.36.Altimmune said it intends to offer, subject to market and other conditions, shares of its common stock in an underwritten public offering and, to certain investors in lieu thereof, pre-funded warrants to purchase shares of its common stock. All of the securities in the offering will be sold by the company.The stock was trading up 8% at $27 premarket Tuesday.On The Radar Adcom Meetings The FDA's Oncologic Drugs Advisory Committee will discuss GlaxoSmithKline plc's (NYSE: GSK) biologic license application for belantamab mafodotin for the treatment of adults with relapsed or refractory multiple myeloma who have received at least four prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent. The drug linker technology for the product candidate was licensed from Seattle Genetics, Inc. (NASDAQ: SGEN).Related Link: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates See more from Benzinga * The Week Ahead In Biotech: J&J; Kickstarts Pharma Earnings, Relay Therapeutics IPO * The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs * The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 07/14/2020
|
Abbott Laboratories and Edwards Lifesciences Settle Patent Fight
- The two companies' agreement puts to rest an escalating dispute over heart valve repair products.
- 07/14/2020
|
Oppenheimer Releases a Buy Rating on Edwards Lifesciences (EW) - Markets
- Oppenheimer analyst Suraj Kalia assigned a Buy rating to Edwards Lifesciences (EW – Research Report) yesterday and set a price
- 07/14/2020
|
Abbott Labs, Edwards Lifesciences settle patent dispute over heart valve products
- Abbott Laboratories undefined and Edwards Lifesciences Corp. undefined said late Monday they settled a patent dispute with each other over certain heart...
- 07/13/2020
|
Abbott Labs, Edwards Lifesciences settle patent dispute over heart valve products
- Abbott Laboratories and Edwards Lifesciences Corp. said late Monday they settled a patent dispute with each other over certain heart valve repair products. The two medical device makers have been embroiled in a legal dispute for more than a year over whether Edwards's Pascal valve products infringe the patents of Abbott's MitraClip products. While both companies said details of the 10-year agreement were confidential, Edwards said it will book a one-time settlement expense in the June-ending quarter and will pay royalties to Abbott through May 2024. Abbott said it will receive a one-time payment and "ongoing payments" based on Pascal sales through 2025 along with a possible milestone payment in 2026.
- 07/13/2020
|
Edwards Lifesciences : Agrees To Global Transcatheter Litigation Settlement With Abbott | MarketScreener
|
Edwards Lifesciences Agrees To Global Transcatheter Litigation Settlement With Abbott
- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has reached an agreement with Abbott to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products. Edwards considers this agreement a positive development, as it allows the company to fully dedicate time and resources to helping patients.
- 07/13/2020
|
New Data to Be Presented at the ISTH 2020 Virtual Congress Demonstrating Octapharma’s Commitment to Patients With Bleeding Disorders
- Octapharma announced today that new research findings from its haematology portfolio will be presented at the upcoming International Society on Thromb
- 07/13/2020
|
Michael A. Mussallem Sells 68,550 Shares of Edwards Lifesciences Corp (NYSE:EW) Stock
- Edwards Lifesciences Corp (NYSE:EW) CEO Michael A. Mussallem sold 68,550 shares of the company’s stock in a transaction dated Thursday, July 9th. The shares were sold at an average price of $68.22, for a total transaction of $4,676,481.00. Following the completion of the sale, the chief executive officer now directly owns 309,770 shares of the […]
- 07/12/2020
|
The DeanBeat: The Final Hours of Half-Life: Alyx gives us a much-needed peek inside Valve
- Geoff Keighley followed the creation of Half-Life: Alyx over four years and he published a peek inside Valve as a Steam app on Thursday.
- 07/10/2020
|
Edwards Lifesciences To Host Earnings Conference Call On July 23, 2020
- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended June 30, 2020 after the market closes on Thursday, July 23, 2020, and will host a conference call at 5:00 p.m. ET that day to discuss those results.
- 07/09/2020
|
Were Hedge Funds Right About Piling Into Edwards Lifesciences Corporation (EW)?
- We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]
- 07/07/2020
|
Here's Why You Should Hold on to Edwards Lifesciences for Now
- Investors continue to be upbeat about Edwards Lifesciences (EW) owing to its strong segmental growth and robust product demand.
- 07/06/2020
|
Protaryx Medical Raises $8.3M in Funding | FinSMEs
- Protaryx Medical, a Baltimore, Maryland-based company committed to improving access to the left atrium for transcatheter cardiac procedures, raised $8.3m in funding
- 06/30/2020
|
$0.41 EPS Expected for Edwards Lifesciences Corp (NYSE:EW) This Quarter
- Wall Street analysts expect Edwards Lifesciences Corp (NYSE:EW) to report earnings per share (EPS) of $0.41 for the current fiscal quarter, according to Zacks. Nine analysts have issued estimates for Edwards Lifesciences’ earnings. The lowest EPS estimate is $0.30 and the highest is $0.51. Edwards Lifesciences reported earnings of $0.46 per share during the same […]
- 06/30/2020
|
‘Dota 2’ Battle Pass Bundle Extended After $8 Million Prize Pool Growth
- Dota 2 developer Valve has announced that the sale of the battle pass level bundle will continue until July 2 after the item caused the prize pool for The International 10 to grow by $8 million in under a week.
- 06/30/2020
|
Irish team begins clinical trial for drug therapy for severe Covid-19 infection
- Research initiated by RCSI and Beaumont Hospital to assess impact of treatment on critically ill
- 06/29/2020
|
Here's Why We Think Edwards Lifesciences (NYSE:EW) Is Well Worth Watching
- It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
- 06/29/2020
|
Edwards Lifesciences Corp (NYSE:EW) Forecasted to Earn Q3 2020 Earnings of $0.43 Per Share
- Edwards Lifesciences Corp (NYSE:EW) – William Blair raised their Q3 2020 EPS estimates for Edwards Lifesciences in a report released on Monday, June 22nd. William Blair analyst M. Kaczor now forecasts that the medical research company will post earnings of $0.43 per share for the quarter, up from their previous forecast of $0.43. William Blair […]
- 06/25/2020
|
Insights & Forecast With Potential Impact of COVID-19 - Annuloplasty Rings Market 2020-2024 | Increasing Prevalence of Heart Valve Diseases to Boost Growth | Technavio
- The Global Annuloplasty Rings Market will grow by USD 28.65 mn during 2020-2024
- 06/25/2020
|
Intensive Care Unit (ICU) Equipment Market to Reach USD 9.03 Billion by 2027; Surge in Cancer Patients to Amplify Business Deals, states Fortune Business Insights™
- Key Companies Covered in the Intensive Care Unit Equipment Market Research Report are Koninklijke Philips N.V, GENERAL ELECTRIC COMPANY, Medtronic, Edwards Lifesciences Corporation, Fresenius SE & Co. KGaA, Invacare Corporation, Medline Industries, Inc, B.
- 06/24/2020
|
Epic Games Store is seeing near-Steam-like engagement levels
- Epic Games doesn't want to pay Valve's rate to have access to Steam's audience, and it may not have to if Epic Games Store continues growing.
- 06/23/2020
|
Best VR headset 2020: the virtual reality headsets you need to try
- You're going to need one of the best VR headsets if you want a truly immersive VR experience.
- 06/23/2020
|
The Best Games for 2020: What You Should Be Playing Now | Digital Trends
- There are a lot of games released each year. Despite that, we've put together a list of the best games for 2020, from the best out of AAA studios to indie hits.
- 06/22/2020
|
Edwards Lifesciences (EW) Receives a Hold from BTIG - Markets
- BTIG analyst Marie Thibault maintained a Hold rating on Edwards Lifesciences (EW – Research Report) today. The company’s shares closed
- 06/18/2020
|
Catheter Market Size is Projected to Witness 8.8% CAGR in Near Future: P&S Intelligence
- Around the world, the volume of interventional radiology procedures is rising, on account of being less invasive than conventional, open medical procedures,
- 06/15/2020
|
Royal heartbreak: How Prince William channelled Princess Diana in hospital gesture
- PRINCESS DIANA often made surprise unannounced visits to hospitals - and the Duke of Cambridge followed in her footsteps yesterday with a special virtual outing.
- 06/12/2020
|
Edited Transcript of EW earnings conference call or presentation 23-Apr-20 9:00pm GMT
- Q1 2020 Edwards Lifesciences Corp Earnings Call
- 06/11/2020
|
Prince William makes surprise video call to Critical Care team
- LiverpoolHospitals Instagram page revealed the Critical Care teams at Aintree and the Royal received a surprise video call from Prince William, 38, - who praised the 'fantastic job' they're doing.
- 06/11/2020
|
Microsoft's Xbox app for Windows finally supports easy-to-find mods for PC gaming
- Microsoft has made some grudging concessions to the PC gaming mods scene by adding support for mods to select games via its Xbox app for Windows 10.
- 06/11/2020
|
Will the Xbox Series X support virtual reality (VR)?
- The answer is no. Here's what Xbox head Phil Spencer had to say about it.
- 06/09/2020
|
Liquid Crystal On Silicon (LCoS) Display Market Size, Status and Estimation 2020 to 2025 | VC Kenwood USA Corporation, Sony Corp, Microsoft Corporation
- Jun 09, 2020 (Market Insight Reports) --
LCoS microdisplay is constructed with a liquid crystal layer sandwiched between a thin-film transistor (TFT) and a...
- 06/09/2020
|
Edwards Lifesciences' SAPIEN 3 THV Cleared for Use in China
- Edwards Lifesciences' (EW) SAPIEN 3 THV to be used an alternative to open-heart surgery for high and extreme-risk AS patients post approval in China.
- 06/09/2020
|
El S&P 500 entra en positivo en el año tras un 'rally' del 30% desde los mínimos del covid
- Ya registra una ganancia del 30% desde los mínimos alcanzados el 23 de marzo. El S&P 500 había alcanzado los máximos históricos el 19 de febrero, en los 3.386 puntos
- 06/08/2020
|
Shares of several healthcare companies are trading higher on continued optimism amid the reopening of the economy, which would increase consumer spending and economic activity.
|
Tailoring Portfolios to Coronavirus and Recession
- In February through May, my firm has been recasting our clients’ portfolios to reflect a continuing coronavirus epidemic, and a recession of unknown length Continue reading...
- 06/08/2020
|
Edwards SAPIEN 3 Transcatheter Heart Valve Receives Approval In China
|
Edwards SAPIEN 3 Transcatheter Heart Valve Receives Approval In China
- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received Chinese regulatory approval for the Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients suffering from severe, symptomatic aortic stenosis (AS) at high risk for or unable to undergo open-heart surgery.
- 06/08/2020
|
Valve Delays Steam Game Festival: Summer Edition to June 16 | Digital Trends
- Valve has postponed the Steam Game Festival: Summer Edition, which will now run from June 16 to June 22, without a definite explanation on the event's delay.
- 06/06/2020
|
PlayStation Ordered By Federal Court In Australia To Settle $2.4 million Fine
- The Federal Court of Australia has ordered Sony Europe to pay a fine of $2.4 million for allegedly misleading customers.
- 06/06/2020
|
Stocks That Hit 52-Week Lows On Friday
|
Edited Transcript of EW earnings conference call or presentation 30-Jan-20 10:00pm GMT
- Q4 2019 Edwards Lifesciences Corp Earnings Call
- 06/05/2020
|
Thursday Morning Market Highlights
- Wall Street cuts gains Continue reading...
- 06/04/2020
|
Cramer Gives His Opinion On Microsoft, Roku And More
|
Oculus Quest Use On SteamVR Increases Following Link USB 2.0 Support
- The percentage of SteamVR players using Oculus Quest increased from 6% to 7.5% in May, according to Valve’s data. PC VR headset companies do not currently reveal sales figures, but Valve’s Steam- the most popular games store on PC- conducts a monthly ‘Hardware Survey’. This opt-in survey is offered to a random sample of Steam users…
- 06/03/2020
|
Healthcare Stock Paints Intriguing Technical Picture - Schaeffer's Investment Research
- Edwards Lifesciences (EW) is historically one of the top performing stocks in June, and just flashed a bullish technical signal
- 06/03/2020
|
Credit Suisse Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $88
|
Stocks That Hit 52-Week Lows On Monday
|
Morgan Stanley Maintains Overweight on Edwards Lifesciences, Lowers Price Target to $83
|
Edwards Lifesciences Start Trading Post 3:1 Stock Split Today
|
Hedge Funds Have Never Been This Bullish On Edwards Lifesciences Corporation (EW)
- In this article we will check out the progression of hedge fund sentiment towards Edwards Lifesciences Corporation (NYSE:EW) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]
- 05/29/2020
|
Wearing masks at home can limit spread: Study
- Close daily contact, such as eating meals at a table or watching TV together raised chances of others getting infected 18-fold while diarrhoea as a symptom in patient zero quadrupled infection risk, showed the review of behavioural and hygiene factors in the home environment.
- 05/28/2020
|
Shares of several healthcare companies are trading higher amid market strength. Strength potentially related to coronavirus efforts including testing, vaccine development and treatment measures from several names in the sector.
|
Chronic Venous Occlusions Treatment Market Size Global Industry, Revenue Growth Development, Business Opportunities, Future Trends, Top Key Players, Market Share and Global Analysis by Forecast to 2026
- May 28, 2020 (The Expresswire) --
Global "Chronic Venous Occlusions Treatment Market" 2020 Industry Research Report is an expert and inside and out...
- 05/28/2020
|
State of Tennessee, Treasury Department Buys Procter & Gamble Co, American Water Works Co ...
|
DOTA 2 down: Game coordinator error, Steam server status latest
- DOTA 2 down reports are on the rise with players of the hit Valve Software title getting a game coordinator error. Here is the Steam server status latest.
- 05/27/2020
|
Pantheon Investment Group, LLC Buys Mercury General Corp, Wells Fargo, Becton, Dickinson and ...
|
Frank Sands Adds 5 Stocks to Portfolio
- Guru releases portfolio for the 1st quarter Continue reading...
- 05/26/2020
|
Here's Why You Should Hold on to Edwards Lifesciences for Now
- Investors continue to be optimistic about Edwards Lifesciences (EW) on robust demand for products and a promising surgical structural heart business.
- 05/26/2020
|
Epic Games Store free games: this week's giveaways revealed
- Free for a week from May 21
- 05/26/2020
|
Outlook on the Worldwide Coronary Artery Bypass Grafts Industry to 2025 - Featuring Abbott, Boston Scientific & Edwards Lifesciences Among Others - ResearchAndMarkets.com
- The "Coronary Artery Bypass Grafts (CABG) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the...
- 05/26/2020
|
Intensive Care Patient Monitoring Products Market 2020 Global Leading Players, Industry Updates, Future Growth, Business Prospects, Forthcoming Developments and Future Investments by Forecast to 2026
- May 26, 2020 (Profound via COMTEX) --
Intensive Care Patient Monitoring Products Market 2020 Report offers a professional and in-depth study on the current...
- 05/26/2020
|
Outlook on the Worldwide Coronary Artery Bypass Grafts Industry to 2025 - Featuring Abbott, Boston Scientific & Edwards Lifesciences Among Others - ResearchAndMarkets.com
|
DOTA 2 Battle Pass 2020: The International Battle Pass price and Steam release news
- VALVE has confirmed that the DOTA 2 Battle Pass release date is coming soon and it looks like fans won't be waiting long to check out the latest International 2020 news.
- 05/25/2020
|
Edwards Lifesciences (EW) Down 1% Since Last Earnings Report: Can It Rebound?
- Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 05/23/2020
|
Best games 2020: the most essential games of this year so far
|
Edwards Lifesciences (EW) Down 1% Since Last Earnings Report: Can It Rebound?
|
Prosthetic Heart Valve Market Recorded Strong Growth in 2019; COVID-19 Pandemic Set to Drop Sales
- May 20, 2020 (MARKITWIRED via COMTEX) --
Latest report on global Prosthetic Heart Valve Market by FMI The market study suggests that the global market size...
- 05/20/2020
|
Explore Aperture Laboratories From Portal In VR Using Half-Life: Alyx Steam Workshop Mod
- Now that Half-Life: Alyx has Steam Workshop support, one modder has managed to bring an entire map from Portal 2 over into Half-Life: Alyx, allowing you to explore a small slice of Aperture Laboratories and pick up the Portal gun. Official Half-Life: Alyx modding support launched last week, and we’re already seeing some awesome content…
- 05/20/2020
|
Edwards Lifesciences Corporation -- Moody's announces completion of a periodic review of ratings of Edwards Lifesciences Corporation
- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Edwards Lifesciences Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
- 05/19/2020
|
Wedgewood Partners Cuts Fastenal, Alphabet, Visa
- Firm's largest sales of the 1st quarter Continue reading...
- 05/18/2020
|
Edwards Lifesciences shares are trading higher after the company's PASCAL transcatheter valve repair system received European approval for tricuspid repair.
|
How To Find, Download And Install Half-Life: Alyx Mods And Custom Maps
- Half-Life: Alyx released in March 2020, and ever since then there’s been a pretty active modding scene for the game. If you’re interested in how to find, download and install custom maps and mods for Half-Life: Alyx, via Steam Workshop or otherwise, we’ve got you covered. It’s possible to play Half-Life: Alyx maps and mods…
- 05/18/2020
|
Edwards PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair
- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received CE Mark for the Edwards PASCAL transcatheter valve repair system for the treatment of European patients with tricuspid regurgitation (TR).
- 05/18/2020
|
Edwards Lifesciences PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair
|
Valve Launches Half-Life: Alyx Workshop And Community Development Tools
- Valve released Steam Workshop support for Half-Life: Alyx alongside a beta release of community development tools. The moment a lot of Half-Life fans have been waiting for is here as the release formally opens up a new era in modding and community VR built around the incredible VR game from Valve which released just a…
- 05/15/2020
|
Williams Jones Wealth Management, LLC. Buys Steris PLC, Progressive Corp, Raytheon Technologies ...
|
Monetary Management Group Inc Buys iShares Russell –……… Growth, Edwards Lifesciences ...
|
Endologix, Inc. (ELGX) CEO John Onopchenko on Q1 2020 Results - Earnings Call Transcript
- Endologix, Inc. (NASDAQ:ELGX) Q1 2020 Results Conference Call May 11, 2020 04:30 PM ET Company Participants John Onopchenko - CEO Vaseem Mahboob - CFO Matthew T
- 05/13/2020
|
Stonehage Fleming Financial Services Holdings Ltd Buys Colgate-Palmolive Co, Edwards ...
|
Editorial: Facebook Should Aim To Replace Its 3 VR Headsets With 1
- Every day people all over the world consider purchasing their first virtual reality headset- more now than ever before. If you’ve got a PlayStation 4 sitting in front of an open living room and want to play VR games like No Man’s Sky, Skyrim VR, and Blood & Truth, what choice to make is fairly…
- 05/12/2020
|
United Kingdom Catheters Market, Forecast to 2025: Cardiovascular, Urological, Intravenous, Specialty, Neurovascular - ResearchAndMarkets.com
|
Is Edwards Lifesciences (EW) a Great Value Stock Right Now?
- Artisan Mid Cap Fund recently released its Q1 2020 Investor Letter, a copy of which you can download below. The fund posted a return of -11.55% for the quarter (investor class), outperforming their benchmark, the Russell Midcap Index which returned -27.07% in the same quarter. You should check out Artisan Mid Cap Fund’s top 5 […]
- 05/11/2020
|
Varma Mutual Pension Insurance Co Buys PowerShares QQQ Trust Ser –, iShares MSCI China ETF, ...
|
'This disease is deadly': Doctor's stark message to 'growing complacency'
- A Teesside doctor has shared his reservations about the Government relaxing the coronavirus regulations in his latest update
- 05/10/2020
|
Interventional Cardiology Devices Market Growth Segment by Industry Scope 2020 Booming Strategies of Top Companies, Global Countries Data Forecast to 2026
- May 10, 2020 (The Expresswire) --
"Final Report will add the analysis of the impact of COVID-19 on this industry" “Interventional Cardiology Devices...
- 05/10/2020
|
The Best Zombie Games of All Time | Digital Trends
- Zombies have been a media staple for decades, including in video games. From iconic franchises to surprising expansions, these are the best zombie games ever.
- 05/08/2020
|
Edwards Lifesciences Corp (EW) Chairman & CEO Michael A Mussallem Sold $5 million of Shares
|
Edwards Announces Updates From Annual Meeting
- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced updates from its annual meeting, in which Edwards' stockholders voted with the board's recommendations on all proxy proposals.
- 05/07/2020
|
Edwards Announces Updates From Annual Meeting
|
Stock Upgrades: Edwards Lifesciences Shows Rising Relative Strength
- On Wednesday, Edwards Lifesciences got a positive adjustment to its Relative Strength (RS) Rating, from 79 to 83. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. Edwards Lifesciences is working on a consolidation with a 247.74 entry.
- 05/06/2020
|
Stock Upgrades: Edwards Lifesciences Shows Rising Relative Strength
|
Edwards Lifesciences Announces May 2020 Investor Conference Schedule
- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to participate in two upcoming investor conferences.
- 05/05/2020
|
Shares of several healthcare companies are trading higher amid positive investor sentiment as some US states begin to reopen their economies and as oil prices gain for the session.
|
Edited Transcript of EW earnings conference call or presentation 23-Apr-20 9:00pm GMT
- Q1 2020 Edwards Lifesciences Corp Earnings Call
- 05/04/2020
|
Why Edwards Lifesciences Shares Rose 15.3% in April
- Edwards Lifesciences (NYSE: EW) shares rose 15.3% in April, according to data provided by S&P; Global Market Intelligence. Edwards Lifesciences, like many other companies across industries, fell in March as the coronavirus outbreak deepened in the U.S. With stay-at-home orders issued across the country, investors worried about the impact of the health crisis on businesses' earnings. Transcatheter aortic valve replacement (TAVR) with the Sapien 3 continued to show favorable results for these patients compared with surgery.
- 05/04/2020
|
Were Hedge Funds Right About Edwards Lifesciences Corporation (EW)?
- Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- 05/04/2020
|
Triodos Investment Management BV Buys International Paper Co, Edwards Lifesciences Corp, The ...
|
SteamVR Support for macOS Ends With No Official Explanation | Digital Trends
- Valve suddenly ended SteamVR support for MacOS, though there were signs leading to it. Support for Linux, however, will stay, as it is preferred by developers.
- 05/03/2020
|
The ADL Says Steam Is A Breeding Ground For Extremists
- ADL says racial extremism is normalized on Steam.
- 05/03/2020
|
2020 Assessment of the Chinese Catheters Industry - Growing Penetration Rate of PTCA Balloon and Central Venous Catheters
- The "China Catheters Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.
- 05/01/2020
|
Analysis of United States' Catheters Market, 2019-2025: Cardiovascular, Urological, Intravenous, Specialty, and Neurovascular Catheters - ResearchAndMarkets.com
- The "US Catheters Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.
- 05/01/2020
|
Commerzbank Aktiengesellschaft FI Sells 105,075 Shares of Edwards Lifesciences Corp (NYSE:EW)
- Commerzbank Aktiengesellschaft FI lowered its position in Edwards Lifesciences Corp (NYSE:EW) by 95.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,796 shares of the medical research company’s stock after selling 105,075 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings […]
- 05/01/2020
|
BBVA USA Bancshares Inc. Lowers Stake in Edwards Lifesciences Corp (NYSE:EW)
- BBVA USA Bancshares Inc. lowered its stake in shares of Edwards Lifesciences Corp (NYSE:EW) by 11.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,951 shares of the medical research company’s stock after selling 264 shares during the period. […]
- 05/01/2020
|
Shares of several healthcare companies are trading lower as markets dip following recent strength. Markets have sold off as investors weigh recent earnings and amid concerns of renewed US-China trade frictions.
|
Valve indefinitely delays Dota 2’s The International 2020
- It’s the latest esports event affected by COVID-19.
- 04/30/2020
|
The Zacks Analyst Blog Highlights: Cisco, Abbott Laboratories, NextEra Energy, Gilead Sciences and Edwards Lifesciences
- The Zacks Analyst Blog Highlights: Cisco, Abbott Laboratories, NextEra Energy, Gilead Sciences and Edwards Lifesciences
- 04/30/2020
|
The Zacks Analyst Blog Highlights: Cisco, Abbott Laboratories, NextEra Energy, Gilead Sciences and Edwards Lifesciences
- The Zacks Analyst Blog Highlights: Cisco, Abbott Laboratories, NextEra Energy, Gilead Sciences and Edwards Lifesciences
- 04/30/2020
|
Why Wedgewood Partners is Bullish on Edwards Lifesciences (EW) Stock?
- Wedgewood Partners, a St. Louis, Missouri-based investment management firm, released its Q1 2020 Investor letter – a copy of which is available for download here. Wedgewood Partners returned -16.30% for the first quarter. Meanwhile, the benchmark Russell 1000 Growth Index and the S&P 500 Index lost 14.10%
- 04/30/2020
|
